Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,A1BG,Alpha-1B-glycoprotein,20182,187,0.95 [0.42-2.15],0.9002813355605335
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AAMDC,Mth938 domain-containing protein,19644,185,1.09 [0.84-1.43],0.5080267077965306
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AARSD1,Alanyl-tRNA editing protein Aarsd1,23056,203,1.17 [0.94-1.45],0.172588567906316
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ABCA2,ATP-binding cassette sub-family A member 2,19464,178,0.74 [0.48-1.12],0.1558331922349848
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ABHD14B,Protein ABHD14B,22899,199,1.07 [0.86-1.33],0.5572395273079653
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ABL1,Tyrosine-protein kinase ABL1,23056,203,0.96 [0.80-1.17],0.709488058182224
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ABO,Histo-blood group ABO system transferase,20164,189,1.09 [0.99-1.20],0.0655882220401531
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ABRAXAS2,BRISC complex subunit Abraxas 2,19464,178,1.01 [0.81-1.26],0.948389385882336
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",22648,194,0.99 [0.84-1.16],0.9152098057599652
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",19789,185,1.06 [0.87-1.28],0.5683777480327556
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",20148,187,0.98 [0.84-1.15],0.8345294469448457
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACAN,Aggrecan core protein,22934,200,0.88 [0.56-1.39],0.5804839754854642
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACE,Angiotensin-converting enzyme,20164,189,0.61 [0.37-1.00],0.047744627714249
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACE2,Angiotensin-converting enzyme 2,22729,202,1.10 [0.87-1.39],0.4177783601007115
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACHE,Acetylcholinesterase,19723,185,0.68 [0.44-1.07],0.0942570375279162
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACOT13,Acyl-coenzyme A thioesterase 13,20054,186,0.99 [0.88-1.12],0.886847238869295
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,23167,200,0.82 [0.63-1.06],0.1279831987321799
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACP1,Low molecular weight phosphotyrosine protein phosphatase,19556,179,1.04 [0.76-1.43],0.7868507093056479
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACP5,Tartrate-resistant acid phosphatase type 5,23289,207,1.12 [0.76-1.64],0.5651232986382793
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACP6,Lysophosphatidic acid phosphatase type 6,23313,204,1.09 [0.90-1.32],0.360229025095684
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACRBP,Acrosin-binding protein,20057,185,0.85 [0.58-1.23],0.3881947369691071
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACRV1,Acrosomal protein SP-10,19556,179,0.94 [0.79-1.12],0.4945060059156427
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACSL1,Long-chain-fatty-acid--CoA ligase 1,19464,178,1.01 [0.69-1.47],0.9591976580991332
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACTA2,"Actin, aortic smooth muscle",22729,202,1.00 [0.75-1.34],0.9750048493205368
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACTN2,Alpha-actinin-2,19464,178,1.39 [1.12-1.72],0.0023012760382277
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACTN4,Alpha-actinin-4,22723,200,1.06 [0.73-1.54],0.7676009974554427
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACVRL1,Serine/threonine-protein kinase receptor R3,22925,199,1.09 [0.66-1.78],0.7431895536206764
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACY1,Aminoacylase-1,23167,200,1.01 [0.82-1.25],0.9001288574596159
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,19464,178,1.08 [0.83-1.40],0.5776928486808035
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ACYP1,Acylphosphatase-1,19650,185,0.99 [0.80-1.23],0.9265262704594788
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADA,Adenosine deaminase,23393,205,0.85 [0.59-1.21],0.3645319441326322
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADA2,Adenosine deaminase 2,23053,204,1.07 [0.80-1.42],0.6427869267424047
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,19556,179,1.15 [0.75-1.78],0.5173568466519411
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,22729,202,1.01 [0.67-1.51],0.9628133610195676
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,22961,199,1.00 [0.71-1.43],0.9795103273876314
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,23393,205,1.20 [0.84-1.73],0.3191987168907906
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,23309,205,0.88 [0.58-1.34],0.5557268706908516
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,20054,186,1.12 [0.70-1.78],0.6325617425554338
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,19556,179,0.59 [0.36-0.97],0.0375951702416169
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,23453,207,0.85 [0.51-1.43],0.546302952899294
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,23056,203,1.01 [0.75-1.36],0.9348385978039054
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,22729,202,1.28 [0.93-1.77],0.124608583613456
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,19556,179,1.40 [0.95-2.08],0.0905285892902122
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,23260,204,0.70 [0.53-0.92],0.0098334371674587
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADAMTSL2,ADAMTS-like protein 2,20163,187,1.03 [0.68-1.58],0.8742438090087143
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADAMTSL4,ADAMTS-like protein 4,19644,185,0.62 [0.34-1.13],0.1183097122216141
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADAMTSL5,ADAMTS-like protein 5,20148,187,0.80 [0.56-1.15],0.2295441840178678
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,22648,194,1.07 [0.77-1.49],0.6893776978034123
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADD1,Alpha-adducin,19723,185,1.04 [0.85-1.27],0.7196112440099178
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADGRB3,Adhesion G protein-coupled receptor B3,22925,199,1.24 [0.86-1.79],0.2546681084937512
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADGRD1,Adhesion G-protein coupled receptor D1,19723,185,0.88 [0.60-1.28],0.5041322747845058
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADGRE1,Adhesion G protein-coupled receptor E1,20054,186,0.89 [0.68-1.15],0.3564770287921061
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADGRE2,Adhesion G protein-coupled receptor E2,23265,203,1.07 [0.69-1.66],0.7608355207426077
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADGRE5,Adhesion G protein-coupled receptor E5,23357,206,0.85 [0.57-1.28],0.4460459896875299
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADGRF5,Adhesion G protein-coupled receptor F5,20148,187,0.86 [0.52-1.42],0.5639167875884078
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADGRG1,Adhesion G-protein coupled receptor G1,23056,203,1.02 [0.87-1.18],0.8453462084456465
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADGRG2,Adhesion G-protein coupled receptor G2,23167,200,0.82 [0.51-1.31],0.4060715685002005
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADGRV1,Adhesion G-protein coupled receptor V1,19490,181,0.99 [0.81-1.22],0.9302748660498862
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADH1B,All-trans-retinol dehydrogenase,19723,185,1.10 [0.91-1.33],0.3369265775905412
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,22729,202,1.07 [0.92-1.25],0.3936825067338469
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADIPOQ,Adiponectin,20182,187,1.02 [0.84-1.26],0.8181480159626721
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADM,Pro-adrenomedullin,23353,206,1.09 [0.68-1.75],0.7257576959230869
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ADRA2A,Alpha-2A adrenergic receptor,19464,178,0.92 [0.74-1.14],0.4406740587303371
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AFAP1,Actin filament-associated protein 1,19723,185,0.97 [0.82-1.16],0.7669644741449099
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AFM,Afamin,20182,187,0.69 [0.34-1.38],0.2924537504394895
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AFP,Alpha-fetoprotein,22882,198,1.05 [0.87-1.26],0.6414379731738662
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AGBL2,Cytosolic carboxypeptidase 2,19490,181,0.86 [0.75-0.98],0.0281055207361516
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AGER,Advanced glycosylation end product-specific receptor,23121,203,1.14 [0.85-1.54],0.384701731754935
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AGR2,Anterior gradient protein 2 homolog,22446,199,0.99 [0.87-1.12],0.8252980845368855
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AGR3,Anterior gradient protein 3,22600,194,0.84 [0.67-1.05],0.1252329951817737
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AGRN,Agrin,23265,203,1.17 [0.82-1.65],0.3840843034630188
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AGRP,Agouti-related protein,23393,205,1.27 [1.00-1.62],0.0543770851168216
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AGT,Angiotensinogen,20164,189,0.82 [0.47-1.44],0.4889059383037099
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AGXT,Serine--pyruvate aminotransferase,23167,200,1.02 [0.86-1.21],0.8036723768382237
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AHCY,Adenosylhomocysteinase,23167,200,0.96 [0.80-1.15],0.6555744416208746
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AHNAK,Neuroblast differentiation-associated protein AHNAK,19644,185,0.60 [0.37-0.98],0.0405991740724275
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AHNAK2,Protein AHNAK2,19644,185,1.08 [0.68-1.73],0.7376147293081954
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,20057,185,0.98 [0.79-1.22],0.8739727357978122
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AHSG,Alpha-2-HS-glycoprotein,20164,189,0.68 [0.43-1.08],0.1014249527031135
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AHSP,Alpha-hemoglobin-stabilizing protein,23149,202,1.05 [0.90-1.21],0.5562300644240689
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AIDA,"Axin interactor, dorsalization-associated protein",19609,185,1.01 [0.85-1.18],0.9511927117953192
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AIF1,Allograft inflammatory factor 1,22648,194,0.95 [0.74-1.21],0.6664833571109121
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AIF1L,Allograft inflammatory factor 1-like,19644,185,1.18 [0.94-1.47],0.1531204555267001
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",23023,202,1.01 [0.90-1.14],0.8849697781650844
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AK1,Adenylate kinase isoenzyme 1,23167,200,0.99 [0.82-1.21],0.9458127588723846
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AK2,"Adenylate kinase 2, mitochondrial",20115,186,0.95 [0.83-1.08],0.4134636791805731
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AKAP12,A-kinase anchor protein 12,19723,185,0.57 [0.28-1.18],0.1296669461600826
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AKR1B1,Aldo-keto reductase family 1 member B1,22648,194,1.15 [0.97-1.36],0.1108725671548831
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AKR1B10,Aldo-keto reductase family 1 member B10,19609,185,0.93 [0.73-1.18],0.5420919744079178
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AKR1C4,Aldo-keto reductase family 1 member C4,22729,202,1.07 [0.86-1.33],0.5585717406033247
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AKR7L,Aflatoxin B1 aldehyde reductase member 4,19556,179,0.95 [0.76-1.18],0.6433426538980636
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AKT1S1,Proline-rich AKT1 substrate 1,22634,201,1.09 [0.90-1.32],0.3843817659984513
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AKT2,RAC-beta serine/threonine-protein kinase,20106,189,1.00 [0.89-1.11],0.9424105767196362
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AKT3,RAC-gamma serine/threonine-protein kinase,22553,194,1.07 [0.86-1.34],0.5445365353381726
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ALCAM,CD166 antigen,23453,207,0.85 [0.45-1.62],0.6309119288142542
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ALDH1A1,Retinal dehydrogenase 1,23193,202,1.09 [0.87-1.37],0.4489410118696282
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ALDH2,"Aldehyde dehydrogenase, mitochondrial",20057,185,0.93 [0.69-1.24],0.6194857604442372
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",23064,204,1.19 [1.02-1.40],0.0295786394037554
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",20106,189,0.97 [0.72-1.31],0.8410173537168737
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ALMS1,Alstrom syndrome protein 1,19789,185,0.81 [0.57-1.15],0.241571684191677
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ALPI,Intestinal-type alkaline phosphatase,19556,179,0.93 [0.82-1.04],0.2116115301858246
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ALPP,"Alkaline phosphatase, placental type",23056,203,0.96 [0.84-1.08],0.4899140126998065
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AMBN,Ameloblastin,22723,200,1.17 [0.76-1.79],0.4839441521997781
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AMBP,Protein AMBP,23316,205,1.04 [0.57-1.90],0.9043737842633304
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,20163,187,0.49 [0.30-0.81],0.0058443830116116
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AMFR,E3 ubiquitin-protein ligase AMFR,22634,201,0.94 [0.77-1.16],0.5651452681653839
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AMIGO1,Amphoterin-induced protein 1,19609,185,0.89 [0.66-1.21],0.4663719381825761
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AMIGO2,Amphoterin-induced protein 2,23056,203,1.03 [0.60-1.76],0.9134407392324266
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AMN,Protein amnionless,22723,200,0.95 [0.72-1.24],0.6830585640525366
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AMOT,Angiomotin,19723,185,1.02 [0.70-1.47],0.9350258154964624
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AMOTL2,Angiomotin-like protein 2,19968,185,1.15 [0.88-1.50],0.2986767363672269
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AMPD3,AMP deaminase 3,20115,186,1.11 [0.92-1.35],0.2794183684695085
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,18876,169,0.97 [0.72-1.32],0.8663276506022164
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AMY2A,Pancreatic alpha-amylase,22252,199,1.00 [0.77-1.30],0.984589159258549
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AMY2B,Alpha-amylase 2B,21587,191,1.00 [0.77-1.30],0.9978152599460518
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANG,Angiogenin,23136,204,1.09 [0.76-1.58],0.6354974617602054
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANGPT1,Angiopoietin-1,23065,203,1.03 [0.89-1.19],0.7128629634460346
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANGPT2,Angiopoietin-2,23353,206,1.17 [0.84-1.61],0.358138833415166
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANGPTL1,Angiopoietin-related protein 1,22841,198,1.00 [0.64-1.56],0.999632400810532
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANGPTL2,Angiopoietin-related protein 2,23191,202,0.91 [0.67-1.25],0.5604891592630089
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANGPTL3,Angiopoietin-related protein 3,23204,204,0.93 [0.65-1.31],0.6639743662826376
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANGPTL4,Angiopoietin-related protein 4,23224,203,0.99 [0.75-1.31],0.9532474041651896
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANGPTL7,Angiopoietin-related protein 7,23353,206,1.21 [0.86-1.71],0.2840860865436992
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANK2,Ankyrin-2,19464,178,1.08 [0.89-1.29],0.443792494707926
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,19556,179,0.96 [0.80-1.15],0.6417533692079559
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANKRA2,Ankyrin repeat family A protein 2,19420,180,0.96 [0.74-1.24],0.7470855641936551
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANKRD54,Ankyrin repeat domain-containing protein 54,22648,194,0.92 [0.73-1.16],0.5029109086988774
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,19644,185,0.97 [0.67-1.39],0.8566453188526786
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANPEP,Aminopeptidase N,23258,204,1.25 [0.81-1.93],0.3201021867471389
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANXA1,Annexin A1,19613,185,1.05 [0.76-1.44],0.7590472101547232
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANXA10,Annexin A10,22634,201,1.03 [0.89-1.19],0.6839139163064312
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANXA11,Annexin A11,23080,204,0.99 [0.82-1.19],0.9206302719346876
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANXA2,Annexin A2,19334,184,0.91 [0.74-1.12],0.3853436072501712
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANXA3,Annexin A3,23309,205,1.06 [0.89-1.26],0.5055365103183627
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANXA4,Annexin A4,23069,199,0.96 [0.80-1.14],0.6290421945172598
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ANXA5,Annexin A5,22563,197,1.05 [0.69-1.60],0.8111602043954593
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AOC1,Amiloride-sensitive amine oxidase [copper-containing],22723,200,1.12 [0.92-1.36],0.2403094521667187
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AOC3,Membrane primary amine oxidase,23291,204,1.14 [0.75-1.74],0.5287904413919411
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AP1G2,AP-1 complex subunit gamma-like 2,20057,185,0.94 [0.79-1.13],0.5147346373111261
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AP2B1,AP-2 complex subunit beta,19609,185,0.93 [0.68-1.25],0.6177526087775655
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AP3B1,AP-3 complex subunit beta-1,20054,186,0.99 [0.83-1.19],0.9405952272527816
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AP3S2,AP-3 complex subunit sigma-2,20115,186,0.97 [0.72-1.31],0.86283489763995
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,23056,203,0.94 [0.71-1.25],0.6813750544143918
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APCS,Serum amyloid P-component,19986,187,0.84 [0.56-1.27],0.4128249097287773
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,23268,204,0.99 [0.80-1.22],0.9166578481217372
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APLP1,Amyloid-like protein 1,23167,200,0.89 [0.69-1.13],0.3338716929964431
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APOA1,Apolipoprotein A-I,20182,187,0.65 [0.37-1.14],0.1351763596144862
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APOA2,Apolipoprotein A-II,20164,189,0.86 [0.64-1.14],0.2906947115243131
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APOA4,Apolipoprotein A-IV,20182,187,0.50 [0.32-0.78],0.0021471992777724
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APOB,Apolipoprotein B-100,20164,189,0.74 [0.41-1.34],0.3176236445420261
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APOBR,Apolipoprotein B receptor,19644,185,0.92 [0.66-1.28],0.6285429121025868
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APOC1,Apolipoprotein C-I,20148,187,0.97 [0.66-1.43],0.894272615874468
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APOD,Apolipoprotein D,19316,172,1.00 [0.70-1.43],0.9950340363148762
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APOE,Apolipoprotein E,20182,187,1.04 [0.87-1.26],0.6601668060224981
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APOF,Apolipoprotein F,20164,189,0.84 [0.47-1.51],0.5656175125334236
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APOH,Beta-2-glycoprotein 1,23193,202,0.90 [0.64-1.28],0.5587065791759591
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APOL1,Apolipoprotein L1,20164,189,1.00 [0.78-1.28],0.989022315818084
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APOM,Apolipoprotein M,23243,204,1.18 [0.76-1.84],0.4653770858087922
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APP,Amyloid-beta precursor protein,23166,201,0.98 [0.81-1.18],0.8373417097804008
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APPL2,DCC-interacting protein 13-beta,19723,185,0.99 [0.88-1.13],0.937852776035393
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,APRT,Adenine phosphoribosyltransferase,22911,199,1.14 [0.87-1.49],0.3394860404676855
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARAF,Serine/threonine-protein kinase A-Raf,19789,185,0.89 [0.71-1.11],0.2902956695311632
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AREG,Amphiregulin,23056,203,1.38 [1.05-1.82],0.0206996873211432
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARF6,ADP-ribosylation factor 6,20054,186,1.01 [0.88-1.15],0.8875390661316798
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARFIP1,Arfaptin-1,20106,189,0.89 [0.72-1.09],0.2555543933401752
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARG1,Arginase-1,23003,204,1.04 [0.82-1.32],0.7467704984380128
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARG2,"Arginase-2, mitochondrial",20057,185,1.04 [0.76-1.43],0.7979495541201711
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARHGAP1,Rho GTPase-activating protein 1,22648,194,1.12 [0.85-1.49],0.4107476934135268
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARHGAP25,Rho GTPase-activating protein 25,22648,194,1.08 [0.88-1.33],0.4773270310224287
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARHGAP30,Rho GTPase-activating protein 30,19789,185,0.77 [0.50-1.17],0.219853694496649
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARHGAP45,Rho GTPase-activating protein 45,19723,185,0.97 [0.81-1.15],0.6933702985457303
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARHGAP5,Rho GTPase-activating protein 5,19420,180,0.91 [0.75-1.11],0.3740865283903761
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARHGEF1,Rho guanine nucleotide exchange factor 1,20115,186,0.96 [0.82-1.12],0.6125647249010191
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARHGEF10,Rho guanine nucleotide exchange factor 10,20106,189,0.97 [0.83-1.12],0.6700151617733519
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARHGEF12,Rho guanine nucleotide exchange factor 12,23111,204,1.02 [0.90-1.15],0.7741023249756162
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARHGEF5,Rho guanine nucleotide exchange factor 5,19490,181,0.96 [0.78-1.17],0.6573644307185712
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARID3A,AT-rich interactive domain-containing protein 3A,19490,181,0.90 [0.62-1.31],0.5862352454430263
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARID4B,AT-rich interactive domain-containing protein 4B,22634,201,0.94 [0.69-1.27],0.6752239691452118
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARL13B,ADP-ribosylation factor-like protein 13B,19464,178,1.04 [0.84-1.27],0.7368522894290574
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,19464,178,0.89 [0.62-1.28],0.5307338586100743
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARMCX2,Armadillo repeat-containing X-linked protein 2,19490,181,0.79 [0.60-1.05],0.1040022595994303
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARNT,Aryl hydrocarbon receptor nuclear translocator,22723,200,1.06 [0.76-1.48],0.736044462185746
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,19464,178,1.10 [0.85-1.41],0.4756568718064132
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARSA,Arylsulfatase A,23193,202,1.02 [0.77-1.35],0.8889456466839375
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARSB,Arylsulfatase B,23056,203,0.99 [0.79-1.24],0.941064763663088
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ART3,Ecto-ADP-ribosyltransferase 3,23291,204,0.57 [0.40-0.81],0.0014698569503603
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ART5,Ecto-ADP-ribosyltransferase 5,19490,181,0.74 [0.55-0.99],0.0435228516372933
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ARTN,Artemin,22723,200,1.17 [0.92-1.49],0.2046684101340444
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ASAH1,Acid ceramidase,19954,186,0.71 [0.51-0.99],0.0443472467489684
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ASAH2,Neutral ceramidase,22961,199,0.95 [0.76-1.19],0.6605112556737003
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ASGR1,Asialoglycoprotein receptor 1,22961,199,0.94 [0.61-1.44],0.7693476655311308
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ASGR2,Asialoglycoprotein receptor 2,20164,189,0.72 [0.43-1.23],0.229278285863076
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ASPN,Asporin,20148,187,0.88 [0.53-1.48],0.6389110787478309
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ASPSCR1,Tether containing UBX domain for GLUT4,20106,189,1.02 [0.82-1.25],0.8829270374162519
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ASRGL1,Isoaspartyl peptidase/L-asparaginase,19644,185,1.01 [0.88-1.16],0.921784040018874
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ASS1,Argininosuccinate synthase,19464,178,1.06 [0.88-1.28],0.5410218889730651
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATF2,Cyclic AMP-dependent transcription factor ATF-2,22634,201,0.91 [0.74-1.12],0.3817909565573247
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATF4,Cyclic AMP-dependent transcription factor ATF-4,19420,180,0.70 [0.44-1.11],0.1310274615955384
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATG16L1,Autophagy-related protein 16-1,20054,186,1.00 [0.84-1.18],0.9820990111489416
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATG4A,Cysteine protease ATG4A,22648,194,1.06 [0.86-1.31],0.578212656098553
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATOX1,Copper transport protein ATOX1,23260,204,0.97 [0.81-1.16],0.7483648383236821
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,19464,178,1.04 [0.77-1.39],0.8129731495459638
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,19464,178,0.93 [0.59-1.46],0.7383579850832018
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,19464,178,0.95 [0.64-1.39],0.7839553845900686
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATP1B4,Protein ATP1B4,19420,180,0.92 [0.65-1.31],0.6330582436412143
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATP2B4,Plasma membrane calcium-transporting ATPase 4,19464,178,1.07 [0.86-1.33],0.5612542356123749
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATP5F1D,"ATP synthase subunit delta, mitochondrial",19464,178,0.78 [0.56-1.10],0.1545544701280273
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATP5IF1,"ATPase inhibitor, mitochondrial",23265,203,0.97 [0.86-1.08],0.5645985814818967
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATP5PO,"ATP synthase subunit O, mitochondrial",22634,201,1.17 [0.88-1.55],0.2729932675932216
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATP6AP2,Renin receptor,22648,194,0.95 [0.68-1.31],0.7407003741082834
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATP6V1D,V-type proton ATPase subunit D,23056,203,0.82 [0.49-1.36],0.4349608444073475
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATP6V1F,V-type proton ATPase subunit F,22599,201,0.93 [0.77-1.13],0.4648012894063494
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATP6V1G1,V-type proton ATPase subunit G 1,19644,185,1.08 [0.89-1.31],0.4598715973100101
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATP6V1G2,V-type proton ATPase subunit G 2,19464,178,0.92 [0.79-1.08],0.2971793074735285
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATRAID,All-trans retinoic acid-induced differentiation factor,20054,186,0.89 [0.54-1.47],0.6479314247011279
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATRN,"Attractin, Isoform 2",20182,187,0.81 [0.35-1.87],0.6145268767615546
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATXN10,Ataxin-10,22634,201,0.97 [0.82-1.16],0.7378169051450714
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATXN2,Ataxin-2,19490,181,0.94 [0.82-1.08],0.381448047732304
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATXN2L,Ataxin-2-like protein,20106,189,1.23 [0.94-1.59],0.1246985324155308
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ATXN3,Ataxin-3,20115,186,1.04 [0.83-1.30],0.7345736596256905
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AXIN1,Axin-1,23111,204,1.02 [0.90-1.17],0.7125103723901656
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AXL,Tyrosine-protein kinase receptor UFO,23291,204,0.98 [0.62-1.55],0.9392393856419587
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AZI2,5-azacytidine-induced protein 2,20106,189,1.04 [0.81-1.33],0.7833835917845741
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,AZU1,Azurocidin,22462,196,1.12 [0.97-1.30],0.1248251718978439
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,B2M,Beta-2-microglobulin,20182,187,0.99 [0.63-1.55],0.9581112261995716
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,19464,178,1.22 [0.63-2.38],0.549153733621907
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",19644,185,1.30 [0.88-1.91],0.1922784927068163
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,B4GALT1,"Beta-1,4-galactosyltransferase 1",23265,203,1.18 [0.76-1.84],0.4548819878451162
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,B4GAT1,"Beta-1,4-glucuronyltransferase 1",23193,202,1.07 [0.64-1.79],0.8014687462463673
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BABAM1,BRISC and BRCA1-A complex member 1,19556,179,0.86 [0.51-1.45],0.575609958787608
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BACH1,Transcription regulator protein BACH1,23111,204,1.03 [0.87-1.22],0.7196720305393435
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BAG3,BAG family molecular chaperone regulator 3,22925,199,0.96 [0.71-1.31],0.8164474891787012
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BAG4,BAG family molecular chaperone regulator 4,19556,179,0.86 [0.63-1.17],0.3286043837189211
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BAG6,Large proline-rich protein BAG6,22729,202,1.07 [0.76-1.52],0.6900354650057942
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,22648,194,0.96 [0.78-1.18],0.6867993339904905
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BAMBI,BMP and activin membrane-bound inhibitor homolog,22648,194,0.94 [0.61-1.46],0.7938643474960636
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BANK1,B-cell scaffold protein with ankyrin repeats,23111,204,1.01 [0.89-1.13],0.9257535657567472
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BAP18,Chromatin complexes subunit BAP18,20115,186,0.98 [0.80-1.20],0.8490903527442918
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BATF,Basic leucine zipper transcriptional factor ATF-like,19609,185,0.96 [0.81-1.15],0.6761739338942258
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BAX,Apoptosis regulator BAX,22600,200,1.00 [0.87-1.16],0.970826627999022
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BCAM,Basal cell adhesion molecule,23193,202,1.59 [0.98-2.57],0.0610660070935929
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BCAN,Brevican core protein,22961,199,0.82 [0.57-1.18],0.29009887649432
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",20148,187,0.57 [0.35-0.94],0.0285585145247866
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",19490,181,1.05 [0.81-1.35],0.7226178909072819
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BCHE,Cholinesterase,19796,185,0.92 [0.55-1.54],0.7601068674543096
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BCL2,Apoptosis regulator Bcl-2,20054,186,0.92 [0.70-1.21],0.5631584398282599
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BCL2L1,Bcl-2-like protein 1,20115,186,0.97 [0.84-1.11],0.624447089929218
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",23111,204,1.08 [0.80-1.45],0.6179150776286448
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BCL2L15,Bcl-2-like protein 15,19556,179,0.87 [0.67-1.13],0.3029081637053347
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BCL7A,B-cell CLL/lymphoma 7 protein family member A,19420,180,1.15 [0.94-1.41],0.1823816159911958
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BCL7B,B-cell CLL/lymphoma 7 protein family member B,20057,185,0.91 [0.66-1.26],0.5857967520914721
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BCR,Breakpoint cluster region protein,23111,204,1.02 [0.89-1.17],0.7749204694122446
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BDNF,Brain-derived neurotrophic factor,20163,187,0.94 [0.80-1.11],0.4590429469619846
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BECN1,Beclin-1,19644,185,1.08 [0.86-1.37],0.4983523012820328
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BEX3,Protein BEX3,19420,180,0.65 [0.45-0.95],0.0257718535003168
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BGLAP,Osteocalcin,20163,187,0.98 [0.84-1.15],0.8154245338558841
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BGN,Biglycan,22604,193,0.90 [0.81-1.01],0.0705288942585156
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BHLHE40,Class E basic helix-loop-helix protein 40,19490,181,1.07 [0.88-1.30],0.4787584823372732
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,19464,178,0.92 [0.52-1.61],0.7662907565172608
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BID,BH3-interacting domain death agonist,23111,204,0.91 [0.76-1.10],0.348227961358197
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BIN2,Bridging integrator 2,23193,202,0.95 [0.83-1.09],0.4725797212188413
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BIRC2,Baculoviral IAP repeat-containing protein 2,22648,194,1.04 [0.85-1.27],0.7169874961233207
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BLMH,Bleomycin hydrolase,23453,207,0.72 [0.50-1.06],0.094966698503278
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BLNK,B-cell linker protein,19556,179,0.80 [0.53-1.19],0.2632583084387954
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,19490,181,1.04 [0.87-1.25],0.6603964787071449
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,20115,186,0.95 [0.66-1.36],0.7792267848203899
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BLVRB,Flavin reductase,23193,202,1.10 [0.92-1.31],0.3050320667520401
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BMP10,Bone morphogenetic protein 10,19723,185,0.96 [0.58-1.57],0.8599462112840176
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BMP4,Bone morphogenetic protein 4,22925,199,1.02 [0.78-1.35],0.8635564762256904
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BMP6,Bone morphogenetic protein 6,22700,202,0.92 [0.67-1.25],0.5819605247347053
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BMPER,BMP-binding endothelial regulator protein,19723,185,0.82 [0.44-1.54],0.5409966201608882
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,20148,187,0.80 [0.52-1.23],0.3081237785031626
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,19556,179,0.90 [0.64-1.27],0.5620856146416326
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BOC,Brother of CDO,22729,202,1.19 [0.70-2.04],0.5238701488453856
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BOLA1,BolA-like protein 1,19490,181,1.09 [0.85-1.41],0.4900929017759042
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BOLA2_BOLA2B,BolA-like protein 2,19644,185,1.04 [0.80-1.35],0.7551669320977328
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BPIFA2,BPI fold-containing family A member 2,18959,174,0.95 [0.83-1.09],0.4654877164017155
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BPIFB1,BPI fold-containing family B member 1,23108,206,0.85 [0.70-1.04],0.1167767227234539
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BPIFB2,BPI fold-containing family B member 2,20103,187,1.14 [0.93-1.40],0.196025659496965
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BRAP,BRCA1-associated protein,19876,185,1.00 [0.88-1.14],0.989100064206096
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BRD1,Bromodomain-containing protein 1,19789,185,1.13 [0.72-1.75],0.5985897093353045
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BRD2,Bromodomain-containing protein 2,19490,181,0.76 [0.48-1.21],0.2435848746601657
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BRD3,Bromodomain-containing protein 3,19464,178,0.91 [0.66-1.25],0.5598012630271223
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BRDT,Bromodomain testis-specific protein,19464,178,1.02 [0.69-1.51],0.9280228971909552
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BRK1,Protein BRICK1,22634,201,0.88 [0.66-1.17],0.3811582464520661
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BRME1,Break repair meiotic recombinase recruitment factor 1,19490,181,1.20 [0.90-1.60],0.2095177863214061
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BRSK2,Serine/threonine-protein kinase BRSK2,20106,189,0.76 [0.52-1.13],0.1814784393887917
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BSG,Basigin,23359,205,0.70 [0.41-1.18],0.1794262340108425
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BSND,Barttin,19420,180,0.84 [0.53-1.33],0.4633364241628243
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,23351,205,0.98 [0.76-1.27],0.8858051801070692
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BST2,Bone marrow stromal antigen 2,23351,205,1.00 [0.78-1.28],0.99700232312036
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BTC,Probetacellulin,22648,194,1.12 [0.95-1.31],0.1810302600469531
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BTD,Biotinidase,20182,187,1.15 [0.58-2.29],0.6892073142747731
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BTLA,B- and T-lymphocyte attenuator,19420,180,0.94 [0.79-1.13],0.5324656598963198
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BTN1A1,Butyrophilin subfamily 1 member A1,20016,184,1.00 [0.69-1.43],0.9868200641541576
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BTN2A1,Butyrophilin subfamily 2 member A1,23265,203,0.92 [0.58-1.46],0.7219189947448521
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BTN3A2,Butyrophilin subfamily 3 member A2,23111,204,1.16 [0.85-1.59],0.3604167520338219
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,BTNL10,Butyrophilin-like protein 10,19420,180,0.93 [0.64-1.34],0.6827023803790426
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C19orf12,Protein C19orf12,22634,201,1.05 [0.86-1.27],0.6387110712337483
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C1GALT1C1,C1GALT1-specific chaperone 1,19464,178,1.12 [0.73-1.72],0.5900946049577496
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C1QA,Complement C1q subcomponent subunit A,23286,205,1.11 [0.64-1.95],0.7060279175300771
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",20106,189,1.06 [0.89-1.26],0.5145086908845297
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C1QL2,Complement C1q-like protein 2,19556,179,0.61 [0.43-0.88],0.0074939444372315
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,23291,204,1.08 [0.81-1.44],0.6159985632762475
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,19723,185,0.90 [0.62-1.31],0.579353308208762
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,20106,189,0.81 [0.51-1.29],0.3722360125499057
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,19686,184,0.83 [0.63-1.10],0.1912257510831662
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C1R,Complement C1r subcomponent,20182,187,0.61 [0.26-1.43],0.2550746559746352
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C1RL,Complement C1r subcomponent-like protein,20143,187,0.82 [0.41-1.65],0.5751737216250562
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C1S,Complement C1s subcomponent,20182,187,0.74 [0.38-1.44],0.3789340221298205
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C2,Complement C2,23243,204,1.08 [0.62-1.89],0.7734629339230656
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C2CD2L,Phospholipid transfer protein C2CD2L,22599,201,0.62 [0.45-0.85],0.0032649738273171
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C2orf69,UPF0565 protein C2orf69,19609,185,1.07 [0.86-1.33],0.5592282550178591
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C3,Complement C3,19129,178,0.87 [0.62-1.23],0.4339403087852054
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C4BPB,C4b-binding protein beta chain,23260,204,1.02 [0.75-1.40],0.8822500277886124
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C5,Complement C5,20182,187,0.40 [0.15-1.08],0.0696246330034832
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C7,Complement component C7,19682,177,1.34 [0.84-2.11],0.2164224823272948
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C7orf50,Uncharacterized protein C7orf50,20115,186,0.63 [0.30-1.34],0.2291494312802732
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C8B,Complement component C8 beta chain,20182,187,1.17 [0.74-1.87],0.4955428608592529
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C9,Complement component C9,20164,189,0.99 [0.76-1.29],0.9602742924156176
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,C9orf40,Uncharacterized protein C9orf40,20054,186,1.03 [0.87-1.22],0.75259873995275
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CA1,Carbonic anhydrase 1,22682,198,1.05 [0.85-1.29],0.6778920021672739
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CA11,Carbonic anhydrase-related protein 11,22648,194,0.94 [0.62-1.42],0.7694018360222786
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CA12,Carbonic anhydrase 12,23056,203,1.09 [0.74-1.60],0.6541816157110338
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CA13,Carbonic anhydrase 13,22927,193,0.97 [0.85-1.09],0.5681061895895296
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CA14,Carbonic anhydrase 14,23353,206,0.64 [0.45-0.90],0.0102425211805611
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CA2,Carbonic anhydrase 2,23104,202,1.04 [0.87-1.24],0.661705653648997
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CA3,Carbonic anhydrase 3,23416,206,1.34 [1.11-1.63],0.0023840191517159
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CA4,Carbonic anhydrase 4,23453,207,0.68 [0.41-1.14],0.1435623344852236
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CA5A,"Carbonic anhydrase 5A, mitochondrial",22729,202,0.96 [0.84-1.11],0.5948578560025926
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CA6,Carbonic anhydrase 6,23125,202,0.94 [0.77-1.15],0.5436977353716566
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CA7,Carbonic anhydrase 7,19789,185,0.78 [0.50-1.22],0.277994144660407
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CA8,Carbonic anhydrase-related protein,19556,179,0.37 [0.17-0.79],0.0099436955139357
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CA9,Carbonic anhydrase 9,23353,206,0.94 [0.72-1.22],0.6363028749344581
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CABP2,Calcium-binding protein 2,19609,185,0.96 [0.77-1.20],0.7085701632693123
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,19490,181,0.53 [0.31-0.89],0.0160913498497296
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,19464,178,1.09 [0.88-1.36],0.4196848890028828
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,19490,181,0.92 [0.72-1.18],0.521162365930878
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,20106,189,0.96 [0.81-1.13],0.5977592801065312
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CACYBP,Calcyclin-binding protein,19695,185,0.97 [0.84-1.11],0.6198279188274554
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CADPS,Calcium-dependent secretion activator 1,19609,185,0.75 [0.50-1.12],0.1563552255692911
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CALB1,Calbindin,23056,203,1.18 [0.89-1.56],0.2592505617565078
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CALB2,Calretinin,22634,201,1.18 [0.81-1.71],0.3834056513122003
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CALCA,Calcitonin,22926,199,1.20 [1.00-1.44],0.0484211906728161
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CALCB,Calcitonin gene-related peptide 2,20115,186,1.05 [0.74-1.49],0.7814669174575618
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,23273,204,1.01 [0.89-1.14],0.9104694773264074
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,19644,185,1.02 [0.85-1.23],0.8157140174803743
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CALY,Neuron-specific vesicular protein calcyon,19464,178,0.87 [0.58-1.31],0.5058410178957929
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,22648,194,1.03 [0.77-1.38],0.8206660643491123
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,19609,185,0.95 [0.72-1.24],0.6919143965024773
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,20106,189,1.01 [0.89-1.16],0.8335530118558051
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CANT1,Soluble calcium-activated nucleotidase 1,23086,200,0.84 [0.45-1.55],0.5742413244733652
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CAPG,Macrophage-capping protein,22967,203,1.01 [0.82-1.25],0.9165970472000596
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CAPN3,Calpain-3,20057,185,1.29 [0.95-1.75],0.0971687200318237
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CAPS,Calcyphosin,20115,186,0.85 [0.71-1.02],0.0837664223286328
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CARHSP1,Calcium-regulated heat-stable protein 1,22634,201,1.05 [0.83-1.32],0.7034145253103019
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CASC3,Protein CASC3,19609,185,0.92 [0.65-1.30],0.6189598090623192
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CASP1,Caspase-1,22634,201,0.95 [0.79-1.13],0.5464591119849945
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CASP10,Caspase-10,22634,201,0.96 [0.81-1.15],0.6868631385299582
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CASP2,Caspase-2,23111,204,1.03 [0.85-1.23],0.789401734399152
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CASP3,Caspase-3,23453,207,1.02 [0.89-1.17],0.7929707324870168
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CASP4,Caspase-4,19789,185,0.98 [0.90-1.06],0.5781340325838766
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CASP7,Caspase-7,20115,186,0.96 [0.81-1.14],0.6554516698507145
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CASP8,Caspase-8,23276,203,1.04 [0.86-1.27],0.66716145784885
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CASP9,Caspase-9,19556,179,0.99 [0.78-1.25],0.920390254031902
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CASQ2,Calsequestrin-2,19464,178,0.92 [0.66-1.26],0.5931776613237745
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CAT,Catalase,19873,188,1.19 [0.93-1.52],0.1638776196947434
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CBLIF,Cobalamin binding intrinsic factor,23124,200,0.97 [0.83-1.14],0.7349167229677098
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CBLN1,Cerebellin-1,19490,181,1.01 [0.87-1.17],0.9277442117078332
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CBLN4,Cerebellin-4,23353,206,1.01 [0.69-1.48],0.9418341683381336
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CBS,Cystathionine beta-synthase,19644,185,1.07 [0.81-1.41],0.6236755835797037
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CBX2,Chromobox protein homolog 2,19464,178,0.91 [0.62-1.34],0.6317096725355444
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,22961,199,1.01 [0.85-1.20],0.89865692608363
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCAR2,Cell cycle and apoptosis regulator protein 2,20115,186,0.75 [0.53-1.05],0.0885246678777061
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCDC134,Coiled-coil domain-containing protein 134,20057,185,0.74 [0.55-1.01],0.0584121089177249
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCDC28A,Coiled-coil domain-containing protein 28A,19609,185,1.12 [0.70-1.81],0.6270341026568784
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCDC50,Coiled-coil domain-containing protein 50,20106,189,1.10 [0.94-1.30],0.2377532621415476
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCDC80,Coiled-coil domain-containing protein 80,23167,200,1.21 [0.87-1.68],0.2679640559048077
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,19644,185,1.13 [0.91-1.41],0.2773145498377834
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL11,Eotaxin,23393,205,1.02 [0.73-1.43],0.8987095336345491
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL13,C-C motif chemokine 13,23357,205,1.12 [0.94-1.33],0.2236357848335183
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL14,C-C motif chemokine 14,23136,204,1.42 [1.08-1.88],0.0119647649546558
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL15,C-C motif chemokine 15,23453,207,1.10 [0.83-1.45],0.5001862173968711
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL16,C-C motif chemokine 16,23453,207,0.78 [0.63-0.97],0.0262871639657645
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL17,C-C motif chemokine 17,23123,203,1.08 [0.94-1.23],0.2651768178991741
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL18,C-C motif chemokine 18,22866,202,1.15 [0.97-1.35],0.099992163586825
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL19,C-C motif chemokine 19,23351,205,1.01 [0.92-1.11],0.789715204323596
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL2,C-C motif chemokine 2,22925,199,1.17 [0.93-1.48],0.1757580033223355
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL20,C-C motif chemokine 20,23393,205,1.00 [0.88-1.15],0.9583349672408188
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL21,C-C motif chemokine 21,23265,203,1.17 [0.89-1.54],0.2586771225048496
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL22,C-C motif chemokine 22,22959,201,1.07 [0.84-1.35],0.5940093361664025
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL23,C-C motif chemokine 23,23265,203,1.16 [0.86-1.56],0.341981445907251
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL24,C-C motif chemokine 24,23224,203,1.04 [0.90-1.21],0.5822151642921556
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL25,C-C motif chemokine 25,23393,205,0.94 [0.73-1.21],0.6212433580897518
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL26,C-C motif chemokine 26,23111,204,0.98 [0.86-1.13],0.7992297649923641
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL27,C-C motif chemokine 27,23167,200,0.93 [0.75-1.15],0.5158896516269538
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL28,C-C motif chemokine 28,23026,204,0.93 [0.75-1.15],0.4933612072798714
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL3,C-C motif chemokine 3,23111,204,1.10 [0.91-1.35],0.3263702170492499
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL4,C-C motif chemokine 4,23197,203,1.16 [1.00-1.34],0.0568747059558664
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL5,C-C motif chemokine 5,23291,204,1.06 [0.93-1.19],0.3836757924799974
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL7,C-C motif chemokine 7,23111,204,1.15 [0.95-1.39],0.1593461992515046
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCL8,C-C motif chemokine 8,23316,205,1.35 [1.09-1.66],0.0048770472748542
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCN1,CCN family member 1,23012,202,1.02 [0.86-1.21],0.8358354569651728
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCN2,CCN family member 2,23133,203,1.13 [0.91-1.41],0.273263009248901
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCN3,CCN family member 3,23414,207,1.21 [0.86-1.72],0.2788402979156557
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCN4,CCN family member 4,23353,206,1.06 [0.78-1.45],0.6941880716907322
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCN5,CCN family member 5,23193,202,0.95 [0.68-1.32],0.752940509813701
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCND2,G1/S-specific cyclin-D2,19789,185,0.65 [0.49-0.87],0.0032933414862957
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCNE1,G1/S-specific cyclin-E1,19556,179,0.82 [0.65-1.02],0.0700623623216087
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCS,Copper chaperone for superoxide dismutase,22961,199,1.17 [0.90-1.51],0.2415174250456203
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CCT5,T-complex protein 1 subunit epsilon,22648,194,1.06 [0.80-1.41],0.6647125022198239
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD101,Immunoglobulin superfamily member 2,20054,186,0.91 [0.67-1.25],0.5716853522343215
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD109,CD109 antigen,23193,202,0.97 [0.66-1.41],0.859399539925941
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD14,Monocyte differentiation antigen CD14,22751,202,0.96 [0.71-1.31],0.8094019449448437
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD160,CD160 antigen,23393,205,0.89 [0.69-1.16],0.3959360339201796
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD163,Scavenger receptor cysteine-rich type 1 protein M130,23291,204,1.03 [0.77-1.38],0.8345771219970314
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD164,Sialomucin core protein 24,23193,202,0.86 [0.52-1.42],0.5494383838380001
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD164L2,CD164 sialomucin-like 2 protein,19609,185,0.85 [0.57-1.28],0.4409595170929422
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD177,CD177 antigen,23155,202,0.99 [0.90-1.08],0.7810119018561437
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD1C,T-cell surface glycoprotein CD1c,23260,204,1.01 [0.61-1.67],0.9662407809982092
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD2,T-cell surface antigen CD2,19464,178,0.92 [0.63-1.36],0.6897876571522638
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD200,OX-2 membrane glycoprotein,23111,204,1.12 [0.71-1.76],0.6339571485056811
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD200R1,Cell surface glycoprotein CD200 receptor 1,23043,204,0.82 [0.57-1.18],0.2818999460649423
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD207,C-type lectin domain family 4 member K,22646,197,1.14 [0.82-1.57],0.4422355913558654
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD209,CD209 antigen,23240,203,0.87 [0.63-1.21],0.4103806320548945
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD22,B-cell receptor CD22,23393,205,0.94 [0.70-1.25],0.662179355195379
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD226,CD226 antigen,19556,179,0.64 [0.45-0.92],0.0142831227275959
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD244,Natural killer cell receptor 2B4,23393,205,0.96 [0.61-1.51],0.8646054884821955
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD248,Endosialin,20163,187,0.62 [0.43-0.87],0.006414896419509
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD27,CD27 antigen,23260,204,0.95 [0.71-1.27],0.7291232220737469
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD274,Programmed cell death 1 ligand 1,22961,199,0.95 [0.65-1.38],0.7834568365943979
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD276,CD276 antigen,23156,203,1.80 [1.27-2.56],0.0009906370878437
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD28,T-cell-specific surface glycoprotein CD28,22648,194,0.95 [0.67-1.34],0.765978361830457
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD2AP,CD2-associated protein,23167,200,0.92 [0.76-1.13],0.4285449482520445
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD300A,CMRF35-like molecule 8,19723,185,0.85 [0.53-1.36],0.4931887508049888
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD300C,CMRF35-like molecule 6,23351,205,0.91 [0.64-1.29],0.5957807671879684
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD300E,CMRF35-like molecule 2,23276,206,0.97 [0.72-1.31],0.8550839667132653
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD300LF,CMRF35-like molecule 1,23353,206,0.90 [0.74-1.09],0.2830740910139074
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD300LG,CMRF35-like molecule 9,23193,202,0.83 [0.60-1.16],0.2782572105544025
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD302,CD302 antigen,23056,203,1.04 [0.69-1.55],0.8650895816707458
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD33,Myeloid cell surface antigen CD33,23260,204,1.04 [0.89-1.22],0.6024341360086662
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD34,Hematopoietic progenitor cell antigen CD34,23286,204,0.81 [0.48-1.36],0.4219627990811248
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD36,Platelet glycoprotein 4,19556,179,0.71 [0.50-1.00],0.0499974795162441
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,23056,203,0.80 [0.54-1.17],0.2459134865979373
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD3D,T-cell surface glycoprotein CD3 delta chain,19490,181,0.99 [0.65-1.50],0.945852759662825
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD3E,T-cell surface glycoprotein CD3 epsilon chain,19789,185,0.95 [0.63-1.42],0.7914475371916775
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD3G,T-cell surface glycoprotein CD3 gamma chain,19556,179,0.89 [0.74-1.08],0.2482415223683117
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD4,T-cell surface glycoprotein CD4,23073,204,0.98 [0.65-1.48],0.9258279530416452
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD40,Tumor necrosis factor receptor superfamily member 5,23156,203,0.91 [0.70-1.18],0.4861244621631335
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD40LG,CD40 ligand,23393,205,1.05 [0.89-1.22],0.5682091799171527
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD46,Membrane cofactor protein,23062,203,1.25 [0.82-1.91],0.305938425122468
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD48,CD48 antigen,23224,203,0.85 [0.56-1.28],0.4232348734662768
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD5,T-cell surface glycoprotein CD5,23316,205,0.98 [0.69-1.40],0.9274589188376762
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD55,Complement decay-accelerating factor,22387,197,0.94 [0.58-1.53],0.8059906051628236
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD58,Lymphocyte function-associated antigen 3,23127,203,0.82 [0.41-1.66],0.585499450275687
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD59,CD59 glycoprotein,22367,199,0.64 [0.36-1.14],0.1304073980784599
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD5L,CD5 antigen-like,20068,187,1.01 [0.75-1.36],0.93130900730768
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD6,T-cell differentiation antigen CD6,23359,205,0.91 [0.72-1.15],0.4110929207785359
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD63,CD63 antigen,22925,199,0.97 [0.76-1.24],0.8105547782812617
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD69,Early activation antigen CD69,23070,200,0.95 [0.83-1.10],0.4940189823765512
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD7,T-cell antigen CD7,19509,178,0.94 [0.67-1.31],0.7023870914042467
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD70,CD70 antigen,23111,204,0.91 [0.69-1.22],0.5409438881535724
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD72,B-cell differentiation antigen CD72,19723,185,1.04 [0.75-1.44],0.8028918412414281
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD74,HLA class II histocompatibility antigen gamma chain,23351,205,1.31 [0.93-1.85],0.1259535028121124
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD79B,B-cell antigen receptor complex-associated protein beta chain,23393,205,0.95 [0.72-1.24],0.6877629041439401
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD80,T-lymphocyte activation antigen CD80,20148,187,1.02 [0.67-1.54],0.9280650491107284
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD82,CD82 antigen,19789,185,1.22 [0.91-1.63],0.1907540621849112
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD83,CD83 antigen,23111,204,1.01 [0.70-1.45],0.9602526404608116
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD84,SLAM family member 5,23111,204,1.13 [0.76-1.68],0.5320530292954355
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD86,T-lymphocyte activation antigen CD86,20054,186,0.75 [0.47-1.20],0.234396564484515
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD8A,T-cell surface glycoprotein CD8 alpha chain,23351,205,0.99 [0.78-1.25],0.9048216667004976
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD93,Complement component C1q receptor,22330,194,0.93 [0.61-1.41],0.7317171658202816
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD99,CD99 antigen,23193,202,0.85 [0.45-1.62],0.6272379570495086
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CD99L2,CD99 antigen-like protein 2,23193,202,0.92 [0.55-1.55],0.7509754200701867
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDA,Cytidine deaminase,20103,187,1.11 [0.83-1.47],0.4784219179132395
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDAN1,Codanin-1,20115,186,0.97 [0.53-1.77],0.9156788568648266
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDC123,Cell division cycle protein 123 homolog,19420,180,0.87 [0.68-1.12],0.2833837600602368
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDC25A,M-phase inducer phosphatase 1,19420,180,0.74 [0.49-1.11],0.1413881668423683
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDC26,Anaphase-promoting complex subunit CDC26,20009,186,0.98 [0.80-1.20],0.8474641236003364
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDC27,Cell division cycle protein 27 homolog,22648,194,0.96 [0.77-1.19],0.7238197123431339
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDC37,Hsp90 co-chaperone Cdc37,23260,204,0.98 [0.84-1.14],0.7676515808526855
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDC42BPB,Serine/threonine-protein kinase MRCK beta,20054,186,0.98 [0.85-1.12],0.7453476290958836
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDCP1,CUB domain-containing protein 1,22961,199,0.94 [0.74-1.19],0.5973965504729504
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDH1,Cadherin-1,22429,198,1.25 [0.93-1.68],0.1408573636601948
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDH15,Cadherin-15,23316,205,0.96 [0.79-1.17],0.6832542554473373
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDH17,Cadherin-17,23167,200,1.10 [0.92-1.31],0.291491736223305
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDH2,Cadherin-2,23167,200,1.07 [0.75-1.53],0.7107817403449105
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDH22,Cadherin-22,19789,185,0.80 [0.47-1.35],0.3969302660201854
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDH23,Cadherin-23,20115,186,0.71 [0.41-1.24],0.2282954357202527
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDH3,Cadherin-3,23351,205,1.27 [0.91-1.76],0.1585913955417675
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDH4,Cadherin-4,19490,181,0.90 [0.66-1.24],0.5271510790278529
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDH5,Cadherin-5,23453,207,0.84 [0.56-1.27],0.414984051347824
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDH6,Cadherin-6,23167,200,1.12 [0.81-1.56],0.492523968504269
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDHR1,Cadherin-related family member 1,22634,201,0.99 [0.74-1.34],0.9701362874733512
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDHR2,Cadherin-related family member 2,23056,203,1.05 [0.87-1.25],0.6324182806435078
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDHR5,Cadherin-related family member 5,23167,200,0.95 [0.69-1.31],0.7468227962305024
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDK1,Cyclin-dependent kinase 1,19420,180,0.82 [0.55-1.21],0.3151796216693125
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,20106,189,1.04 [0.82-1.31],0.7680573602513486
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDKL5,Cyclin-dependent kinase-like 5,19490,181,0.77 [0.56-1.06],0.1055163403919549
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDKN1A,Cyclin-dependent kinase inhibitor 1,23056,203,1.01 [0.90-1.14],0.8506069144598769
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,23056,203,1.02 [0.89-1.16],0.7848383771882205
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDNF,Cerebral dopamine neurotrophic factor,23056,203,0.68 [0.46-1.01],0.0566473571218901
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,23191,203,0.95 [0.59-1.54],0.8420185087781773
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CDSN,Corneodesmosin,23323,204,1.07 [0.81-1.42],0.6166385836094684
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,23220,204,0.68 [0.37-1.24],0.2074902167842102
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,20054,186,0.88 [0.73-1.05],0.147756854657237
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,19789,185,0.99 [0.81-1.22],0.9387429761988088
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,20054,186,0.93 [0.66-1.32],0.698567055422892
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,19789,185,1.06 [0.78-1.44],0.7113924649095513
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,23111,204,0.95 [0.82-1.10],0.4792118605263741
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,22648,194,0.97 [0.74-1.27],0.8111428113193085
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,22377,192,0.92 [0.75-1.13],0.4547503007936769
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,20163,187,0.96 [0.67-1.38],0.8281087246272304
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,22729,202,0.93 [0.72-1.19],0.5505898492800569
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEBPA,CCAAT/enhancer-binding protein alpha,19556,179,0.76 [0.47-1.22],0.253783193305093
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEBPB,CCAAT/enhancer-binding protein beta,22729,202,0.96 [0.69-1.34],0.8322219678828304
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CELA2A,Chymotrypsin-like elastase family member 2A,20163,187,0.96 [0.77-1.20],0.7037566647010702
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CELA3A,Chymotrypsin-like elastase family member 3A,23418,207,0.98 [0.79-1.21],0.8487613080599358
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,19723,185,0.88 [0.55-1.43],0.6165902592590695
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEMIP2,Cell surface hyaluronidase,19556,179,0.52 [0.30-0.89],0.0180977779445571
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEND1,Cell cycle exit and neuronal differentiation protein 1,19490,181,1.09 [0.87-1.35],0.4470468062673657
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CENPF,Centromere protein F,19789,185,0.90 [0.69-1.18],0.4584945385662726
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CENPJ,Centromere protein J,19789,185,0.82 [0.65-1.03],0.0874761408567649
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEP112,Centrosomal protein of 112 kDa,19464,178,0.94 [0.67-1.32],0.7246637027989827
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEP152,Centrosomal protein of 152 kDa,19420,180,0.85 [0.59-1.22],0.3868975933697516
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEP164,Centrosomal protein of 164 kDa,22723,200,1.03 [0.85-1.24],0.7600535848169946
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEP170,Centrosomal protein of 170 kDa,19644,185,1.00 [0.83-1.21],0.9598002280371082
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEP20,Centrosomal protein 20,22648,194,0.96 [0.80-1.14],0.6153970338281547
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEP290,Centrosomal protein of 290 kDa,19789,185,0.62 [0.44-0.87],0.0052616158144394
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEP350,Centrosome-associated protein 350,19420,180,0.93 [0.63-1.37],0.6963844110236571
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEP43,Centrosomal protein 43,22549,201,1.00 [0.84-1.21],0.961863384548888
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CEP85,Centrosomal protein of 85 kDa,22648,194,0.96 [0.78-1.18],0.6889290250511927
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CERT,Ceramide transfer protein,22634,201,1.05 [0.85-1.29],0.647998881906847
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CES1,Liver carboxylesterase 1,23247,203,1.09 [0.93-1.26],0.2840985085191567
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CES2,Cocaine esterase,23056,203,0.91 [0.72-1.15],0.4437923467439536
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CES3,Carboxylesterase 3,23056,203,1.03 [0.87-1.23],0.703142080763677
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CETN2,Centrin-2,22634,201,1.01 [0.84-1.22],0.8777374005219238
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CETN3,Centrin-3,20054,186,0.97 [0.80-1.16],0.7199685091889214
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CFB,Complement factor B,19819,183,0.94 [0.60-1.46],0.7671494429564316
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CFC1,Cryptic protein,22648,194,0.69 [0.51-0.94],0.0172023080933175
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CFD,Complement factor D,20182,187,0.68 [0.34-1.39],0.2934838706358962
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CFH,Complement factor H,18989,175,0.93 [0.49-1.77],0.8196997973248289
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CFHR2,Complement factor H-related protein 2,20027,186,1.08 [0.84-1.39],0.5552489214809262
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CFHR4,Complement factor H-related protein 4,20145,186,1.06 [0.87-1.29],0.5613635553948824
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CFHR5,Complement factor H-related protein 5,19892,189,1.18 [0.83-1.66],0.3535909693032785
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CFI,Complement factor I,20182,187,0.70 [0.34-1.43],0.3313632370636044
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CFP,Properdin,20182,187,0.60 [0.30-1.21],0.1524610068741412
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CGA,Glycoprotein hormones alpha chain,23193,202,0.99 [0.81-1.21],0.9342815247562618
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,20164,189,1.50 [1.04-2.17],0.0318923126856724
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CGN,Cingulin,19609,185,0.95 [0.66-1.36],0.7817758878281553
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CGREF1,Cell growth regulator with EF hand domain protein 1,23167,200,0.88 [0.66-1.19],0.4135868751097091
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,22648,194,1.06 [0.86-1.31],0.6009798124256193
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHAD,Chondroadherin,19723,185,0.83 [0.63-1.09],0.1712915779009514
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",20115,186,1.19 [0.85-1.66],0.3070688768478001
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHCHD6,MICOS complex subunit MIC25,20057,185,0.93 [0.55-1.57],0.7896311410603029
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHEK2,Serine/threonine-protein kinase Chk2,22729,202,0.99 [0.68-1.45],0.9502511200520808
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHGA,Chromogranin-A,20163,187,1.00 [0.86-1.16],0.980273527575816
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHGB,Secretogranin-1,23281,205,0.91 [0.67-1.22],0.5250170317760194
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHI3L1,Chitinase-3-like protein 1,22706,201,0.98 [0.84-1.14],0.7779625872762731
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHIT1,Chitotriosidase-1,23273,205,1.03 [0.95-1.12],0.4791024865194472
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHL1,Neural cell adhesion molecule L1-like protein,23255,204,0.92 [0.61-1.40],0.7132030679729224
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHM,Rab proteins geranylgeranyltransferase component A 1,19609,185,0.92 [0.73-1.17],0.4964758478357963
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHMP1A,Charged multivesicular body protein 1a,22961,199,1.04 [0.89-1.22],0.6313379803522201
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHMP6,Charged multivesicular body protein 6,20148,187,0.94 [0.73-1.20],0.6004196709664591
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHP1,Calcineurin B homologous protein 1,19490,181,0.90 [0.73-1.11],0.3390756117340562
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHRDL1,Chordin-like protein 1,23224,203,1.28 [0.87-1.90],0.2119221814363653
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHRDL2,Chordin-like protein 2,23167,200,0.97 [0.74-1.27],0.8381417199792457
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CHRM1,Muscarinic acetylcholine receptor M1,19609,185,0.78 [0.51-1.20],0.2549253905544335
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CIAPIN1,Anamorsin,23260,204,1.04 [0.85-1.28],0.6721739955989
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CILP,Cartilage intermediate layer protein 1,20163,187,1.23 [0.94-1.61],0.1235077328001646
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CINP,Cyclin-dependent kinase 2-interacting protein,19789,185,0.91 [0.65-1.27],0.569112339146373
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CIRBP,Cold-inducible RNA-binding protein,20054,186,1.01 [0.87-1.17],0.869227613826977
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CIT,Citron Rho-interacting kinase,19609,185,0.70 [0.50-0.98],0.040699196336917
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CKAP4,Cytoskeleton-associated protein 4,23292,205,0.89 [0.57-1.39],0.6088987844953604
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CKB,Creatine kinase B-type,20163,187,1.06 [0.83-1.35],0.6307145533870748
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",23092,203,0.90 [0.76-1.07],0.2271383646772247
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLASP1,CLIP-associating protein 1,19420,180,1.07 [0.89-1.29],0.4828140838595879
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLC,Galectin-10,23128,200,0.84 [0.69-1.03],0.0956864233540522
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLEC10A,C-type lectin domain family 10 member A,22961,199,0.94 [0.67-1.34],0.7515915190826913
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLEC11A,C-type lectin domain family 11 member A,23158,202,1.05 [0.81-1.35],0.7301705576644779
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLEC12A,C-type lectin domain family 12 member A,19556,179,0.55 [0.27-1.14],0.1106436050617701
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLEC14A,C-type lectin domain family 14 member A,23193,202,0.83 [0.56-1.23],0.3501877859546582
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLEC1A,C-type lectin domain family 1 member A,22729,202,0.88 [0.60-1.28],0.4927679065861257
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLEC1B,C-type lectin domain family 1 member B,23351,205,0.98 [0.86-1.12],0.7592102771912708
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLEC2L,C-type lectin domain family 2 member L,19609,185,0.90 [0.67-1.22],0.494210190179514
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLEC3B,Tetranectin,19701,181,0.92 [0.46-1.82],0.8047689595916647
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLEC4A,C-type lectin domain family 4 member A,23111,204,0.64 [0.46-0.90],0.0098817490204902
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLEC4C,C-type lectin domain family 4 member C,23111,204,0.84 [0.65-1.08],0.1757010009315265
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLEC4D,C-type lectin domain family 4 member D,23111,204,1.08 [0.89-1.32],0.4438095797885076
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLEC4G,C-type lectin domain family 4 member G,23111,204,1.51 [1.04-2.18],0.0287636429349802
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLEC4M,C-type lectin domain family 4 member M,20127,187,0.99 [0.75-1.32],0.9566791623091132
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLEC5A,C-type lectin domain family 5 member A,23101,200,1.16 [0.76-1.75],0.4948802207366081
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLEC6A,C-type lectin domain family 6 member A,22648,194,0.97 [0.73-1.27],0.7999129999514011
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLEC7A,C-type lectin domain family 7 member A,23393,205,0.90 [0.75-1.07],0.2391984686561164
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLGN,Calmegin,19609,185,0.87 [0.63-1.20],0.3969914826498285
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLIC5,Chloride intracellular channel protein 5,19609,185,0.76 [0.46-1.24],0.2735686443680831
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLINT1,Clathrin interactor 1,19420,180,0.95 [0.69-1.31],0.7554226379174906
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLIP2,CAP-Gly domain-containing linker protein 2,23111,204,0.99 [0.88-1.10],0.8167268548062019
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLMP,CXADR-like membrane protein,23353,206,0.92 [0.52-1.64],0.7802906296813767
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLNS1A,Methylosome subunit pICln,19609,185,0.92 [0.60-1.40],0.6841217274579467
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",22926,199,0.96 [0.84-1.09],0.5089501559753856
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLPS,Colipase,23149,202,0.95 [0.80-1.13],0.5456146285486203
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLSPN,Claspin,22599,201,1.29 [0.99-1.70],0.0637155466699236
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLSTN1,Calsyntenin-1,22634,201,1.08 [0.87-1.35],0.4739994897059649
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLSTN2,Calsyntenin-2,23393,205,1.08 [0.79-1.47],0.6327041926438073
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLSTN3,Calsyntenin-3,20115,186,0.75 [0.47-1.21],0.2438431687004099
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLTA,Clathrin light chain A,22729,202,1.10 [0.85-1.42],0.4641371326466165
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLU,Clusterin,20182,187,0.79 [0.44-1.43],0.4433551842480754
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CLUL1,Clusterin-like protein 1,23130,200,0.81 [0.61-1.08],0.1449063253802741
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CMC1,COX assembly mitochondrial protein homolog,20148,187,0.98 [0.84-1.14],0.7768360310519411
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CMIP,C-Maf-inducing protein,20057,185,0.96 [0.81-1.14],0.6551923725384379
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CNDP1,Beta-Ala-His dipeptidase,23291,204,0.92 [0.70-1.20],0.5395013275970071
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CNGB3,Cyclic nucleotide-gated cation channel beta-3,19490,181,0.82 [0.60-1.13],0.2252753880114097
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",19608,185,1.02 [0.85-1.22],0.8604937014971488
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CNPY2,Protein canopy homolog 2,22729,202,1.08 [0.90-1.31],0.3982671001981426
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CNPY4,Protein canopy homolog 4,23056,203,1.04 [0.88-1.23],0.6580454902420072
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CNST,Consortin,23167,200,0.96 [0.85-1.07],0.4520043687765424
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CNTF,Ciliary neurotrophic factor,19490,181,0.73 [0.48-1.11],0.1428687842819177
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CNTN1,Contactin-1,23453,207,0.99 [0.64-1.55],0.973773466941548
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CNTN2,Contactin-2,23353,206,0.99 [0.75-1.31],0.940219885126424
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CNTN3,Contactin-3,23193,202,1.08 [0.72-1.63],0.7042159315635181
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CNTN4,Contactin-4,23193,202,0.72 [0.43-1.22],0.2221321845355928
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CNTN5,Contactin-5,23209,204,0.93 [0.67-1.30],0.6827673576659539
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CNTNAP2,Contactin-associated protein-like 2,23111,204,0.89 [0.66-1.20],0.4416833951438463
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CNTNAP4,Contactin-associated protein-like 4,19609,185,0.88 [0.75-1.03],0.1179462358976765
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COCH,Cochlin,20148,187,0.83 [0.61-1.12],0.224774707715624
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COL15A1,Collagen alpha-1(XV) chain,20163,187,0.82 [0.49-1.39],0.4675729250876427
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COL18A1,Collagen alpha-1(XVIII) chain,23287,205,0.75 [0.45-1.28],0.2952729327710544
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COL1A1,Collagen alpha-1(I) chain,23453,207,0.81 [0.50-1.33],0.4065442724982321
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COL24A1,Collagen alpha-1(XXIV) chain,20054,186,1.00 [0.78-1.29],0.9742661350167802
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COL28A1,Collagen alpha-1(XXVIII) chain,19609,185,0.88 [0.72-1.06],0.1804958444341543
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COL2A1,Collagen alpha-1(II) chain,19644,185,0.91 [0.76-1.09],0.2854546949205903
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COL3A1,Collagen alpha-1(III) chain,20163,187,0.58 [0.32-1.05],0.0727833420942418
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COL4A1,Collagen alpha-1(IV) chain,23167,200,0.92 [0.66-1.27],0.6106591631251315
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COL4A4,Collagen alpha-4(IV) chain,19758,185,0.91 [0.71-1.18],0.4886758586067252
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COL5A1,Collagen alpha-1(V) chain,19723,185,1.19 [0.84-1.68],0.3288927821152161
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COL6A3,Collagen alpha-3(VI) chain,23453,207,1.18 [0.84-1.64],0.3426756808577011
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COL9A1,Collagen alpha-1(IX) chain,23111,204,0.92 [0.71-1.20],0.5347225515669056
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COL9A2,Collagen alpha-2(IX) chain,19789,185,1.13 [0.85-1.51],0.4074867972222895
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COLEC12,Collectin-12,23156,203,0.83 [0.52-1.33],0.435765307566101
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COMMD1,COMM domain-containing protein 1,19644,185,1.03 [0.82-1.31],0.7809440547690082
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COMMD9,COMM domain-containing protein 9,20057,185,0.80 [0.54-1.17],0.2530543672213042
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COMP,Cartilage oligomeric matrix protein,22938,202,1.24 [0.85-1.80],0.2631095038638522
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COMT,Catechol O-methyltransferase,22489,198,1.05 [0.90-1.23],0.501792684639502
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COPB2,Coatomer subunit beta',19464,178,0.81 [0.57-1.15],0.2368794979273272
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COPE,Coatomer subunit epsilon,22634,201,1.00 [0.77-1.31],0.9843223973380244
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",19644,185,0.86 [0.61-1.22],0.4099063073314917
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CORO1A,Coronin-1A,22693,198,0.92 [0.79-1.07],0.2720732987327509
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CORO6,Coronin-6,19490,181,1.39 [0.99-1.95],0.0550250676781362
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",23056,203,1.05 [0.88-1.25],0.5909831972967939
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,COX6B1,Cytochrome c oxidase subunit 6B1,20148,187,1.08 [0.70-1.65],0.733260116357158
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CPA1,Carboxypeptidase A1,23453,207,0.85 [0.70-1.04],0.1209478493602756
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CPA2,Carboxypeptidase A2,23284,203,0.88 [0.73-1.06],0.1851375335862473
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CPA4,Carboxypeptidase A4,19331,182,0.98 [0.70-1.37],0.9100058247439898
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CPB1,Carboxypeptidase B,23453,207,0.90 [0.73-1.11],0.337459154645827
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CPB2,Carboxypeptidase B2,20148,187,0.92 [0.49-1.73],0.7923810778748389
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CPE,Carboxypeptidase E,23154,203,0.81 [0.60-1.09],0.1545734649087858
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CPLX2,Complexin-2,19420,180,0.96 [0.61-1.52],0.8656042873770644
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CPM,Carboxypeptidase M,23225,205,0.96 [0.67-1.40],0.8487385821668887
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",19556,179,0.49 [0.27-0.86],0.0130485141007932
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CPPED1,Serine/threonine-protein phosphatase CPPED1,23351,205,1.05 [0.87-1.26],0.6050465035222425
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CPQ,Carboxypeptidase Q,20122,187,1.24 [0.83-1.85],0.2873397368759796
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CPTP,Ceramide-1-phosphate transfer protein,19464,178,1.03 [0.71-1.48],0.891588253394238
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CPVL,Probable serine carboxypeptidase CPVL,23321,206,1.18 [0.87-1.60],0.2830711647664904
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CPXM1,Probable carboxypeptidase X1,23260,204,1.04 [0.87-1.24],0.6953639412915418
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CPXM2,Inactive carboxypeptidase-like protein X2,20148,187,0.88 [0.51-1.53],0.6545644690591159
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CR1,Complement receptor type 1,20089,189,0.94 [0.63-1.39],0.7547815760801949
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CR2,Complement receptor type 2,23291,204,1.09 [0.84-1.41],0.527755202462243
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,22648,194,1.03 [0.88-1.19],0.7396429192495004
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRADD,Death domain-containing protein CRADD,22926,199,1.07 [0.90-1.27],0.4384018344397372
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CREB3,Cyclic AMP-responsive element-binding protein 3,19420,180,0.85 [0.64-1.12],0.2456862010447411
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CREBZF,CREB/ATF bZIP transcription factor,19420,180,0.56 [0.31-1.00],0.0493520487243839
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CREG1,Protein CREG1,22895,203,1.03 [0.75-1.42],0.8568978980092584
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRELD1,Protein disulfide isomerase CRELD1,19723,185,0.87 [0.59-1.28],0.4860790724698822
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRELD2,Protein disulfide isomerase CRELD2,23224,203,1.03 [0.81-1.31],0.8108407862712941
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRH,Corticoliberin,22609,193,1.01 [0.87-1.17],0.9005009791688069
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRHBP,Corticotropin-releasing factor-binding protein,23156,203,0.90 [0.57-1.41],0.6401664938796547
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRHR1,Corticotropin-releasing factor receptor 1,22729,202,0.88 [0.70-1.10],0.264643429091992
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRIM1,Cysteine-rich motor neuron 1 protein,23265,203,1.02 [0.55-1.87],0.9614734265879256
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRIP2,Cysteine-rich protein 2,22961,199,0.87 [0.61-1.24],0.4383480065149003
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRISP2,Cysteine-rich secretory protein 2,23353,206,1.07 [0.86-1.32],0.5344501096954958
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRISP3,Cysteine-rich secretory protein 3,19988,184,0.80 [0.48-1.35],0.4103972357982557
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRKL,Crk-like protein,23195,203,1.04 [0.92-1.17],0.5580639953712011
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRLF1,Cytokine receptor-like factor 1,23265,203,1.28 [0.78-2.11],0.3314484274808401
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRNN,Cornulin,22532,195,1.08 [0.90-1.30],0.4209958859430964
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRTAC1,Cartilage acidic protein 1,23453,207,0.66 [0.45-0.98],0.0408079159815563
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRTAM,Cytotoxic and regulatory T-cell molecule,22961,199,1.07 [0.84-1.37],0.5786607739207379
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRTAP,Cartilage-associated protein,19609,185,0.74 [0.53-1.05],0.0908732461041355
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRX,Cone-rod homeobox protein,22729,202,1.06 [0.95-1.18],0.2837835623648055
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRYBB1,Beta-crystallin B1,20148,187,1.01 [0.81-1.26],0.9255353457505648
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRYBB2,Beta-crystallin B2,20115,186,0.91 [0.74-1.12],0.3651449220532021
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRYGD,Gamma-crystallin D,20115,186,1.00 [0.87-1.16],0.9839634936235736
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRYM,Ketimine reductase mu-crystallin,19490,181,1.05 [0.87-1.27],0.586689904664385
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CRYZL1,Quinone oxidoreductase-like protein 1,19644,185,1.00 [0.86-1.17],0.9715277981403856
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CSDE1,Cold shock domain-containing protein E1,19464,178,0.92 [0.81-1.05],0.2318563996826385
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CSF1,Macrophage colony-stimulating factor 1,23265,203,1.04 [0.66-1.64],0.8696869502597927
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CSF1R,Macrophage colony-stimulating factor 1 receptor,20164,189,0.80 [0.57-1.14],0.2179804791897797
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CSF2,Granulocyte-macrophage colony-stimulating factor,19464,178,0.98 [0.66-1.47],0.9368131200936748
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,22961,199,0.91 [0.74-1.12],0.394817669152762
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CSF2RB,Cytokine receptor common subunit beta,19556,179,0.93 [0.67-1.30],0.6708852478232481
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CSF3,Granulocyte colony-stimulating factor,22723,200,1.02 [0.79-1.33],0.856301879220689
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CSF3R,Granulocyte colony-stimulating factor receptor,19556,179,0.75 [0.45-1.24],0.2623338195888063
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CSH1,Chorionic somatomammotropin hormone 1,20164,189,1.11 [0.69-1.80],0.663383702829281
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CSNK1D,Casein kinase I isoform delta,19556,179,0.85 [0.66-1.08],0.1833996031614679
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CSNK2A1,Casein kinase II subunit alpha,20106,189,1.04 [0.76-1.42],0.7927724491537784
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CSPG4,Chondroitin sulfate proteoglycan 4,20163,187,0.72 [0.46-1.10],0.1284686676459276
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CSPG5,Chondroitin sulfate proteoglycan 5,19490,181,1.07 [0.81-1.40],0.6431839965182626
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CSRP3,Cysteine and glycine-rich protein 3,19464,178,1.27 [1.13-1.43],4.617619974781369e-05
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CST1,Cystatin-SN,17536,161,0.94 [0.80-1.09],0.3847922443396776
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CST3,Cystatin-C,23254,203,1.19 [0.78-1.81],0.4160505292782867
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CST5,Cystatin-D,22718,198,0.85 [0.67-1.06],0.1534347735876931
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CST6,Cystatin-M,22543,201,1.26 [0.98-1.62],0.0710254224464785
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CST7,Cystatin-F,23197,203,1.00 [0.87-1.14],0.947193326568446
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CSTB,Cystatin-B,22859,204,1.12 [0.84-1.49],0.4552089283696194
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTAG1A_CTAG1B,Cancer/testis antigen 1,19757,185,0.91 [0.68-1.22],0.5417470993431142
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTBS,Di-N-acetylchitobiase,19851,189,0.80 [0.48-1.34],0.4061602499811954
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTF1,Cardiotrophin-1,22729,202,0.99 [0.86-1.15],0.934430535050872
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTHRC1,Collagen triple helix repeat-containing protein 1,20163,187,1.19 [0.73-1.93],0.4816122793664948
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTLA4,Cytotoxic T-lymphocyte protein 4,20163,187,0.67 [0.42-1.08],0.0999317417146414
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTNNA1,Catenin alpha-1,19490,181,0.91 [0.59-1.41],0.6838700956754951
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTRB1,Chymotrypsinogen B,23193,202,0.95 [0.76-1.19],0.6551386749500487
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTRC,Chymotrypsin-C,23158,203,0.90 [0.75-1.09],0.2949995567996913
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTRL,Chymotrypsin-like protease CTRL-1,20115,186,1.02 [0.83-1.25],0.8407285717442669
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTSB,Cathepsin B,23218,205,0.94 [0.75-1.19],0.6013000984497445
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTSC,Dipeptidyl peptidase 1,23118,202,1.19 [0.90-1.56],0.2213757911243268
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTSD,Cathepsin D,21721,194,1.09 [0.80-1.49],0.5714564220422047
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTSE,Cathepsin E,19723,185,0.78 [0.59-1.03],0.0817323972608419
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTSF,Cathepsin F,23260,204,0.99 [0.72-1.36],0.9565038281497044
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTSH,Pro-cathepsin H,22646,202,1.01 [0.85-1.19],0.9356029953737808
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTSL,Cathepsin L1,23167,200,1.43 [0.87-2.36],0.1635765738398462
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTSO,Cathepsin O,23393,205,1.14 [0.77-1.71],0.5127400195793066
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTSS,Cathepsin S,18111,144,1.22 [0.62-2.39],0.5627351668060911
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTSV,Cathepsin L2,23277,206,0.95 [0.70-1.28],0.7270740358494099
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CTSZ,Cathepsin Z,23229,204,1.25 [0.85-1.85],0.2507055230359008
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CUZD1,CUB and zona pellucida-like domain-containing protein 1,19609,185,0.96 [0.65-1.40],0.8167289186328113
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CWC15,Spliceosome-associated protein CWC15 homolog,19929,184,0.99 [0.79-1.25],0.9345733279817536
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CX3CL1,Fractalkine,22961,199,1.06 [0.73-1.54],0.7518939266980649
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CXADR,Coxsackievirus and adenovirus receptor,23111,204,0.94 [0.73-1.20],0.6155726544238791
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CXCL1,Growth-regulated alpha protein,23123,202,1.03 [0.91-1.18],0.6033382794005409
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CXCL10,C-X-C motif chemokine 10,23265,203,1.17 [0.99-1.39],0.0680669307891573
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CXCL11,C-X-C motif chemokine 11,23351,205,1.05 [0.90-1.22],0.5284077861865035
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CXCL12,Stromal cell-derived factor 1,22723,200,1.18 [0.86-1.62],0.3003400793658707
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CXCL13,C-X-C motif chemokine 13,23351,205,1.21 [1.03-1.42],0.0190853372193088
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CXCL14,C-X-C motif chemokine 14,22723,200,1.03 [0.83-1.27],0.8062376745006006
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CXCL16,C-X-C motif chemokine 16,23423,207,0.58 [0.34-0.99],0.0443418255087449
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CXCL17,C-X-C motif chemokine 17,23393,205,1.02 [0.75-1.39],0.8917947168740745
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CXCL3,C-X-C motif chemokine 3,23156,203,1.00 [0.87-1.13],0.9477980630575048
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CXCL5,C-X-C motif chemokine 5,23096,199,1.05 [0.94-1.18],0.3541311338458571
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CXCL6,C-X-C motif chemokine 6,23393,205,1.13 [0.96-1.32],0.1377432252021339
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CXCL8,Interleukin-8,23000,204,1.04 [0.87-1.23],0.6846904045213325
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CXCL9,C-X-C motif chemokine 9,23265,203,1.17 [0.98-1.39],0.0835630120110739
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CYB5A,Cytochrome b5,19420,180,1.06 [0.88-1.28],0.5131166167984069
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CYB5R2,NADH-cytochrome b5 reductase 2,19847,185,0.96 [0.75-1.25],0.7850457508458578
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",19464,178,0.83 [0.67-1.01],0.0649600416410692
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CYTH3,Cytohesin-3,19420,180,0.82 [0.65-1.03],0.0857782950185377
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,CYTL1,Cytokine-like protein 1,20163,187,0.93 [0.53-1.62],0.790733207690375
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DAAM1,Disheveled-associated activator of morphogenesis 1,19723,185,0.95 [0.80-1.13],0.5938136643429569
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DAB2,Disabled homolog 2,23353,206,1.01 [0.91-1.13],0.8231814398193874
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DAG1,Dystroglycan,23265,203,1.05 [0.81-1.38],0.7084733505393664
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DAND5,DAN domain family member 5,19556,179,1.02 [0.80-1.31],0.8602034111308299
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DAPK2,Death-associated protein kinase 2,19556,179,0.70 [0.52-0.95],0.020057707488918
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,23111,204,1.01 [0.91-1.12],0.8933117207476099
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DARS1,"Aspartate--tRNA ligase, cytoplasmic",22926,199,1.08 [0.90-1.28],0.4128062982854896
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DBH,Dopamine beta-hydroxylase,20119,189,1.02 [0.90-1.17],0.7244110662196566
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DBI,Acyl-CoA-binding protein,23090,202,1.06 [0.90-1.24],0.511580555573228
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DBN1,Drebrin,19556,179,0.87 [0.64-1.17],0.3502224567489442
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DBNL,Drebrin-like protein,23265,203,1.01 [0.88-1.15],0.9381956243331854
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",23260,204,1.04 [0.73-1.48],0.8245114397524674
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DCC,Netrin receptor DCC,19609,185,1.39 [0.86-2.24],0.1853714602222969
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DCDC2C,Doublecortin domain-containing protein 2C,19420,180,0.90 [0.70-1.14],0.3713248097893733
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DCLRE1C,Protein artemis,19420,180,0.90 [0.56-1.45],0.6660396956894272
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DCN,Decorin,22729,202,1.07 [0.63-1.82],0.7907524523030467
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DCTD,Deoxycytidylate deaminase,19723,185,0.98 [0.85-1.14],0.8431579601746765
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DCTN1,Dynactin subunit 1,23353,206,1.10 [0.91-1.32],0.3431759611236274
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DCTN2,Dynactin subunit 2,23056,203,1.06 [0.93-1.21],0.3800015848470115
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DCTN6,Dynactin subunit 6,22634,201,0.99 [0.83-1.18],0.8806308200280528
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DCTPP1,dCTP pyrophosphatase 1,23167,200,0.77 [0.51-1.14],0.1897802351363952
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DCUN1D1,DCN1-like protein 1,19490,181,0.84 [0.67-1.04],0.1105193830472966
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DCUN1D2,DCN1-like protein 2,19420,180,1.00 [0.84-1.20],0.9914679439434096
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DCXR,L-xylulose reductase,23260,204,1.07 [0.84-1.35],0.5956100119574201
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DDA1,DET1- and DDB1-associated protein 1,19464,178,0.92 [0.63-1.35],0.6738463394435656
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",23056,203,1.23 [0.94-1.61],0.1309792643572153
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DDC,Aromatic-L-amino-acid decarboxylase,23124,200,0.94 [0.72-1.23],0.670675569063224
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DDHD2,Phospholipase DDHD2,20106,189,0.98 [0.79-1.22],0.8697164275060667
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DDI2,Protein DDI1 homolog 2,19723,185,0.95 [0.79-1.14],0.5957834547510767
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DDR1,Epithelial discoidin domain-containing receptor 1,23351,205,1.70 [1.01-2.87],0.047301909360531
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DDT,D-dopachrome decarboxylase,20163,187,1.17 [0.85-1.61],0.3489844871483459
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DDX1,ATP-dependent RNA helicase DDX1,20054,186,0.90 [0.66-1.22],0.492332665206199
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DDX25,ATP-dependent RNA helicase DDX25,19609,185,0.94 [0.64-1.39],0.7620417994736678
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DDX39A,ATP-dependent RNA helicase DDX39A,19556,179,0.55 [0.28-1.09],0.0883233813327763
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DDX4,Probable ATP-dependent RNA helicase DDX4,19556,179,0.84 [0.62-1.15],0.2780767372541181
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DDX53,Probable ATP-dependent RNA helicase DDX53,19609,185,0.97 [0.66-1.45],0.893489320116172
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DDX58,Antiviral innate immune response receptor RIG-I,22648,194,0.90 [0.70-1.14],0.3635353697726465
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",23111,204,1.01 [0.89-1.15],0.8306990823186458
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DEFA1_DEFA1B,Neutrophil defensin 1,22720,202,1.09 [0.88-1.36],0.4365425352360075
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DEFB103A_DEFB103B,Beta-defensin 103,19394,179,1.15 [0.85-1.55],0.3635951758826499
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DEFB104A_DEFB104B,Beta-defensin 104,19490,181,1.09 [0.85-1.41],0.4778874637944366
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DEFB116,Beta-defensin 116,19490,181,1.09 [0.92-1.30],0.3286398395193478
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DEFB118,Beta-defensin 118,19490,181,0.79 [0.58-1.09],0.1517615223662887
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DEFB4A_DEFB4B,Beta-defensin 4A,22862,199,1.03 [0.95-1.12],0.4970264851370535
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DENND2B,DENN domain-containing protein 2B,19464,178,1.09 [0.84-1.42],0.5203725388099494
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DENR,Density-regulated protein,19556,179,1.07 [0.83-1.37],0.598789101798268
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DFFA,DNA fragmentation factor subunit alpha,23393,205,1.09 [0.90-1.30],0.3772416833662375
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DGCR6,Protein DGCR6,19490,181,0.82 [0.57-1.20],0.3119114740517578
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DGKA,Diacylglycerol kinase alpha,19556,179,0.88 [0.67-1.15],0.3489629823024179
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DGKZ,Diacylglycerol kinase zeta,22723,200,1.03 [0.72-1.47],0.8731364783315063
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DHODH,Dihydroorotate dehydrogenase,19464,178,1.13 [0.86-1.48],0.3859142139373303
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DHPS,Deoxyhypusine synthase,20057,185,0.80 [0.54-1.17],0.2452250885429805
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,20115,186,0.98 [0.72-1.32],0.8732202727705581
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DIABLO,"Diablo homolog, mitochondrial",23101,200,0.94 [0.84-1.05],0.2961085365292255
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DIPK1C,Divergent protein kinase domain 1C,19609,185,1.03 [0.73-1.44],0.8803227846054383
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DIPK2B,Divergent protein kinase domain 2B,19723,185,0.60 [0.36-1.01],0.0554662229565106
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DKK1,Dickkopf-related protein 1,23351,205,0.95 [0.77-1.18],0.6661034396968313
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DKK3,Dickkopf-related protein 3,23453,207,0.85 [0.56-1.29],0.4426604055036521
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DKK4,Dickkopf-related protein 4,22928,199,0.95 [0.72-1.25],0.6924380264969726
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DKKL1,Dickkopf-like protein 1,23056,203,1.03 [0.89-1.19],0.6534062919201966
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DLG4,Disks large homolog 4,20115,186,0.93 [0.76-1.14],0.5094154047103565
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DLGAP5,Disks large-associated protein 5,20106,189,1.00 [0.76-1.31],0.9911781457290152
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DLK1,Protein delta homolog 1,23453,207,0.89 [0.71-1.11],0.3004779359796291
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DLL1,Delta-like protein 1,23260,204,1.29 [0.87-1.93],0.2038957099296572
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DLL4,Delta-like protein 4,19644,185,1.01 [0.86-1.18],0.9352382289655908
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DMD,Dystrophin,19644,185,1.35 [1.08-1.69],0.0090819198012254
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DMP1,Dentin matrix acidic phosphoprotein 1,19644,185,0.80 [0.65-1.00],0.050041828270507
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNAJA1,DnaJ homolog subfamily A member 1,19420,180,0.65 [0.45-0.94],0.0223821865476642
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNAJA2,DnaJ homolog subfamily A member 2,23326,205,1.00 [0.86-1.17],0.974453679105863
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNAJA4,DnaJ homolog subfamily A member 4,20115,186,1.02 [0.84-1.24],0.8171789852105469
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNAJB1,DnaJ homolog subfamily B member 1,23056,203,1.04 [0.90-1.20],0.5823317875050217
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNAJB14,DnaJ homolog subfamily B member 14,20054,186,0.90 [0.72-1.13],0.3808464375442201
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNAJB2,DnaJ homolog subfamily B member 2,19723,185,1.04 [0.80-1.35],0.7484520689141254
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNAJB6,DnaJ homolog subfamily B member 6,19538,184,0.98 [0.82-1.16],0.8041596159195885
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNAJB8,DnaJ homolog subfamily B member 8,22729,202,1.05 [0.85-1.30],0.6346516835600606
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNAJC21,DnaJ homolog subfamily C member 21,20115,186,0.88 [0.61-1.28],0.5037353315688063
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNAJC6,Putative tyrosine-protein phosphatase auxilin,19644,185,1.07 [0.90-1.27],0.4403273231464469
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNAJC9,DnaJ homolog subfamily C member 9,20054,186,0.98 [0.82-1.18],0.8649845322534051
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNER,Delta and Notch-like epidermal growth factor-related receptor,23115,203,0.91 [0.55-1.50],0.7204126084014796
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNLZ,DNL-type zinc finger protein,19490,181,0.97 [0.82-1.15],0.7412475465987649
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNM1,Dynamin-1,20054,186,1.02 [0.90-1.15],0.7633263573319857
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNM3,Dynamin-3,20106,189,1.04 [0.81-1.34],0.7591323487745603
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNMBP,Dynamin-binding protein,22961,199,0.93 [0.75-1.15],0.5143097543604711
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNPEP,Aspartyl aminopeptidase,20115,186,0.80 [0.62-1.01],0.065562433753463
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,23236,203,1.06 [0.83-1.34],0.6418018015804504
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DOC2B,Double C2-like domain-containing protein beta,19609,185,0.85 [0.55-1.31],0.4610231187690939
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DOCK9,Dedicator of cytokinesis protein 9,19490,181,1.09 [0.98-1.21],0.1059291089178147
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DOK1,Docking protein 1,20115,186,1.01 [0.91-1.11],0.923450408547258
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DOK2,Docking protein 2,23167,200,0.97 [0.88-1.08],0.5861198888549863
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DPEP1,Dipeptidase 1,22926,199,1.27 [0.98-1.65],0.0713338881760787
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DPEP2,Dipeptidase 2,23056,203,0.97 [0.63-1.49],0.9005851168506571
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DPP10,Inactive dipeptidyl peptidase 10,23111,204,0.95 [0.67-1.36],0.785025364590756
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DPP4,Dipeptidyl peptidase 4,22777,199,0.96 [0.60-1.51],0.8451184979868809
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DPP6,Dipeptidyl aminopeptidase-like protein 6,23056,203,0.97 [0.67-1.40],0.876477988821387
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DPP7,Dipeptidyl peptidase 2,22994,199,0.83 [0.67-1.02],0.0742824222944665
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DPT,Dermatopontin,23453,207,0.75 [0.47-1.19],0.2217410823151509
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DPY30,Protein dpy-30 homolog,23268,204,0.94 [0.76-1.17],0.5901652209712506
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DRAXIN,Draxin,22961,199,1.02 [0.76-1.36],0.9099467711893756
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DRG2,Developmentally-regulated GTP-binding protein 2,23056,203,0.99 [0.80-1.24],0.961805118679754
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DSC2,Desmocollin-2,22956,200,1.18 [0.82-1.69],0.3661386717598311
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DSCAM,Down syndrome cell adhesion molecule,20106,189,1.60 [1.09-2.34],0.0162252966374834
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DSG2,Desmoglein-2,23193,202,1.10 [0.70-1.75],0.6802274708207625
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DSG3,Desmoglein-3,23268,206,1.07 [0.75-1.53],0.704851206892802
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DSG4,Desmoglein-4,22989,202,0.95 [0.74-1.22],0.6710741892319034
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DTD1,D-aminoacyl-tRNA deacylase 1,19723,185,0.97 [0.82-1.14],0.7144627229332721
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DTNB,Dystrobrevin beta,20012,185,1.61 [1.20-2.17],0.0014719277770581
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DTX2,Probable E3 ubiquitin-protein ligase DTX2,19609,185,0.88 [0.69-1.13],0.3255280125142968
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DTX3,Probable E3 ubiquitin-protein ligase DTX3,23056,203,0.96 [0.57-1.60],0.8645015577844912
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DTYMK,Thymidylate kinase,20148,187,0.99 [0.80-1.21],0.911685330051782
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DUOX2,Dual oxidase 2,22729,202,0.97 [0.81-1.16],0.7379144475175872
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DUSP13,Dual specificity protein phosphatase 13 isoform A,20057,185,0.73 [0.51-1.05],0.0912419835495961
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DUSP29,Dual specificity phosphatase 29,19609,185,1.19 [0.99-1.42],0.0631540550849763
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DUSP3,Dual specificity protein phosphatase 3,22634,201,0.92 [0.78-1.07],0.2762098792917999
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",20054,186,0.97 [0.85-1.12],0.7146522794774741
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DXO,Decapping and exoribonuclease protein,20115,186,0.95 [0.69-1.29],0.7376383943825581
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,20057,185,0.59 [0.40-0.88],0.0090206376574297
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DYNLT1,Dynein light chain Tctex-type 1,19609,185,0.89 [0.74-1.07],0.2215489833790919
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,DYNLT3,Dynein light chain Tctex-type 3,20057,185,0.84 [0.61-1.17],0.3028510350072754
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,22961,199,1.02 [0.90-1.17],0.7298637836494334
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EBI3_IL27,Interleukin-27,23313,204,1.46 [0.98-2.17],0.059919434498462
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ECE1,Endothelin-converting enzyme 1,22634,201,0.78 [0.54-1.12],0.172748107207948
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",20148,187,0.99 [0.82-1.21],0.9544412666470526
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ECHS1,"Enoyl-CoA hydratase, mitochondrial",19644,185,0.99 [0.85-1.14],0.8448513452546397
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ECI2,Enoyl-CoA delta isomerase 2,19464,178,1.04 [0.83-1.31],0.7248947669509922
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ECM1,Extracellular matrix protein 1,19651,180,0.85 [0.59-1.23],0.3844028750347659
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ECSCR,Endothelial cell-specific chemotaxis regulator,19490,181,1.02 [0.78-1.34],0.8745178056433858
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EDA2R,Tumor necrosis factor receptor superfamily member 27,23353,206,1.67 [1.25-2.23],0.000569316160445
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EDAR,Tumor necrosis factor receptor superfamily member EDAR,23111,204,1.01 [0.89-1.16],0.8304719461569178
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EDDM3B,Epididymal secretory protein E3-beta,20057,185,0.94 [0.72-1.23],0.6641275084205349
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,19464,178,1.29 [0.94-1.78],0.1186464810157003
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EDF1,Endothelial differentiation-related factor 1,20106,189,0.83 [0.66-1.04],0.1018951004373317
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,22729,202,0.90 [0.61-1.31],0.5761284822593349
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EDN1,Endothelin-1,19644,185,1.23 [0.76-1.99],0.3963610174394959
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EDNRB,Endothelin receptor type B,19556,179,0.73 [0.49-1.08],0.1147066213129744
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EEF1D,Elongation factor 1-delta,20148,187,0.94 [0.81-1.10],0.4380705117722203
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EFCAB14,EF-hand calcium-binding domain-containing protein 14,20054,186,0.72 [0.42-1.23],0.2277244818709999
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EFCAB2,Dynein regulatory complex protein 8,19789,185,0.92 [0.61-1.40],0.6996194379458847
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,23261,204,1.05 [0.70-1.55],0.8261886397914413
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EFHD1,EF-hand domain-containing protein D1,20106,189,0.87 [0.58-1.32],0.5172857916763847
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EFNA1,Ephrin-A1,23159,202,1.28 [0.84-1.93],0.2526592662374586
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EFNA4,Ephrin-A4,22925,199,1.01 [0.68-1.50],0.956921641124721
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EFNB2,Ephrin-B2,19609,185,1.09 [0.86-1.39],0.4512157971805391
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EGF,Pro-epidermal growth factor,23123,202,1.05 [0.93-1.18],0.436145055746975
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EGFL7,Epidermal growth factor-like protein 7,22648,194,0.96 [0.69-1.32],0.7827063773116791
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EGFLAM,Pikachurin,20054,186,0.34 [0.21-0.56],1.921677719765064e-05
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EGFR,Epidermal growth factor receptor,23453,207,0.43 [0.20-0.90],0.0254438317608081
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EGLN1,Egl nine homolog 1,23111,204,0.96 [0.76-1.20],0.7091135082231139
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EHBP1,EH domain-binding protein 1,20148,187,0.98 [0.81-1.19],0.85938692395431
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EHD3,EH domain-containing protein 3,19644,185,1.00 [0.89-1.13],0.9700829038833853
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",20115,186,0.86 [0.65-1.14],0.2888098334710535
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",19964,185,1.00 [0.88-1.14],0.9985700235833652
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,19464,178,1.06 [0.85-1.31],0.6229222648451557
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,19644,185,1.00 [0.71-1.40],0.992305102205138
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EIF4B,Eukaryotic translation initiation factor 4B,22961,199,1.03 [0.83-1.28],0.7975238720302482
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EIF4E,Eukaryotic translation initiation factor 4E,19556,179,0.93 [0.79-1.09],0.3724973688504429
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,23167,200,1.01 [0.83-1.22],0.9321897478353802
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,23393,205,0.99 [0.88-1.13],0.9118511597020486
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,20106,189,0.94 [0.76-1.17],0.6083929634839073
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EIF5,Eukaryotic translation initiation factor 5,19464,178,1.18 [0.87-1.61],0.2963781170200981
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EIF5A,Eukaryotic translation initiation factor 5A-1,22723,200,1.47 [1.07-2.03],0.0171182140665698
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ELAC1,Zinc phosphodiesterase ELAC protein 1,20106,189,0.96 [0.82-1.14],0.6513771106036859
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ELAVL4,ELAV-like protein 4,19490,181,1.10 [0.94-1.29],0.2406699625169656
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ELN,Elastin,20148,187,1.05 [0.71-1.57],0.7956169958661335
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ELOA,Elongin-A,23056,203,0.95 [0.75-1.20],0.6610019359378468
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ELOB,Elongin-B,19464,178,1.03 [0.71-1.48],0.8879221265826649
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENAH,Protein enabled homolog,22723,200,0.88 [0.67-1.16],0.3666691368585355
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENDOU,Poly(U)-specific endoribonuclease,18595,181,1.20 [0.92-1.56],0.1735445132015564
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENG,Endoglin,23453,207,0.62 [0.30-1.26],0.1857010526638016
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENO1,Alpha-enolase,23142,202,1.08 [0.92-1.26],0.3536486682843447
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENO2,Gamma-enolase,23351,205,0.97 [0.80-1.17],0.7423227257907843
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENO3,Beta-enolase,19644,185,1.05 [0.83-1.34],0.6804619197599167
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENOPH1,Enolase-phosphatase E1,20057,185,1.01 [0.78-1.31],0.9515840107837324
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,19464,178,0.87 [0.51-1.47],0.5962143257754151
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENPEP,Glutamyl aminopeptidase,19464,178,0.96 [0.69-1.33],0.7902522603870418
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,23453,207,0.98 [0.62-1.55],0.9251762690326528
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,23265,203,1.04 [0.77-1.39],0.812377009286188
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,19644,185,0.99 [0.67-1.46],0.9521433273167712
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,22395,197,0.89 [0.77-1.04],0.1403914261530145
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENSA,Alpha-endosulfine,20057,185,1.04 [0.80-1.36],0.7635685837266576
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,22648,194,1.10 [0.82-1.48],0.5201218576136641
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,22729,202,1.06 [0.59-1.91],0.8344627862014689
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,22729,202,1.00 [0.64-1.57],0.9864185873719992
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ENTR1,Endosome-associated-trafficking regulator 1,19644,185,1.02 [0.80-1.31],0.8489943545477683
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EP300,Histone acetyltransferase p300,19556,179,0.69 [0.42-1.13],0.1378318311595834
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EPB41L5,Band 4.1-like protein 5,19609,185,1.02 [0.81-1.28],0.881415555544628
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EPCAM,Epithelial cell adhesion molecule,23147,203,0.96 [0.85-1.09],0.5667040350721243
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EPGN,Epigen,20057,185,1.23 [0.97-1.57],0.0945689780681428
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EPHA1,Ephrin type-A receptor 1,23236,203,0.84 [0.57-1.22],0.3527564752715327
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EPHA10,Ephrin type-A receptor 10,22634,201,1.08 [0.91-1.29],0.3729075505953464
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EPHA2,Ephrin type-A receptor 2,22324,199,0.88 [0.58-1.32],0.533820182439527
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EPHA4,Ephrin type-A receptor 4,19723,185,0.70 [0.43-1.14],0.1515824597196548
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EPHB4,Ephrin type-B receptor 4,23453,207,0.85 [0.52-1.38],0.5068881144801644
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EPHB6,Ephrin type-B receptor 6,22926,199,1.09 [0.74-1.60],0.669217224266508
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EPHX2,Bifunctional epoxide hydrolase 2,22729,202,0.99 [0.80-1.21],0.8900795838009309
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EPN1,Epsin-1,19789,185,0.87 [0.62-1.24],0.4565050018568385
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EPO,Erythropoietin,23111,204,0.92 [0.77-1.10],0.3506007755490514
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EPPK1,Epiplakin,19644,185,1.03 [0.85-1.26],0.755411282252155
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,23308,206,0.57 [0.37-0.87],0.0100572283779185
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ERBB2,Receptor tyrosine-protein kinase erbB-2,23260,204,0.88 [0.52-1.49],0.6271385612502357
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ERBB3,Receptor tyrosine-protein kinase erbB-3,23094,203,1.10 [0.58-2.09],0.780264493844616
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ERBB4,Receptor tyrosine-protein kinase erbB-4,23260,204,1.08 [0.64-1.83],0.7665594023758847
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ERBIN,Erbin,23056,203,1.00 [0.89-1.13],0.9418574695777528
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ERC2,ERC protein 2,19609,185,1.02 [0.84-1.23],0.8628633913351998
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ERCC1,DNA excision repair protein ERCC-1,19420,180,0.90 [0.57-1.41],0.645369179319746
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EREG,Proepiregulin,22926,199,1.05 [0.90-1.22],0.5572920729054948
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ERI1,3'-5' exoribonuclease 1,19789,185,0.84 [0.55-1.30],0.4342864521216037
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ERMAP,Erythroid membrane-associated protein,19556,179,0.94 [0.68-1.31],0.7302873424241847
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,20057,185,0.89 [0.60-1.31],0.5414516385223798
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ERP29,Endoplasmic reticulum resident protein 29,19723,185,0.98 [0.87-1.10],0.7309650046283855
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ERP44,Endoplasmic reticulum resident protein 44,23012,202,1.12 [0.69-1.83],0.6354253916468342
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,19464,178,0.90 [0.64-1.28],0.5634689825664643
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ESAM,Endothelial cell-selective adhesion molecule,23453,207,0.88 [0.60-1.30],0.5299495666334757
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ESM1,Endothelial cell-specific molecule 1,23156,203,0.79 [0.55-1.14],0.2111416680728914
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ESPL1,Separin,19420,180,0.88 [0.67-1.16],0.3665874438795924
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ESR1,Estrogen receptor,19556,179,0.89 [0.67-1.18],0.4024622148925698
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ESYT2,Extended synaptotagmin-2,20115,186,1.00 [0.84-1.19],0.985259357927932
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EVI2B,Protein EVI2B,19420,180,0.66 [0.42-1.03],0.064428394771954
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EVI5,Ecotropic viral integration site 5 protein homolog,19556,179,0.89 [0.75-1.05],0.1593489922627326
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EVPL,Envoplakin,19789,185,0.79 [0.50-1.24],0.3067896709015046
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EXOSC10,Exosome component 10,19464,178,0.93 [0.72-1.21],0.5955281316740899
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EXTL1,Exostosin-like 1,19464,178,0.97 [0.72-1.33],0.8691923545655857
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,EZR,Ezrin,23351,205,0.99 [0.59-1.66],0.972257564446373
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,F10,Coagulation factor X,20164,189,0.95 [0.58-1.55],0.8266193046690038
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,F11,Coagulation factor XI,19898,184,0.98 [0.61-1.58],0.9258750633367472
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,F11R,Junctional adhesion molecule A,23193,202,1.01 [0.81-1.27],0.9061037117106484
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,F12,Coagulation factor XII,20182,187,1.24 [0.87-1.76],0.2289775246236954
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,F13B,Coagulation factor XIII B chain,20068,187,0.90 [0.52-1.56],0.7010170147043212
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,F2,Prothrombin,20182,187,0.53 [0.21-1.33],0.1788876107453534
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,F2R,Proteinase-activated receptor 1,23224,203,1.01 [0.81-1.27],0.8980489208486092
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,F3,Tissue factor,23214,202,0.78 [0.49-1.26],0.3149459074475426
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,F7,Coagulation factor VII,23253,204,1.25 [0.83-1.88],0.2848355514742345
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,F9,Coagulation factor IX,23243,204,1.62 [0.82-3.20],0.1669366510722711
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FABP1,"Fatty acid-binding protein, liver",23156,203,0.91 [0.79-1.04],0.1546994012158636
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FABP2,"Fatty acid-binding protein, intestinal",23167,200,0.91 [0.77-1.07],0.2381841485201871
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FABP3,"Fatty acid-binding protein, heart",20148,187,1.32 [1.02-1.69],0.0327429992829368
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FABP4,"Fatty acid-binding protein, adipocyte",23453,207,0.90 [0.70-1.16],0.4195065054995635
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FABP5,Fatty acid-binding protein 5,23263,205,1.11 [0.93-1.33],0.2373329550972203
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FABP6,Gastrotropin,22686,201,1.03 [0.83-1.27],0.8048190488782705
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FABP9,Fatty acid-binding protein 9,23111,204,0.88 [0.70-1.10],0.2615573185658661
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FADD,FAS-associated death domain protein,23167,200,1.01 [0.85-1.19],0.9326606481973324
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FAM13A,Protein FAM13A,20054,186,1.00 [0.81-1.24],0.9934265632673972
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FAM171A2,Protein FAM171A2,20106,189,0.98 [0.90-1.08],0.7309544970192453
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FAM171B,Protein FAM171B,20057,185,0.67 [0.37-1.22],0.1868229894426915
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FAM172A,Cotranscriptional regulator FAM172A,19644,185,1.00 [0.79-1.26],0.983871132130922
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FAM20A,Pseudokinase FAM20A,20148,187,1.34 [0.83-2.18],0.2369622842038706
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FAM3B,Protein FAM3B,23056,203,0.74 [0.52-1.05],0.0964731046832334
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FAM3C,Protein FAM3C,23124,200,0.71 [0.46-1.08],0.1082655564081434
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FAM3D,Protein FAM3D,20054,186,1.01 [0.86-1.19],0.91636486152738
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FAP,Prolyl endopeptidase FAP,23453,207,1.08 [0.68-1.71],0.7366758945504358
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FARSA,Phenylalanine--tRNA ligase alpha subunit,19609,185,1.01 [0.83-1.24],0.8898788904994802
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FAS,Tumor necrosis factor receptor superfamily member 6,23385,207,0.77 [0.51-1.17],0.2258764084332123
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FASLG,Tumor necrosis factor ligand superfamily member 6,23393,205,0.74 [0.53-1.02],0.0693775501210447
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FBLN2,Fibulin-2,20163,187,0.75 [0.48-1.18],0.2148790468708364
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FBN2,Fibrillin-2,19609,185,1.13 [0.89-1.43],0.3173806211009594
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FBP1,"Fructose-1,6-bisphosphatase 1",23167,200,0.91 [0.76-1.08],0.2769070459652072
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,20148,187,0.94 [0.78-1.14],0.5395629120527979
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FCAR,Immunoglobulin alpha Fc receptor,23111,204,0.83 [0.64-1.07],0.1565970047766006
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,20106,189,0.72 [0.40-1.28],0.2611343136376974
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FCER2,Low affinity immunoglobulin epsilon Fc receptor,23193,202,1.13 [0.90-1.41],0.2860072147284836
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,23094,203,1.19 [0.94-1.50],0.1415316111349318
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,22648,194,0.95 [0.76-1.19],0.6730326176056634
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,23214,203,0.87 [0.68-1.11],0.2575223862569448
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FCN1,Ficolin-1,20119,189,0.87 [0.69-1.10],0.2484917909505614
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FCN2,Ficolin-2,23096,204,1.03 [0.76-1.40],0.8563397341974578
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FCRL1,Fc receptor-like protein 1,23167,200,1.06 [0.81-1.38],0.6949689758385915
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FCRL2,Fc receptor-like protein 2,23272,204,0.88 [0.69-1.13],0.3169475046525363
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FCRL3,Fc receptor-like protein 3,22723,200,1.00 [0.80-1.25],0.9864995786143058
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FCRL5,Fc receptor-like protein 5,23193,202,0.80 [0.64-0.99],0.039735513351114
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FCRL6,Fc receptor-like protein 6,23111,204,0.96 [0.81-1.15],0.6777945510996245
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FCRLB,Fc receptor-like B,22648,194,0.97 [0.78-1.19],0.7445589182743295
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FDX1,"Adrenodoxin, mitochondrial",19464,178,0.99 [0.78-1.26],0.9506691132730242
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FDX2,"Ferredoxin-2, mitochondrial",19464,178,0.88 [0.67-1.16],0.373874411114252
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FEN1,Flap endonuclease 1,22648,194,1.01 [0.83-1.22],0.936451398902585
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FES,Tyrosine-protein kinase Fes/Fps,22648,194,0.99 [0.76-1.30],0.958214477244466
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FETUB,Fetuin-B,23243,204,1.25 [0.84-1.86],0.2711451434409621
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGA,Fibrinogen alpha chain,19711,181,1.25 [0.79-1.99],0.3469106895113223
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",20106,189,0.98 [0.82-1.16],0.7885372100588974
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGF12,Fibroblast growth factor 12,19556,179,0.90 [0.63-1.28],0.5419947795133002
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGF16,Fibroblast growth factor 16,19556,179,1.04 [0.77-1.40],0.8123143875008387
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGF19,Fibroblast growth factor 19,23265,203,1.00 [0.85-1.17],0.9512252619702768
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGF2,Fibroblast growth factor 2,23111,204,0.99 [0.83-1.19],0.9135844186417914
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGF20,Fibroblast growth factor 20,19556,179,0.87 [0.61-1.24],0.4437070608917084
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGF21,Fibroblast growth factor 21,23313,204,1.11 [1.00-1.24],0.0405233179971558
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGF23,Fibroblast growth factor 23,23319,206,1.09 [0.87-1.37],0.450248260243963
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGF3,Fibroblast growth factor 3,19556,179,0.82 [0.48-1.38],0.4515153615217155
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGF5,Fibroblast growth factor 5,22723,200,1.30 [0.90-1.88],0.1695133210884294
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGF6,Fibroblast growth factor 6,19556,179,1.06 [0.76-1.48],0.7257146158112082
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGF7,Fibroblast growth factor 7,19420,180,0.92 [0.76-1.13],0.4411295765558116
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGF9,Fibroblast growth factor 9,19390,180,0.75 [0.54-1.05],0.0960085079541127
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGFBP1,Fibroblast growth factor-binding protein 1,23260,204,0.93 [0.64-1.37],0.7304238491678245
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGFBP2,Fibroblast growth factor-binding protein 2,20163,187,0.85 [0.64-1.12],0.2514982244852744
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGFBP3,Fibroblast growth factor-binding protein 3,20115,186,0.59 [0.40-0.87],0.0072929612022019
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGFR2,Fibroblast growth factor receptor 2,23260,204,0.93 [0.52-1.65],0.8038077975430777
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGFR4,Fibroblast growth factor receptor 4,19723,185,0.85 [0.65-1.11],0.2288121474342504
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGL1,Fibrinogen-like protein 1,20164,189,1.03 [0.83-1.27],0.8052160163184905
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FGR,Tyrosine-protein kinase Fgr,22634,201,1.08 [0.89-1.30],0.4416194359650468
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FH,"Fumarate hydratase, mitochondrial",19490,181,1.10 [0.95-1.28],0.2118327671684448
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FHIP2A,FHF complex subunit HOOK interacting protein 2A,19464,178,0.81 [0.58-1.13],0.2089429394300324
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FHIT,Bis(5'-adenosyl)-triphosphatase,22634,201,1.10 [0.92-1.31],0.285778540597285
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FIS1,Mitochondrial fission 1 protein,23168,203,1.02 [0.87-1.20],0.7885622165083135
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,20106,189,0.97 [0.84-1.12],0.6966781310910042
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,23208,203,1.02 [0.91-1.14],0.7134684312360762
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,22961,199,1.16 [0.87-1.55],0.3112879515147567
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,22961,199,1.06 [0.93-1.21],0.4032182135109066
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,22599,201,0.93 [0.71-1.23],0.6244490688334343
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FKBPL,FK506-binding protein-like,20054,186,1.03 [0.81-1.31],0.8137193590751373
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FLI1,Friend leukemia integration 1 transcription factor,22648,194,0.97 [0.86-1.09],0.6073502554177614
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,22961,199,1.32 [0.85-2.05],0.215205929717185
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FLT1,Vascular endothelial growth factor receptor 1,23017,203,1.01 [0.57-1.81],0.9629866859654164
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FLT3,Receptor-type tyrosine-protein kinase FLT3,22648,194,0.88 [0.58-1.35],0.5696954733598354
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FLT3LG,Fms-related tyrosine kinase 3 ligand,23393,205,0.92 [0.65-1.32],0.6635310115141569
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FLT4,Vascular endothelial growth factor receptor 3,23260,204,0.73 [0.51-1.04],0.0820583076206648
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FMNL1,Formin-like protein 1,22634,201,1.04 [0.87-1.25],0.6472401352365211
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FMR1,Synaptic functional regulator FMR1,22648,194,1.17 [0.82-1.68],0.3896271967622563
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FN1,Fibronectin,20182,187,0.89 [0.52-1.51],0.6550253673727348
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FNDC1,Fibronectin type III domain-containing protein 1,20115,186,1.08 [0.80-1.46],0.6159193073721168
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,20057,185,0.85 [0.56-1.31],0.4651392199696096
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FOLH1,Glutamate carboxypeptidase 2,19556,179,0.90 [0.76-1.06],0.2045917005414639
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FOLR1,Folate receptor alpha,23160,203,1.21 [0.80-1.83],0.3637690840150335
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FOLR2,Folate receptor beta,23351,205,1.47 [0.97-2.23],0.0682805960914896
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FOLR3,Folate receptor gamma,23187,203,1.02 [0.96-1.09],0.5233541820220529
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FOS,Proto-oncogene c-Fos,19390,180,0.87 [0.58-1.30],0.4981866491409311
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FOSB,Protein fosB,22634,201,0.89 [0.63-1.26],0.5017924092730042
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FOXJ3,Forkhead box protein J3,19556,179,0.92 [0.66-1.29],0.6361682831691042
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FOXO1,Forkhead box protein O1,23111,204,1.00 [0.86-1.15],0.9672207602501536
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FOXO3,Forkhead box protein O3,22648,194,0.91 [0.79-1.05],0.1874213854624508
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FRMD4B,FERM domain-containing protein 4B,19464,178,1.08 [0.88-1.32],0.4646222193508511
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FRMD7,FERM domain-containing protein 7,19609,185,1.06 [0.70-1.61],0.7694440111881896
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FRZB,Secreted frizzled-related protein 3,22889,199,1.13 [0.68-1.90],0.6302729746866713
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FSHB,Follitropin subunit beta,19644,185,1.01 [0.78-1.32],0.9141034033402916
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FST,Follistatin,23224,203,0.95 [0.73-1.22],0.672884385456223
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FSTL1,Follistatin-related protein 1,19644,185,1.36 [0.73-2.53],0.337888587865186
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FSTL3,Follistatin-related protein 3,23117,203,0.99 [0.67-1.47],0.9748656076206138
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FTCD,Formimidoyltransferase-cyclodeaminase,20070,186,0.99 [0.83-1.17],0.8864623463861245
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FUCA1,Tissue alpha-L-fucosidase,23324,207,1.04 [0.89-1.20],0.6382360444503593
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FUOM,Fucose mutarotase,19723,185,1.03 [0.82-1.30],0.7829231671230267
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FURIN,Furin,23260,204,1.16 [0.79-1.71],0.4425476121159784
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FUS,RNA-binding protein FUS,22615,194,0.99 [0.71-1.37],0.9439202588353972
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",19747,185,1.09 [0.88-1.34],0.4348814491433905
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,23351,205,0.98 [0.75-1.27],0.8553829383333608
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FUT8,"Alpha-(1,6)-fucosyltransferase",22961,199,0.99 [0.80-1.23],0.9504986707534784
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FXN,"Frataxin, mitochondrial",23353,206,1.03 [0.87-1.22],0.7122731118645231
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FXYD5,FXYD domain-containing ion transport regulator 5,22723,200,1.00 [0.82-1.22],0.9918486225306092
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FYB1,FYN-binding protein 1,23149,202,0.99 [0.86-1.13],0.8303070797206573
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FZD10,Frizzled-10,19609,185,1.00 [0.79-1.27],0.9696493205953776
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,FZD8,Frizzled-8,19490,181,1.14 [0.84-1.53],0.3986609354634242
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GABARAP,Gamma-aminobutyric acid receptor-associated protein,20057,185,0.88 [0.65-1.19],0.4086578261039372
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,19789,185,0.98 [0.79-1.22],0.8352816405994032
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,19490,181,1.04 [0.83-1.30],0.7315209463619565
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GAD1,Glutamate decarboxylase 1,19420,180,0.56 [0.32-0.97],0.0369934373381468
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GAD2,Glutamate decarboxylase 2,19556,179,0.82 [0.57-1.16],0.2612174136453243
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,19789,185,0.96 [0.70-1.31],0.8004322669672942
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,19644,185,1.02 [0.78-1.34],0.886680242522063
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GAGE2A,G antigen 2A,19420,180,0.90 [0.71-1.15],0.4170083417445568
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GAL,Galanin peptides,23265,203,1.25 [1.04-1.51],0.0197283922033872
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,23056,203,1.02 [0.65-1.60],0.9248936212520964
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,23353,206,0.47 [0.29-0.74],0.0010715720630041
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,22723,200,0.97 [0.72-1.30],0.8273618836793035
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,20148,187,1.33 [0.82-2.16],0.2519007662637152
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GALNT7,N-acetylgalactosaminyltransferase 7,23056,203,0.77 [0.43-1.38],0.3808910650534852
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GAMT,Guanidinoacetate N-methyltransferase,19464,178,0.96 [0.65-1.44],0.8610278446056154
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,19274,182,1.08 [0.69-1.68],0.7497800145957667
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GART,Trifunctional purine biosynthetic protein adenosine-3,20106,189,0.73 [0.41-1.30],0.2838062432573589
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GAS2,Growth arrest-specific protein 2,19789,185,0.90 [0.66-1.21],0.4746456684250723
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GAS6,Growth arrest-specific protein 6,23320,206,0.78 [0.48-1.28],0.3259402983897059
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GASK1A,Golgi-associated kinase 1A,19464,178,1.08 [0.77-1.51],0.6612179670426453
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GAST,Gastrin,20115,186,1.01 [0.92-1.12],0.7992652842377334
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,19420,180,0.63 [0.36-1.08],0.0926359313349915
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",19644,185,1.03 [0.85-1.24],0.784109889921401
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GBA,Lysosomal acid glucosylceramidase,19609,185,0.74 [0.57-0.97],0.0272868924611322
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GBP1,Guanylate-binding protein 1,20079,186,0.83 [0.68-1.02],0.0841069976570948
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GBP2,Guanylate-binding protein 2,22723,200,1.07 [0.87-1.32],0.5031613821314063
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GBP4,Guanylate-binding protein 4,22634,201,1.00 [0.77-1.29],0.9837735261029416
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GBP6,Guanylate-binding protein 6,19464,178,1.05 [0.77-1.43],0.7682770255593456
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GC,Vitamin D-binding protein,20182,187,1.59 [0.93-2.69],0.0883170917012958
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GCC1,GRIP and coiled-coil domain-containing protein 1,20115,186,0.97 [0.86-1.11],0.6988326425859028
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GCG,Pro-glucagon,22648,194,0.97 [0.88-1.08],0.5720999957974318
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,19242,180,0.89 [0.65-1.21],0.4620380862183283
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GCLM,Glutamate--cysteine ligase regulatory subunit,19464,178,1.13 [0.85-1.51],0.3910957681405186
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",23056,203,1.03 [0.72-1.48],0.8553235161985093
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GDF15,Growth/differentiation factor 15,23453,207,1.17 [0.90-1.54],0.2471201274596984
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GDF2,Growth/differentiation factor 2,23167,200,1.08 [0.76-1.53],0.681629273732552
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GDNF,Glial cell line-derived neurotrophic factor,22634,201,1.00 [0.72-1.39],0.9899238293344984
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GET3,ATPase GET3,20148,187,1.04 [0.80-1.34],0.782977766630432
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GFAP,Glial fibrillary acidic protein,22609,194,0.89 [0.68-1.16],0.4000258766822117
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GFER,FAD-linked sulfhydryl oxidase ALR,22648,194,1.07 [0.87-1.30],0.5375756419031981
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,22648,194,1.04 [0.95-1.15],0.3999349146731616
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GFRA1,GDNF family receptor alpha-1,23313,204,1.73 [1.15-2.60],0.0087186910905358
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GFRA2,GDNF family receptor alpha-2,23056,203,1.49 [0.83-2.66],0.1789429488536288
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GFRA3,GDNF family receptor alpha-3,22895,197,1.12 [0.72-1.75],0.6196502047146151
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GFRAL,GDNF family receptor alpha-like,19500,178,0.95 [0.75-1.21],0.6960814779830595
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GGA1,ADP-ribosylation factor-binding protein GGA1,22634,201,0.98 [0.80-1.19],0.8200788719893303
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GGACT,Gamma-glutamylaminecyclotransferase,20148,187,1.03 [0.84-1.25],0.7787274121492651
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GGCT,Gamma-glutamylcyclotransferase,20107,187,0.98 [0.73-1.32],0.8999344897639615
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GGH,Gamma-glutamyl hydrolase,22822,202,1.35 [0.95-1.92],0.0901356842145149
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GGT1,Glutathione hydrolase 1 proenzyme,23159,202,0.98 [0.76-1.27],0.9058343726525228
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GGT5,Glutathione hydrolase 5 proenzyme,22961,199,1.27 [0.74-2.18],0.3927752375515226
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GH1,Somatotropin,23124,200,1.01 [0.94-1.08],0.8670454554627821
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GH2,Growth hormone variant,22648,194,0.99 [0.92-1.07],0.8971600078174529
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GHR,Growth hormone receptor,19723,185,0.81 [0.49-1.35],0.4188961835870647
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GHRHR,Growth hormone-releasing hormone receptor,22634,201,1.00 [0.79-1.26],0.9935987117488468
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GHRL,Appetite-regulating hormone,23167,200,0.94 [0.81-1.09],0.3914077761335383
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GID8,Glucose-induced degradation protein 8 homolog,20106,189,0.80 [0.50-1.29],0.3590061360676561
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GIGYF2,GRB10-interacting GYF protein 2,20106,189,1.02 [0.85-1.22],0.8514329559570152
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GIMAP7,GTPase IMAP family member 7,19723,185,0.72 [0.44-1.17],0.1881426929400907
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GIMAP8,GTPase IMAP family member 8,19420,180,1.09 [0.84-1.42],0.5009350384455099
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GIP,Gastric inhibitory polypeptide,19644,185,0.99 [0.78-1.26],0.9502300811184766
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GIPC2,PDZ domain-containing protein GIPC2,20115,186,0.87 [0.54-1.39],0.5549473549593016
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GIPC3,PDZ domain-containing protein GIPC3,20054,186,0.96 [0.84-1.11],0.6068913730682852
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GIPR,Gastric inhibitory polypeptide receptor,19556,179,0.86 [0.61-1.20],0.3735148209825831
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GIT1,ARF GTPase-activating protein GIT1,19556,179,0.97 [0.84-1.13],0.7303987007378696
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GJA8,Gap junction alpha-8 protein,19420,180,0.86 [0.66-1.11],0.2337844768245647
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GKN1,Gastrokine-1,22200,193,0.83 [0.52-1.32],0.4222733993156028
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GLA,Alpha-galactosidase A,19695,185,1.13 [0.77-1.65],0.5307426634457295
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GLB1,Beta-galactosidase,22961,199,1.10 [0.81-1.49],0.527041739668806
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GLI2,Zinc finger protein GLI2,19556,179,0.68 [0.41-1.12],0.1279439934141848
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GLO1,Lactoylglutathione lyase,22729,202,1.11 [0.90-1.38],0.3221088781419352
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GLOD4,Glyoxalase domain-containing protein 4,23127,203,1.17 [0.82-1.67],0.3915296140228149
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GLP1R,Glucagon-like peptide 1 receptor,19490,181,1.24 [0.88-1.73],0.2161528938831772
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GLRX,Glutaredoxin-1,23011,199,0.99 [0.79-1.23],0.91605584349634
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",19723,185,0.98 [0.84-1.15],0.8302859000902827
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,22634,201,1.08 [0.83-1.40],0.562607087915101
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GLYR1,Putative oxidoreductase GLYR1,20057,185,0.86 [0.65-1.13],0.2675485476203436
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GM2A,Ganglioside GM2 activator,19653,182,0.92 [0.63-1.34],0.6560409054176339
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GMFG,Glia maturation factor gamma,20148,187,0.90 [0.74-1.10],0.3153222709480476
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GMPR,GMP reductase 1,23393,205,1.04 [0.81-1.34],0.7396421862333366
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GMPR2,GMP reductase 2,19723,185,1.01 [0.81-1.24],0.9504450941828756
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GNAS,Neuroendocrine secretory protein 55,20106,189,0.97 [0.82-1.15],0.700603816965395
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,22648,194,1.05 [0.86-1.27],0.6347442019554466
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,19609,185,0.79 [0.57-1.10],0.1639567905983584
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GNLY,Granulysin,23193,202,0.83 [0.66-1.05],0.1143856330524022
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GNPDA1,Glucosamine-6-phosphate isomerase 1,19644,185,0.82 [0.51-1.31],0.4026792702613428
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GNPDA2,Glucosamine-6-phosphate isomerase 2,19723,185,0.81 [0.55-1.21],0.3022952722168544
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GOLGA3,Golgin subfamily A member 3,20106,189,1.01 [0.85-1.21],0.8986372751035969
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GOLM2,Protein GOLM2,23351,205,1.14 [0.66-1.96],0.6443335162433996
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,23111,204,1.05 [0.93-1.18],0.4685278959553045
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GORASP2,Golgi reassembly-stacking protein 2,20054,186,0.82 [0.60-1.11],0.20416925343304
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GOT1,"Aspartate aminotransferase, cytoplasmic",20163,187,1.04 [0.74-1.45],0.8249532899205345
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GP1BA,Platelet glycoprotein Ib alpha chain,23092,204,1.08 [0.74-1.58],0.6753315604749119
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GP1BB,Platelet glycoprotein Ib beta chain,19464,178,0.96 [0.78-1.19],0.7119701422005329
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,22440,198,1.07 [0.93-1.24],0.3331781655884548
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GP5,Platelet glycoprotein V,19723,185,0.79 [0.54-1.16],0.2350072797457657
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GP6,Platelet glycoprotein VI,23149,202,1.02 [0.89-1.18],0.7458469678792341
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GPA33,Cell surface A33 antigen,23056,203,0.98 [0.89-1.07],0.5920653939487299
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GPC1,Glypican-1,23353,206,1.00 [0.66-1.51],0.9844581222385624
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GPC5,Glypican-5,22961,199,0.85 [0.68-1.06],0.1504340867252973
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GPD1,Glycerol-3-phosphate dehydrogenase,20057,185,0.91 [0.68-1.21],0.5146166109695764
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GPHA2,Glycoprotein hormone alpha-2,20054,186,0.90 [0.65-1.27],0.5578414095703503
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GPI,Glucose-6-phosphate isomerase,20164,189,0.90 [0.66-1.21],0.4759740415566381
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,20054,186,0.90 [0.74-1.08],0.2431399005442999
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GPKOW,G-patch domain and KOW motifs-containing protein,22634,201,0.85 [0.54-1.34],0.4906265839877746
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GPNMB,Transmembrane glycoprotein NMB,22537,197,0.83 [0.54-1.30],0.4193634023200119
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GPR101,Probable G-protein coupled receptor 101,19490,181,0.86 [0.65-1.14],0.2835114553347622
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GPR158,Probable G-protein coupled receptor 158,20106,189,0.78 [0.50-1.20],0.2529684009895599
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GPR15L,Protein GPR15L,20054,186,0.92 [0.73-1.16],0.4939121548879898
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GPR37,Prosaposin receptor GPR37,22729,202,1.11 [0.92-1.35],0.2584480258295059
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GPRC5C,G-protein coupled receptor family C group 5 member C,20057,185,0.90 [0.69-1.18],0.4469309152522983
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GRAP2,GRB2-related adapter protein 2,23167,200,0.99 [0.90-1.09],0.8587579847010427
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,20148,187,1.02 [0.81-1.27],0.8797067975333864
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GRIK2,"Glutamate receptor ionotropic, kainate 2",20106,189,0.96 [0.69-1.32],0.7849736396899709
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",19490,181,1.08 [0.86-1.36],0.5141793351058352
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GRK5,G protein-coupled receptor kinase 5,22729,202,1.02 [0.80-1.31],0.858175405250443
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GRN,Progranulin,23081,202,1.14 [0.68-1.92],0.6091187723716701
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GRP,Gastrin-releasing peptide,19644,185,0.97 [0.75-1.25],0.8027839350041417
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GRPEL1,"GrpE protein homolog 1, mitochondrial",23056,203,1.05 [0.85-1.29],0.669505770892797
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GRSF1,G-rich sequence factor 1,19321,179,0.88 [0.73-1.06],0.191598835974027
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GSAP,Gamma-secretase-activating protein,22648,194,1.08 [0.94-1.23],0.267625420528474
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GSN,Gelsolin,20097,186,0.85 [0.42-1.74],0.6542300893775039
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GSR,"Glutathione reductase, mitochondrial",20045,189,0.83 [0.45-1.56],0.5689567871866347
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GSTA1,Glutathione S-transferase A1,23128,200,0.99 [0.85-1.15],0.8817069575160074
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GSTA3,Glutathione S-transferase A3,22648,194,0.99 [0.83-1.17],0.8896766938409592
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GSTM4,Glutathione S-transferase Mu 4,19464,178,0.95 [0.77-1.17],0.651755937590441
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GSTP1,Glutathione S-transferase P,22493,200,1.00 [0.83-1.20],0.9969372369988208
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GSTT2B,Glutathione S-transferase theta-2B,20115,186,0.98 [0.93-1.04],0.5491032678564315
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,19789,185,0.94 [0.76-1.17],0.5916989192671998
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GTPBP2,GTP-binding protein 2,19609,185,0.99 [0.83-1.18],0.9025245736896004
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GUCA2A,Guanylin,23075,202,0.97 [0.68-1.39],0.882066546826424
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GUCY2C,Heat-stable enterotoxin receptor,19789,185,0.72 [0.57-0.91],0.005659885094363
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GUK1,Guanylate kinase,19464,178,0.90 [0.60-1.34],0.6083423181937433
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GUSB,Beta-glucuronidase,23289,207,0.76 [0.62-0.94],0.0102529290692261
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GYS1,"Glycogen [starch] synthase, muscle",22729,202,1.02 [0.89-1.17],0.7462170630211784
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GZMA,Granzyme A,23393,205,0.82 [0.57-1.17],0.274944881517104
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GZMB,Granzyme B,23111,204,0.92 [0.75-1.12],0.3882636225163377
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,GZMH,Granzyme H,22729,202,0.92 [0.78-1.09],0.3344583140308559
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,H2AP,Huntingtin-interacting protein M,19420,180,0.84 [0.60-1.17],0.3006882604612627
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",19464,178,1.28 [1.12-1.48],0.0005059219203036
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",23276,203,0.98 [0.83-1.16],0.8167691161827838
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HAO1,Hydroxyacid oxidase 1,23353,206,0.99 [0.90-1.10],0.9000818005703849
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HARS1,"Histidine--tRNA ligase, cytoplasmic",23193,202,0.99 [0.84-1.17],0.9193402348712684
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HAVCR1,Hepatitis A virus cellular receptor 1,23316,205,1.13 [0.94-1.37],0.1928323651720951
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HAVCR2,Hepatitis A virus cellular receptor 2,23193,202,0.98 [0.69-1.39],0.9153857770737838
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HBEGF,Proheparin-binding EGF-like growth factor,23276,203,1.07 [0.91-1.27],0.4084329459802561
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HBQ1,Hemoglobin subunit theta-1,23353,206,0.94 [0.77-1.15],0.5396880160757609
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HBZ,Hemoglobin subunit zeta,20148,187,1.10 [0.97-1.26],0.1329396016059156
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HCG22,Protein PBMUCL2,19464,178,0.92 [0.68-1.24],0.568053078368866
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HCLS1,Hematopoietic lineage cell-specific protein,23393,205,0.98 [0.79-1.23],0.8787809750964528
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HDAC8,Histone deacetylase 8,19556,179,0.93 [0.72-1.20],0.557114832706677
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HDAC9,Histone deacetylase 9,19490,181,1.02 [0.83-1.26],0.8499173313730641
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HDDC2,5'-deoxynucleotidase HDDC2,20054,186,1.03 [0.75-1.41],0.8569597112711212
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HDGF,Hepatoma-derived growth factor,23310,206,0.96 [0.84-1.09],0.5170070098400753
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HDGFL2,Hepatoma-derived growth factor-related protein 2,20115,186,0.94 [0.75-1.18],0.5967094406749661
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HEBP1,Heme-binding protein 1,22729,202,1.10 [0.89-1.36],0.3964426008163514
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HEG1,Protein HEG homolog 1,19723,185,0.64 [0.38-1.10],0.1082313310130664
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HEPACAM2,HEPACAM family member 2,20115,186,0.93 [0.67-1.30],0.6664213893210118
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HEPH,Hephaestin,20148,187,1.06 [0.62-1.81],0.8416665846707446
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HEXIM1,Protein HEXIM1,23111,204,1.04 [0.89-1.21],0.6075672052173873
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HGF,Hepatocyte growth factor,23393,205,1.12 [0.78-1.60],0.5362026690915793
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HGFAC,Hepatocyte growth factor activator,19972,189,0.69 [0.48-0.98],0.0401452052326062
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,22648,194,1.04 [0.88-1.23],0.6314733433804176
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HHEX,Hematopoietically-expressed homeobox protein HHEX,20115,186,1.06 [0.88-1.27],0.5537601149874705
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HIF1A,Hypoxia-inducible factor 1-alpha,19556,179,0.91 [0.71-1.17],0.4643967438516925
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HIP1,Huntingtin-interacting protein 1,19464,178,0.71 [0.43-1.17],0.1759102280614575
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HIP1R,Huntingtin-interacting protein 1-related protein,20069,186,0.92 [0.66-1.28],0.6216182120997453
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HJV,Hemojuvelin,20106,189,0.87 [0.62-1.23],0.439585721274939
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HK2,Hexokinase-2,22729,202,1.44 [0.94-2.20],0.0931936918294046
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HLA-A,"HLA class I histocompatibility antigen, A alpha chain",20106,189,1.20 [0.78-1.83],0.4089854536546365
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",23044,204,0.90 [0.64-1.27],0.5649736131833532
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",23111,204,0.97 [0.64-1.48],0.9056088583114932
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HMBS,Porphobilinogen deaminase,23353,206,1.04 [0.79-1.39],0.7679140475383991
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HMCN2,Hemicentin-2,19691,185,1.07 [0.84-1.38],0.5822104984141858
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",19644,185,0.89 [0.66-1.20],0.4551048989036275
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",19464,178,1.22 [0.91-1.64],0.1863450060345879
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HMMR,Hyaluronan mediated motility receptor,19376,180,0.92 [0.68-1.25],0.5943966259520043
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HMOX1,Heme oxygenase 1,22907,199,0.91 [0.70-1.18],0.4668060209120266
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HMOX2,Heme oxygenase 2,22634,201,0.86 [0.64-1.15],0.3003873668743833
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HNF1A,Hepatocyte nuclear factor 1-alpha,19609,185,0.92 [0.74-1.15],0.4696481189183973
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HNMT,Histamine N-methyltransferase,22854,198,0.93 [0.71-1.22],0.6127884116876786
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,22666,202,1.02 [0.87-1.21],0.7695194723635003
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,20106,189,1.00 [0.76-1.33],0.9791713306067942
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HPCAL1,Hippocalcin-like protein 1,23393,205,1.07 [0.91-1.27],0.4157133663129474
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HPGDS,Hematopoietic prostaglandin D synthase,22648,194,0.81 [0.58-1.15],0.2432178596917998
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HPSE,Heparanase,19892,185,0.99 [0.85-1.15],0.8485001222463059
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HRAS,GTPase Hras,19741,184,0.94 [0.80-1.10],0.4338774850527199
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,19644,185,0.84 [0.54-1.30],0.4270341446247678
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HRG,Histidine-rich glycoprotein,20068,187,1.13 [0.72-1.77],0.5936108910335096
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HS1BP3,HCLS1-binding protein 3,19644,185,1.01 [0.86-1.19],0.8699635321743684
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,23056,203,0.87 [0.62-1.21],0.3963886161873748
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,23353,206,1.05 [0.74-1.50],0.7749618905370823
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,19556,179,1.82 [1.25-2.64],0.0017558149849531
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HSBP1,Heat shock factor-binding protein 1,19644,185,1.06 [0.92-1.24],0.4224851987233873
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,23111,204,0.85 [0.62-1.16],0.3125557398566983
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,20115,186,1.09 [0.87-1.36],0.4650175209846678
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HSD17B3,Testosterone 17-beta-dehydrogenase 3,19464,178,1.19 [0.91-1.55],0.1971506686572841
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,19644,185,0.92 [0.68-1.24],0.5894204160748642
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HSP90B1,Endoplasmin,22518,199,0.95 [0.78-1.17],0.653410934957054
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HSPA1A,Heat shock 70 kDa protein 1A,23236,203,0.99 [0.83-1.18],0.8800257834771353
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HSPA2,Heat shock-related 70 kDa protein 2,20057,185,1.56 [1.11-2.18],0.0095812425844736
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HSPB1,Heat shock protein beta-1,22820,199,1.00 [0.83-1.20],0.99616281562327
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HSPB6,Heat shock protein beta-6,23353,206,1.70 [1.27-2.26],0.0003093052076985
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,23019,202,1.09 [0.68-1.73],0.7241038566415419
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HTR1A,5-hydroxytryptamine receptor 1A,19490,181,1.08 [0.91-1.28],0.4001705642350111
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HTR1B,5-hydroxytryptamine receptor 1B,19490,181,0.65 [0.44-0.97],0.0325401039523474
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HTRA2,"Serine protease HTRA2, mitochondrial",23260,204,0.99 [0.81-1.22],0.9392687341519844
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HYAL1,Hyaluronidase-1,23072,203,1.06 [0.61-1.82],0.8447121635298765
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,HYOU1,Hypoxia up-regulated protein 1,23453,207,0.74 [0.43-1.26],0.2604594823656115
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ICA1,Islet cell autoantigen 1,22723,200,1.06 [0.90-1.24],0.507583588297323
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ICAM1,Intercellular adhesion molecule 1,23086,204,1.25 [0.81-1.91],0.3165971647248766
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ICAM2,Intercellular adhesion molecule 2,23453,207,0.80 [0.55-1.16],0.2391065000589481
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ICAM3,Intercellular adhesion molecule 3,23453,207,0.68 [0.42-1.08],0.1025044335317851
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ICAM4,Intercellular adhesion molecule 4,23111,204,1.00 [0.79-1.27],0.9780856091219772
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ICAM5,Intercellular adhesion molecule 5,23167,200,0.85 [0.65-1.12],0.2412969406291781
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ICOSLG,ICOS ligand,23056,203,1.00 [0.52-1.91],0.9998226084945834
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ID4,DNA-binding protein inhibitor ID-4,19789,185,0.99 [0.71-1.37],0.9312094831332178
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IDI2,Isopentenyl-diphosphate delta-isomerase 2,22634,201,1.11 [0.87-1.43],0.394006637110089
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IDO1,"Indoleamine 2,3-dioxygenase 1",19644,185,0.76 [0.60-0.96],0.0217097417638122
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IDS,Iduronate 2-sulfatase,23393,205,2.09 [0.48-9.12],0.3256869201676555
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IDUA,Alpha-L-iduronidase,23353,206,0.96 [0.74-1.25],0.7507406814312962
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,19553,185,0.89 [0.61-1.29],0.533779717135966
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,19789,185,1.11 [0.86-1.44],0.4086391410489483
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,19789,185,0.89 [0.60-1.30],0.5401819240040556
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IFNAR1,Interferon alpha/beta receptor 1,20054,186,0.94 [0.54-1.64],0.8382348192482595
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IFNG,Interferon gamma,22723,200,1.04 [0.93-1.17],0.4710333278702202
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IFNGR1,Interferon gamma receptor 1,23265,203,0.91 [0.51-1.64],0.7542903587570555
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IFNGR2,Interferon gamma receptor 2,22961,199,0.94 [0.73-1.20],0.617604142429625
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IFNL1,Interferon lambda-1,22634,201,1.00 [0.76-1.32],0.9914579642124915
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IFNL2,Interferon lambda-2,19490,181,0.92 [0.72-1.19],0.5343408877670073
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IFNLR1,Interferon lambda receptor 1,23111,204,0.82 [0.57-1.19],0.2942966912269565
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IFNW1,Interferon omega-1,19464,178,1.03 [0.70-1.52],0.8623397264839253
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IFT20,Intraflagellar transport protein 20 homolog,19609,185,0.85 [0.60-1.19],0.3396329815792173
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGBP1,Immunoglobulin-binding protein 1,20106,189,0.98 [0.78-1.23],0.8532749359552018
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,19490,181,1.13 [0.88-1.45],0.3406829146183688
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,20163,187,1.20 [0.71-2.03],0.4898606005191688
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGF1R,Insulin-like growth factor 1 receptor,23056,203,0.85 [0.47-1.53],0.5853492713521293
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,19464,178,0.93 [0.67-1.29],0.6595607894003851
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGF2R,Cation-independent mannose-6-phosphate receptor,23193,202,1.12 [0.65-1.91],0.6911186049909273
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGFBP1,Insulin-like growth factor-binding protein 1,23416,206,0.98 [0.88-1.09],0.7056464213093423
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGFBP2,Insulin-like growth factor-binding protein 2,23425,206,1.10 [0.90-1.36],0.3544637765754246
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGFBP3,Insulin-like growth factor-binding protein 3,23291,204,1.41 [0.93-2.13],0.106249960154587
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGFBP4,Insulin-like growth factor-binding protein 4,22894,200,1.02 [0.77-1.35],0.866732454579586
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGFBP6,Insulin-like growth factor-binding protein 6,23083,203,1.10 [0.74-1.63],0.6477254218712619
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGFBP7,Insulin-like growth factor-binding protein 7,23453,207,0.92 [0.61-1.38],0.6727797521379495
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGFBPL1,Insulin-like growth factor-binding protein-like 1,23167,200,1.07 [0.74-1.55],0.7248190638062861
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGFL4,Insulin growth factor-like family member 4,19556,179,1.09 [0.92-1.29],0.3297127418075303
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGHMBP2,DNA-binding protein SMUBP-2,19464,178,0.84 [0.63-1.11],0.2112965744952567
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGLC2,Immunoglobulin lambda constant 2,20141,186,0.70 [0.36-1.37],0.3042551302441482
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGLON5,IgLON family member 5,19420,180,0.90 [0.75-1.07],0.2346503251988153
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGSF21,Immunoglobulin superfamily member 21,19644,185,1.05 [0.73-1.50],0.7953044228097998
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGSF3,Immunoglobulin superfamily member 3,23056,203,1.01 [0.71-1.45],0.9539206914814676
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGSF8,Immunoglobulin superfamily member 8,23167,200,0.98 [0.65-1.49],0.9422471559927236
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IGSF9,Protein turtle homolog A,20148,187,0.99 [0.83-1.18],0.907468035623588
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IKBKG,NF-kappa-B essential modulator,23111,204,1.05 [0.92-1.20],0.4800834801492351
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IKZF2,Zinc finger protein Helios,22648,194,1.00 [0.87-1.16],0.9804934623749972
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL10,Interleukin-10,22723,200,1.09 [0.95-1.26],0.2126940805883133
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL10RA,Interleukin-10 receptor subunit alpha,22723,200,0.83 [0.64-1.08],0.1632366267723844
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL10RB,Interleukin-10 receptor subunit beta,23265,203,0.96 [0.62-1.47],0.8336867264791812
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL11,Interleukin-11,22723,200,1.14 [0.96-1.36],0.1356505261250783
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL12A_IL12B,Interleukin-12,23056,203,1.12 [0.96-1.30],0.1590328546721972
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL12B,Interleukin-12 subunit beta,23393,205,1.16 [0.93-1.45],0.1861534122715096
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL12RB1,Interleukin-12 receptor subunit beta-1,22723,200,1.08 [0.78-1.50],0.647595329925762
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL12RB2,Interleukin-12 receptor subunit beta-2,19556,179,0.81 [0.56-1.17],0.2528821266711261
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL13,Interleukin-13,22723,200,1.09 [0.86-1.38],0.4693511248746147
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL13RA1,Interleukin-13 receptor subunit alpha-1,22908,200,0.92 [0.52-1.63],0.7816532567489372
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL13RA2,Interleukin-13 receptor subunit alpha-2,19490,181,0.73 [0.45-1.20],0.2184396184978355
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL15,Interleukin-15,23111,204,1.06 [0.73-1.54],0.7525317990261305
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL15RA,Interleukin-15 receptor subunit alpha,22723,200,0.95 [0.66-1.35],0.7620656769955325
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL16,Pro-interleukin-16,23393,205,0.91 [0.67-1.23],0.5287151804664397
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL17A,Interleukin-17A,22689,200,1.03 [0.78-1.37],0.832270766471053
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL17C,Interleukin-17C,22723,200,1.02 [0.86-1.21],0.8114546268714892
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL17D,Interleukin-17D,22723,200,0.88 [0.59-1.31],0.5193815213843382
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL17F,Interleukin-17F,22723,200,0.99 [0.83-1.17],0.8749808033469452
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL17RA,Interleukin-17 receptor A,23193,202,0.98 [0.74-1.30],0.8815246490622884
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL17RB,Interleukin-17 receptor B,22833,201,1.03 [0.81-1.31],0.8012077590868781
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL18,Interleukin-18,23088,202,0.95 [0.72-1.24],0.696873747747646
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL18BP,Interleukin-18-binding protein,23291,204,1.25 [0.85-1.84],0.2568528843653
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL18R1,Interleukin-18 receptor 1,23393,205,0.99 [0.68-1.45],0.9699072017608662
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL18RAP,Interleukin-18 receptor accessory protein,22817,199,0.98 [0.91-1.06],0.6000287415442644
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL19,Interleukin-19,22583,190,1.16 [0.97-1.37],0.100787530492891
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL1A,Interleukin-1 alpha,22723,200,1.13 [0.94-1.35],0.2055974400588348
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL1B,Interleukin-1 beta,22622,196,0.93 [0.74-1.17],0.5482905555776607
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL1R1,Interleukin-1 receptor type 1,23159,202,0.98 [0.57-1.69],0.9379269732704126
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL1R2,Interleukin-1 receptor type 2,23118,203,0.87 [0.46-1.63],0.6623295714188644
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL1RAP,Interleukin-1 receptor accessory protein,23193,202,0.87 [0.66-1.15],0.3180554402702099
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL1RL1,Interleukin-1 receptor-like 1,23385,207,1.09 [0.83-1.43],0.5302071752395539
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL1RL2,Interleukin-1 receptor-like 2,22723,200,1.01 [0.72-1.41],0.9636116526048382
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL1RN,Interleukin-1 receptor antagonist protein,23125,203,1.13 [0.90-1.41],0.2835049753590977
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL2,Interleukin-2,22723,200,1.03 [0.70-1.53],0.870811486401333
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL20,Interleukin-20,22723,200,0.91 [0.69-1.20],0.5065121077971673
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL20RA,Interleukin-20 receptor subunit alpha,22723,200,1.11 [0.87-1.42],0.3828419868912104
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL20RB,Interleukin-20 receptor subunit beta,19556,179,0.71 [0.49-1.02],0.0622582324668845
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL21R,Interleukin-21 receptor,19556,179,0.93 [0.71-1.23],0.6153418169433866
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL22,Interleukin-22,20057,185,1.07 [0.87-1.30],0.5229076768271455
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL22RA1,Interleukin-22 receptor subunit alpha-1,22723,200,0.90 [0.66-1.23],0.5083924016621645
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL24,Interleukin-24,22723,200,0.86 [0.66-1.13],0.287975170962657
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL25,Interleukin-25,19353,180,0.60 [0.40-0.91],0.015196066796334
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL2RA,Interleukin-2 receptor subunit alpha,22983,203,1.09 [0.81-1.46],0.5913426412656836
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL2RB,Interleukin-2 receptor subunit beta,22723,200,1.16 [0.87-1.55],0.3197842339814215
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL2RG,Cytokine receptor common subunit gamma,20057,185,0.94 [0.64-1.40],0.7762232035586083
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL3,Interleukin-3,19420,180,1.24 [0.96-1.60],0.0921578540013589
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL31,Interleukin-31,19556,179,0.88 [0.66-1.17],0.3760723504526887
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL31RA,Interleukin-31 receptor subunit alpha,19474,177,0.66 [0.45-0.97],0.0352071042944026
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL32,Interleukin-32,23111,204,1.15 [0.87-1.53],0.3305197299157966
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL33,Interleukin-33,22723,200,0.89 [0.65-1.23],0.4931799628461512
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL34,Interleukin-34,22600,200,1.03 [0.73-1.46],0.8772048586447523
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL36A,Interleukin-36 alpha,19556,179,0.87 [0.65-1.16],0.3460416379903497
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL36G,Interleukin-36 gamma,19467,179,1.14 [0.95-1.38],0.1678919058783545
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL3RA,Interleukin-3 receptor subunit alpha,22723,200,0.86 [0.58-1.28],0.4488422439356399
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL4,Interleukin-4,22723,200,0.93 [0.82-1.04],0.2108668368636064
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL4R,Interleukin-4 receptor subunit alpha,23111,204,1.09 [0.78-1.53],0.5983509761218503
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL5,Interleukin-5,22723,200,1.05 [0.97-1.14],0.2271084543250419
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL5RA,Interleukin-5 receptor subunit alpha,23111,204,0.85 [0.68-1.07],0.1616886087192405
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL6,Interleukin-6,23056,203,1.03 [0.88-1.21],0.6800181536053349
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL6R,Interleukin-6 receptor subunit alpha,23059,204,0.99 [0.69-1.43],0.967270647792712
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL6ST,Interleukin-6 receptor subunit beta,23167,200,0.95 [0.46-1.96],0.8854195449118414
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL7,Interleukin-7,23111,204,0.93 [0.76-1.13],0.4406744448173839
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL7R,Interleukin-7 receptor subunit alpha,23193,202,0.93 [0.73-1.18],0.555728820052677
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IL9,Interleukin-9,19789,185,0.82 [0.61-1.10],0.1925215201590717
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,22594,200,1.05 [0.85-1.30],0.6690407530481954
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IMMT,MICOS complex subunit MIC60,20057,185,1.06 [0.77-1.45],0.7299643851603992
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IMPA1,Inositol monophosphatase 1,22961,199,1.12 [0.91-1.38],0.2714806236746455
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IMPACT,Protein IMPACT,20115,186,0.99 [0.77-1.27],0.9173230144203552
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IMPG1,Interphotoreceptor matrix proteoglycan 1,19490,181,1.02 [0.64-1.63],0.9318066906162984
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ING1,Inhibitor of growth protein 1,22599,201,0.87 [0.66-1.15],0.3288127251124952
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,INHBB,Inhibin beta B chain,19723,185,0.87 [0.67-1.15],0.3340565830627234
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,INHBC,Inhibin beta C chain,23193,202,1.21 [0.88-1.64],0.2368857049060109
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,INPP1,Inositol polyphosphate 1-phosphatase,23056,203,0.98 [0.77-1.24],0.8664032392688422
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",19644,185,0.99 [0.77-1.28],0.9594048902342628
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",20106,189,1.38 [1.08-1.76],0.0097724016348633
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",23056,203,1.03 [0.90-1.17],0.7024230769164496
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,INSL3,Insulin-like 3,20115,186,0.98 [0.83-1.17],0.8551475271843585
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,INSL4,Early placenta insulin-like peptide,20057,185,0.69 [0.48-0.98],0.0393238218121502
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,INSL5,Insulin-like peptide INSL5,20054,186,0.90 [0.77-1.05],0.1678177705126612
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,INSR,Insulin receptor,19556,179,0.46 [0.20-1.09],0.0794530001342182
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IPCEF1,Interactor protein for cytohesin exchange factors 1,22925,199,1.02 [0.88-1.17],0.8213553479311891
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IQGAP2,Ras GTPase-activating-like protein IQGAP2,23056,203,0.97 [0.77-1.22],0.7918561985178754
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",22729,202,0.91 [0.78-1.06],0.2224313179533762
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IRAK1,Interleukin-1 receptor-associated kinase 1,22723,200,1.03 [0.86-1.24],0.7573200064340471
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IRAK4,Interleukin-1 receptor-associated kinase 4,23111,204,1.02 [0.91-1.15],0.7218515783678624
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,22327,197,0.97 [0.69-1.37],0.8714888464075257
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ISM1,Isthmin-1,23111,204,1.04 [0.75-1.44],0.8258672077687348
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ISM2,Isthmin-2,20163,187,0.76 [0.54-1.08],0.1299535567795563
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IST1,IST1 homolog,19906,185,1.00 [0.86-1.15],0.9564347745304737
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGA11,Integrin alpha-11,23111,204,0.56 [0.39-0.80],0.0016504737717455
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGA2,Integrin alpha-2,19723,185,0.65 [0.43-0.98],0.0386378609168557
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGA5,Integrin alpha-5,23193,202,0.69 [0.42-1.16],0.161761687373249
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGA6,Integrin alpha-6,23111,204,0.94 [0.73-1.20],0.6184587760032885
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGAL,Integrin alpha-L,19556,179,0.76 [0.56-1.02],0.0691612015804958
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGAM,Integrin alpha-M,23193,202,0.47 [0.32-0.71],0.0003209736673769
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGAV,Integrin alpha-V,23353,206,0.32 [0.18-0.56],8.004429937989622e-05
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGAX,Integrin alpha-X,19789,185,0.90 [0.68-1.19],0.4510437658430012
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGB1,Integrin beta-1,23178,204,1.06 [0.59-1.90],0.8567078114497779
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGB1BP1,Integrin beta-1-binding protein 1,22648,194,1.03 [0.76-1.41],0.8302424112723306
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGB1BP2,Integrin beta-1-binding protein 2,22729,202,1.03 [0.92-1.16],0.5687409802205595
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGB2,Integrin beta-2,23046,204,0.40 [0.26-0.64],9.665383334845656e-05
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGB5,Integrin beta-5,23260,204,0.56 [0.39-0.80],0.0015385110091806
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGB6,Integrin beta-6,22723,200,0.77 [0.51-1.17],0.2235144332104538
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGB7,Integrin beta-7,23353,206,0.84 [0.64-1.11],0.2146788514832107
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITGBL1,Integrin beta-like protein 1,20163,187,0.94 [0.64-1.37],0.7333911106742188
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,20182,187,0.39 [0.19-0.82],0.0124165342070252
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,23291,204,1.28 [0.91-1.78],0.1518936437994598
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,20182,187,0.89 [0.51-1.56],0.6921815098257773
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,20057,185,0.80 [0.57-1.13],0.2120395905126913
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITM2A,Integral membrane protein 2A,23111,204,1.00 [0.82-1.23],0.9689368411896522
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITPA,Inosine triphosphate pyrophosphatase,19464,178,1.10 [0.89-1.37],0.3629498142680782
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",19644,185,0.98 [0.79-1.21],0.8255202190329485
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",19490,181,0.98 [0.70-1.37],0.9120291591639798
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",22634,201,0.99 [0.77-1.27],0.9232813813223698
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,IZUMO1,Izumo sperm-egg fusion protein 1,19420,180,0.74 [0.52-1.07],0.1106021902304231
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,JAM2,Junctional adhesion molecule B,23351,205,1.00 [0.63-1.58],0.987204120201696
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,JAM3,Junctional adhesion molecule C,19723,185,0.87 [0.64-1.17],0.3458137591418387
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,JCHAIN,Immunoglobulin J chain,22723,200,0.97 [0.79-1.19],0.7601470532999534
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,19420,180,0.96 [0.74-1.24],0.7593460084088667
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,JPT2,Jupiter microtubule associated homolog 2,20054,186,0.98 [0.83-1.15],0.7841460052555684
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,JUN,Transcription factor AP-1,22723,200,1.04 [0.81-1.33],0.7718384919494924
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,23056,203,1.06 [0.81-1.40],0.66977654337649
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KAZN,Kazrin,20054,186,1.01 [0.88-1.15],0.9202056497474108
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KCNC4,Potassium voltage-gated channel subfamily C member 4,19490,181,1.21 [0.98-1.49],0.0818964112901808
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KCNH2,Potassium voltage-gated channel subfamily H member 2,19609,185,0.88 [0.71-1.08],0.2182373474987133
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KCNIP4,Kv channel-interacting protein 4,22634,201,0.93 [0.71-1.21],0.5743670973713878
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KCTD5,BTB/POZ domain-containing protein KCTD5,19749,186,0.92 [0.67-1.28],0.6305711689238949
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KDM3A,Lysine-specific demethylase 3A,19556,179,0.88 [0.73-1.07],0.2012011586846412
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KDR,Vascular endothelial growth factor receptor 2,23260,204,0.89 [0.54-1.46],0.6358067765739652
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KEL,Kell blood group glycoprotein,22634,201,0.78 [0.55-1.10],0.1554476566071129
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KHDC3L,KH domain-containing protein 3,19420,180,0.77 [0.59-1.01],0.0622665446048462
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KHK,Ketohexokinase,19644,185,1.05 [0.84-1.33],0.656388745845851
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KIAA0319,Dyslexia-associated protein KIAA0319,20115,186,0.65 [0.40-1.06],0.0823021207937266
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KIAA1549,UPF0606 protein KIAA1549,19789,185,0.81 [0.67-0.99],0.039227258791547
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KIAA1549L,UPF0606 protein KIAA1549L,19789,185,0.79 [0.47-1.32],0.3649861334815012
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KIAA2013,Uncharacterized protein KIAA2013,20057,185,1.03 [0.80-1.33],0.8022139399157547
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KIF1C,Kinesin-like protein KIF1C,19464,178,1.06 [0.71-1.58],0.7920774196120943
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KIF20B,Kinesin-like protein KIF20B,19490,181,1.07 [0.90-1.27],0.4621762834068502
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KIF22,Kinesin-like protein KIF22,19464,178,1.00 [0.89-1.12],0.9894038209541998
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KIFBP,KIF-binding protein,23056,203,1.00 [0.86-1.17],0.974244296619684
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,20057,185,1.00 [0.86-1.17],0.9853763930425956
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,22648,194,1.04 [0.89-1.22],0.61047043988397
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,20054,186,0.99 [0.91-1.07],0.7907426760763665
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,22648,194,1.00 [0.90-1.10],0.9239733110099532
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,19420,180,0.92 [0.76-1.12],0.4072096628471687
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KIRREL1,Kin of IRRE-like protein 1,19490,181,1.11 [0.89-1.39],0.3463487139305345
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KIRREL2,Kin of IRRE-like protein 2,22634,201,0.92 [0.67-1.27],0.6251076391121309
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KIT,Mast/stem cell growth factor receptor Kit,23243,204,1.10 [0.72-1.67],0.6594154384477493
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KITLG,Kit ligand,23167,200,0.88 [0.63-1.24],0.4732001401173462
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLB,Beta-klotho,22634,201,1.00 [0.85-1.18],0.9989536133630642
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLF4,Krueppel-like factor 4,19490,181,1.06 [0.75-1.49],0.7547923665544627
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLHL41,Kelch-like protein 41,20106,189,1.22 [0.94-1.59],0.140940988173229
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLK1,Kallikrein-1,22955,201,0.95 [0.86-1.05],0.2991554217294622
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLK10,Kallikrein-10,23189,204,1.07 [0.79-1.44],0.6716408241203983
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLK11,Kallikrein-11,23044,201,0.90 [0.60-1.35],0.6196976893406239
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLK12,Kallikrein-12,22648,194,1.04 [0.94-1.14],0.4474646526167496
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLK13,Kallikrein-13,22668,199,1.38 [1.05-1.81],0.0212693862943931
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLK14,Kallikrein-14,23353,206,1.24 [0.96-1.61],0.0975074552252642
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLK15,Kallikrein-15,20015,185,0.89 [0.69-1.17],0.4101380363409832
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLK3,Prostate-specific antigen,20163,187,0.90 [0.78-1.03],0.1334745073674894
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLK4,Kallikrein-4,23353,206,1.16 [0.96-1.40],0.1313441187333558
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLK6,Kallikrein-6,23215,203,1.02 [0.69-1.52],0.925398732208804
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLK7,Kallikrein-7,19221,181,1.44 [1.02-2.05],0.0396342091803548
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLK8,Kallikrein-8,22405,196,0.90 [0.63-1.28],0.5555690480732614
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLKB1,Plasma kallikrein,19755,182,0.86 [0.48-1.54],0.609211007814232
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLRB1,Killer cell lectin-like receptor subfamily B member 1,23393,205,0.81 [0.59-1.12],0.2130496117191249
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,19490,181,0.95 [0.74-1.22],0.6703054444516066
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLRD1,Natural killer cells antigen CD94,23393,205,1.02 [0.78-1.32],0.8937052215388406
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLRF1,Killer cell lectin-like receptor subfamily F member 1,19556,179,0.84 [0.58-1.21],0.3567907086349123
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KLRK1,NKG2-D type II integral membrane protein,20115,186,0.91 [0.68-1.23],0.5487476072006379
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KRT14,"Keratin, type I cytoskeletal 14",21930,193,0.87 [0.55-1.40],0.5772685119181328
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KRT17,"Keratin, type I cytoskeletal 17",19464,178,1.00 [0.69-1.46],0.9916465436767182
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KRT18,"Keratin, type I cytoskeletal 18",23056,203,1.06 [0.91-1.24],0.455004445889931
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KRT19,"Keratin, type I cytoskeletal 19",23064,204,0.85 [0.71-1.03],0.1057032317153056
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KRT5,"Keratin, type II cytoskeletal 5",22634,201,0.90 [0.70-1.16],0.4110842720719602
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KRT6C,"Keratin, type II cytoskeletal 6C",19464,178,0.98 [0.66-1.45],0.904441623298194
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KRT8,"Keratin, type II cytoskeletal 8",19490,181,1.07 [0.91-1.27],0.4070210724957793
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KYAT1,Kynurenine--oxoglutarate transaminase 1,23137,200,0.98 [0.78-1.22],0.8558983134277347
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,KYNU,Kynureninase,23393,205,1.00 [0.76-1.33],0.99231648439252
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,L1CAM,Neural cell adhesion molecule L1,23260,204,0.67 [0.44-1.03],0.0655484862025116
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,20148,187,0.93 [0.79-1.09],0.3683874580593488
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LACRT,Extracellular glycoprotein lacritin,20017,185,0.86 [0.63-1.17],0.3387214108432838
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LACTB2,Endoribonuclease LACTB2,23167,200,1.01 [0.83-1.22],0.951428451679792
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LAG3,Lymphocyte activation gene 3 protein,23056,203,1.02 [0.75-1.39],0.878188797376664
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,23156,203,0.95 [0.68-1.33],0.7844762155611462
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,22961,199,1.02 [0.90-1.15],0.7651290378404176
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LAMA1,Laminin subunit alpha-1,19464,178,1.07 [0.83-1.38],0.5947464093506194
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LAMA4,Laminin subunit alpha-4,23265,203,0.88 [0.60-1.28],0.4985462232868746
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LAMB1,Laminin subunit beta-1,19644,185,1.60 [0.99-2.59],0.0526942021480723
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LAMP1,Lysosome-associated membrane glycoprotein 1,19587,181,0.52 [0.27-1.01],0.0520521857746439
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LAMP2,Lysosome-associated membrane glycoprotein 2,22458,198,0.84 [0.45-1.58],0.5819065935895014
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LAMP3,Lysosome-associated membrane glycoprotein 3,23359,205,1.01 [0.79-1.27],0.9656145377281704
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LAMTOR5,Ragulator complex protein LAMTOR5,20057,185,1.05 [0.75-1.47],0.7727479187210905
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LAP3,Cytosol aminopeptidase,22723,200,1.06 [0.82-1.37],0.6768174092672226
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LARP1,La-related protein 1,20057,185,0.95 [0.75-1.20],0.6754765401611276
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LAT,Linker for activation of T-cells family member 1,23393,205,1.06 [0.90-1.24],0.5148170164999337
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LAT2,Linker for activation of T-cells family member 2,23056,203,1.02 [0.93-1.13],0.6482861291248326
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LATS1,Serine/threonine-protein kinase LATS1,19556,179,0.88 [0.74-1.05],0.1527600197216746
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LAYN,Layilin,22926,199,0.93 [0.65-1.33],0.6792806182020429
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LBP,Lipopolysaccharide-binding protein,23291,204,1.00 [0.81-1.23],0.996194430895565
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LBR,Delta(14)-sterol reductase LBR,23351,205,0.94 [0.78-1.14],0.5388782456974308
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LCAT,Phosphatidylcholine-sterol acyltransferase,20164,189,0.92 [0.49-1.73],0.7975300181849831
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LCN15,Lipocalin-15,20106,189,0.92 [0.73-1.18],0.5231088313216314
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LCN2,Neutrophil gelatinase-associated lipocalin,22516,197,1.03 [0.75-1.41],0.8672843334409521
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LCP1,Plastin-2,20163,187,0.83 [0.61-1.12],0.2213773297372036
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LDLR,Low-density lipoprotein receptor,23224,203,1.08 [0.85-1.38],0.5332255124472176
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LDLRAP1,Low density lipoprotein receptor adapter protein 1,20106,189,0.97 [0.84-1.12],0.6883507615434983
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LECT2,Leukocyte cell-derived chemotaxin-2,20148,187,0.83 [0.67-1.03],0.0876571543520255
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LEFTY2,Left-right determination factor 2,23313,204,0.78 [0.61-1.00],0.0470180006883604
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LEG1,Protein LEG1 homolog,19086,175,0.77 [0.61-0.96],0.0206626757403581
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LELP1,Late cornified envelope-like proline-rich protein 1,19490,181,1.02 [0.84-1.23],0.871469768648374
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LEO1,RNA polymerase-associated protein LEO1,20106,189,0.92 [0.59-1.46],0.7366809203374702
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LEP,Leptin,23167,200,0.90 [0.75-1.09],0.2721124735464532
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LEPR,Leptin receptor,23167,200,0.70 [0.46-1.06],0.0884571733833066
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LETM1,Mitochondrial proton/calcium exchanger protein,20106,189,1.02 [0.79-1.33],0.8544348193518375
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LGALS1,Galectin-1,23167,200,0.83 [0.57-1.20],0.3173758170594164
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LGALS3,Galectin-3,23230,206,0.74 [0.49-1.12],0.1557095427343301
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LGALS3BP,Galectin-3-binding protein,20182,187,0.86 [0.53-1.38],0.521601939399591
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LGALS4,Galectin-4,23156,203,0.91 [0.73-1.14],0.4284027813503439
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LGALS7_LGALS7B,Galectin-7,23075,204,1.31 [1.01-1.72],0.0458666081601141
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LGALS8,Galectin-8,23351,205,0.95 [0.77-1.17],0.6518818415030154
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LGALS9,Galectin-9,23156,203,0.88 [0.59-1.31],0.5204380268283697
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LGMN,Legumain,23265,203,1.20 [0.85-1.69],0.296742445694348
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LHB,Lutropin subunit beta,22648,194,1.10 [0.96-1.26],0.1863286477119478
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,23193,203,1.02 [0.83-1.25],0.8734205188116027
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LIF,Leukemia inhibitory factor,22634,201,0.96 [0.75-1.24],0.7605285381591997
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LIFR,Leukemia inhibitory factor receptor,23111,204,1.10 [0.65-1.85],0.7225780990625041
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,23193,202,0.81 [0.57-1.13],0.2174270898356853
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,20163,187,1.01 [0.91-1.12],0.8559828233569619
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,19464,178,0.88 [0.65-1.20],0.419837388576587
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,23124,200,0.74 [0.50-1.09],0.1309826803374982
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,20148,187,0.97 [0.80-1.17],0.7203846673068868
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,23453,207,0.93 [0.59-1.45],0.7506339311645621
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,23357,206,0.93 [0.66-1.33],0.6988770761074686
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,22723,200,1.26 [0.95-1.65],0.1037390693300593
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,23453,207,0.90 [0.76-1.06],0.2005749494079417
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LIPF,Gastric triacylglycerol lipase,19644,185,0.90 [0.71-1.13],0.3576062910879841
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LMNB1,Lamin-B1,20021,186,0.98 [0.78-1.23],0.8596766843725261
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LMNB2,Lamin-B2,20115,186,1.13 [0.69-1.85],0.62556201403754
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LMOD1,Leiomodin-1,20106,189,0.81 [0.53-1.25],0.3470111967983778
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LMOD2,Leiomodin-2,19490,181,0.78 [0.60-1.01],0.0600719478939008
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LONP1,"Lon protease homolog, mitochondrial",19644,185,0.98 [0.83-1.15],0.7788334280630604
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LPA,Apolipoprotein(a),19722,182,0.98 [0.90-1.06],0.5833400100765025
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LPCAT2,Lysophosphatidylcholine acyltransferase 2,23056,203,0.94 [0.69-1.28],0.6819379470942359
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LPL,Lipoprotein lipase,23167,200,0.85 [0.66-1.11],0.2289145169031871
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LPO,Lactoperoxidase,22370,195,0.97 [0.78-1.20],0.7517688005510552
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LPP,Lipoma-preferred partner,19464,178,1.03 [0.82-1.28],0.821094090445551
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,19464,178,0.98 [0.79-1.21],0.8225158400539001
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,19609,185,0.89 [0.64-1.24],0.4880060599312705
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRG1,Leucine-rich alpha-2-glycoprotein,20182,187,0.77 [0.46-1.30],0.3333401968240579
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,23276,203,0.93 [0.65-1.32],0.6707686131662901
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,19489,179,1.27 [0.79-2.05],0.3195282102815037
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRP1,Prolow-density lipoprotein receptor-related protein 1,23056,203,1.00 [0.62-1.59],0.9845982902548752
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRP11,Low-density lipoprotein receptor-related protein 11,23167,200,1.24 [0.88-1.74],0.2154579834677691
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRP2,Low-density lipoprotein receptor-related protein 2,19609,185,0.85 [0.56-1.27],0.4237733928125895
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRP2BP,LRP2-binding protein,19609,185,0.96 [0.80-1.14],0.6151665416756701
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,23351,205,1.12 [0.92-1.37],0.240602368672058
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRRC25,Leucine-rich repeat-containing protein 25,23056,203,0.95 [0.69-1.32],0.7570471491463625
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRRC37A2,Leucine-rich repeat-containing protein 37A2,20054,186,0.74 [0.53-1.02],0.0665805599749042
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRRC38,Leucine-rich repeat-containing protein 38,19609,185,0.79 [0.58-1.08],0.1380383786730241
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRRC59,Leucine-rich repeat-containing protein 59,20148,187,0.92 [0.68-1.24],0.5995164005480644
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,20057,185,1.19 [0.90-1.58],0.2139648280893618
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRRN1,Leucine-rich repeat neuronal protein 1,22723,200,0.74 [0.54-1.01],0.0602061367133506
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,19609,185,1.00 [0.71-1.41],0.9981272489478245
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,20106,189,0.80 [0.46-1.38],0.4197430518543281
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LSM1,U6 snRNA-associated Sm-like protein LSm1,22648,194,1.24 [1.03-1.50],0.0253876645024067
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LSM8,U6 snRNA-associated Sm-like protein LSm8,19789,185,1.14 [0.99-1.30],0.0647865171170043
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LSP1,Lymphocyte-specific protein 1,23111,204,1.00 [0.73-1.36],0.9821851869983866
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LTA,Lymphotoxin-alpha,23111,204,1.05 [0.77-1.42],0.7661412531379235
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LTA4H,Leukotriene A-4 hydrolase,23353,206,1.00 [0.81-1.23],0.9896685363688
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LTB,Lymphotoxin-beta,20057,185,1.46 [1.11-1.93],0.0071762256377469
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LTBP2,Latent-transforming growth factor beta-binding protein 2,23453,207,1.04 [0.70-1.53],0.8450015272856389
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LTBP3,Latent-transforming growth factor beta-binding protein 3,22648,194,0.92 [0.71-1.18],0.4997036065939322
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LTBR,Tumor necrosis factor receptor superfamily member 3,23059,203,0.97 [0.63-1.48],0.8783449042063565
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LTO1,Protein LTO1 homolog,22723,200,1.09 [0.82-1.46],0.5331529913336809
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LUZP2,Leucine zipper protein 2,20057,185,0.81 [0.58-1.13],0.2172497884831385
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LXN,Latexin,22863,199,1.13 [0.95-1.34],0.1720228098614526
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LY6D,Lymphocyte antigen 6D,23057,203,1.06 [0.77-1.46],0.7078955717121072
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LY75,Lymphocyte antigen 75,23111,204,1.11 [0.81-1.53],0.524503947035632
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LY9,T-lymphocyte surface antigen Ly-9,22863,200,0.86 [0.56-1.31],0.4722686085818482
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LY96,Lymphocyte antigen 96,22961,199,0.87 [0.61-1.25],0.4563490259018552
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LYAR,Cell growth-regulating nucleolar protein,22648,194,0.90 [0.69-1.16],0.4180184312717043
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LYN,Tyrosine-protein kinase Lyn,23056,203,1.02 [0.88-1.18],0.8035830314314538
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LYPD1,Ly6/PLAUR domain-containing protein 1,22634,201,0.84 [0.65-1.07],0.1533273235670031
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LYPD3,Ly6/PLAUR domain-containing protein 3,23066,202,1.16 [0.80-1.67],0.4370689197840902
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LYPD8,Ly6/PLAUR domain-containing protein 8,22648,194,1.14 [0.89-1.47],0.2955321278203314
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LYPLA2,Acyl-protein thioesterase 2,19490,181,1.17 [1.05-1.30],0.0037843621872279
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,19609,185,1.06 [0.93-1.20],0.3820710745452431
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,20182,187,0.76 [0.37-1.55],0.4503880645198332
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LYZL2,Lysozyme-like protein 2,19420,180,0.57 [0.36-0.90],0.0162891698137758
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,LZTFL1,Leucine zipper transcription factor-like protein 1,19723,185,0.96 [0.79-1.18],0.6988003353168031
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,M6PR,Cation-dependent mannose-6-phosphate receptor,19644,185,1.01 [0.71-1.45],0.9444583760423396
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,22881,198,1.06 [0.84-1.35],0.6169442723397529
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAEA,E3 ubiquitin-protein transferase MAEA,22648,194,1.19 [0.87-1.61],0.2714992682695978
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAG,Myelin-associated glycoprotein,19609,185,1.11 [0.83-1.49],0.4772648822650109
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAGEA3,Melanoma-associated antigen 3,19789,185,0.96 [0.82-1.13],0.6152740231631184
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAGED1,Melanoma-associated antigen D1,22648,194,0.84 [0.64-1.11],0.2210126689928146
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAMDC2,MAM domain-containing protein 2,20148,187,0.85 [0.57-1.27],0.4265611610510373
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAMDC4,Apical endosomal glycoprotein,20057,185,1.07 [0.83-1.38],0.6233895824088211
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",19644,185,1.27 [0.73-2.24],0.3981235512080714
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAN2B2,Epididymis-specific alpha-mannosidase,20148,187,1.12 [0.88-1.41],0.3487459039600725
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",19420,180,0.76 [0.57-1.01],0.0610097748057377
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MANF,Mesencephalic astrocyte-derived neurotrophic factor,23265,203,1.01 [0.91-1.13],0.7797649375904846
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MANSC1,MANSC domain-containing protein 1,23260,204,0.85 [0.54-1.34],0.4868105898466005
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MANSC4,MANSC domain-containing protein 4,19464,178,0.82 [0.66-1.02],0.0716212236262538
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,19490,181,1.16 [0.74-1.82],0.5292619889309834
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,19464,178,1.05 [0.86-1.29],0.6300746578377305
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAP2,Microtubule-associated protein 2,20115,186,0.87 [0.63-1.20],0.3819504831412876
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,20054,186,0.99 [0.80-1.24],0.9583215554708202
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,23111,204,0.98 [0.87-1.11],0.7955153836851481
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,22648,194,0.97 [0.85-1.11],0.6227982552661271
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,22926,199,1.00 [0.89-1.12],0.9749249449996826
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAPK13,Mitogen-activated protein kinase 13,19420,180,0.91 [0.64-1.28],0.5896382761084732
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAPK9,Mitogen-activated protein kinase 9,23111,204,1.02 [0.76-1.36],0.9076244522596546
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAPKAPK2,MAP kinase-activated protein kinase 2,19789,185,0.98 [0.81-1.19],0.8749854958941067
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAPRE3,Microtubule-associated protein RP/EB family member 3,19420,180,0.92 [0.82-1.03],0.1437558518542322
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAPT,Microtubule-associated protein tau,22634,201,1.01 [0.79-1.28],0.9661254708982712
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MARCO,Macrophage receptor MARCO,23167,200,0.87 [0.54-1.41],0.5785101065858211
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MARS1,"Methionine--tRNA ligase, cytoplasmic",19695,185,0.98 [0.83-1.16],0.782815393364246
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MASP1,Mannan-binding lectin serine protease 1,22926,199,1.26 [0.73-2.17],0.4103725386466822
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MATN2,Matrilin-2,23191,203,1.16 [0.76-1.77],0.5010874943831822
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MATN3,Matrilin-3,22925,199,1.16 [0.79-1.70],0.4465604092154189
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAVS,Mitochondrial antiviral-signaling protein,22648,194,1.03 [0.90-1.19],0.6607812126039851
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MAX,Protein max,22634,201,1.03 [0.91-1.16],0.652298151704158
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MB,Myoglobin,23453,207,1.34 [1.09-1.66],0.0059933143357233
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MBL2,Mannose-binding protein C,19897,184,1.00 [0.88-1.14],0.9750717741173622
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MCAM,Cell surface glycoprotein MUC18,23291,204,0.97 [0.66-1.42],0.8724954131926118
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",20106,189,1.23 [0.92-1.63],0.1582433355720584
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MCEMP1,Mast cell-expressed membrane protein 1,19556,179,0.94 [0.79-1.10],0.4210124624790965
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MCFD2,Multiple coagulation factor deficiency protein 2,23049,200,0.86 [0.64-1.15],0.3092515147411495
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MCTS1,Malignant T-cell-amplified sequence 1,20054,186,0.75 [0.42-1.34],0.3345697552602092
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,22961,199,1.02 [0.85-1.22],0.8483266586990582
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MDH1,"Malate dehydrogenase, cytoplasmic",20052,189,1.11 [0.79-1.56],0.5539160542325051
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MDK,Midkine,23195,204,1.17 [0.93-1.46],0.1780275111153426
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MDM1,Nuclear protein MDM1,19609,185,0.82 [0.52-1.31],0.4127359422325347
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",19644,185,0.98 [0.84-1.15],0.7969749519944141
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MED18,Mediator of RNA polymerase II transcription subunit 18,22648,194,1.00 [0.85-1.18],0.9906634557219784
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MED21,Mediator of RNA polymerase II transcription subunit 21,19464,178,0.88 [0.64-1.22],0.4508307813011036
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MEGF10,Multiple epidermal growth factor-like domains protein 10,23156,203,1.68 [1.22-2.32],0.001544736969698
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MEGF11,Multiple epidermal growth factor-like domains protein 11,19464,178,1.11 [0.74-1.67],0.6204339867089586
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MEGF9,Multiple epidermal growth factor-like domains protein 9,23385,207,0.67 [0.35-1.27],0.2159329212223081
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MELTF,Melanotransferrin,20148,187,0.89 [0.55-1.42],0.6232787076676254
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MENT,Protein MENT,19723,185,0.51 [0.28-0.94],0.0315360861319589
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MEP1A,Meprin A subunit alpha,20054,186,0.81 [0.66-0.99],0.0360237962014335
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MEP1B,Meprin A subunit beta,23167,200,0.95 [0.86-1.06],0.3597029476129842
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MEPE,Matrix extracellular phosphoglycoprotein,23156,203,0.98 [0.60-1.61],0.941428974110232
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MERTK,Tyrosine-protein kinase Mer,23393,205,0.90 [0.55-1.48],0.686512082623578
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MESD,LRP chaperone MESD,23193,202,1.00 [0.90-1.11],0.993116709090591
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MET,Hepatocyte growth factor receptor,23222,203,0.51 [0.27-0.95],0.0341323914044514
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,METAP1,Methionine aminopeptidase 1,22634,201,1.10 [0.72-1.67],0.6651058776071669
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",23111,204,1.03 [0.89-1.20],0.663509768508757
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,METAP2,Methionine aminopeptidase 2,23313,204,1.03 [0.83-1.28],0.7860737210021524
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MFAP3,Microfibril-associated glycoprotein 3,22729,202,0.78 [0.58-1.04],0.0864896179724978
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MFAP3L,Microfibrillar-associated protein 3-like,19609,185,1.00 [0.81-1.24],0.9919063949884948
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MFAP4,Microfibril-associated glycoprotein 4,19723,185,0.78 [0.50-1.22],0.2719685263162953
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MFAP5,Microfibrillar-associated protein 5,23453,207,1.00 [0.74-1.36],0.9755889891894716
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MFGE8,Lactadherin,23193,202,0.97 [0.73-1.30],0.8541659590606355
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MGLL,Monoglyceride lipase,23224,203,1.01 [0.87-1.16],0.931618526129632
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MGMT,Methylated-DNA--protein-cysteine methyltransferase,23111,204,1.02 [0.92-1.13],0.6790910708759552
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MIA,Melanoma-derived growth regulatory protein,23260,204,1.46 [1.07-1.98],0.0159867707812354
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MICALL2,MICAL-like protein 2,19609,185,0.94 [0.75-1.16],0.5511389104219195
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,23111,204,0.97 [0.90-1.05],0.4817719489246979
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MIF,Macrophage migration inhibitory factor,23157,202,1.08 [0.90-1.30],0.4252300725726766
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MILR1,Allergin-1,22723,200,0.97 [0.76-1.24],0.817025769230505
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,20057,185,0.96 [0.84-1.09],0.5041088550173402
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MINK1,Misshapen-like kinase 1,20115,186,0.96 [0.82-1.11],0.5523015718205404
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MITD1,MIT domain-containing protein 1,22961,199,1.02 [0.89-1.16],0.7991763734524439
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MKI67,Proliferation marker protein Ki-67,19556,179,0.80 [0.53-1.20],0.2854878734843773
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MLLT1,Protein ENL,19420,180,0.83 [0.65-1.06],0.1313195885447626
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MLN,Promotilin,23111,204,0.89 [0.78-1.03],0.1148809441838483
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MME,Neprilysin,23056,203,0.93 [0.80-1.10],0.4052504346182541
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MMP1,Interstitial collagenase,22305,199,1.05 [0.91-1.21],0.5069601795109242
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MMP10,Stromelysin-2,23100,203,0.78 [0.62-0.97],0.0261578268841389
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MMP12,Macrophage metalloelastase,23166,203,0.96 [0.76-1.20],0.7045898341237038
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MMP13,Collagenase 3,22634,201,1.02 [0.69-1.49],0.9271183393088605
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MMP15,Matrix metalloproteinase-15,20148,187,0.78 [0.54-1.12],0.1716424184277797
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MMP3,Stromelysin-1,23193,202,0.97 [0.75-1.25],0.7974027434322801
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MMP7,Matrilysin,22693,200,1.00 [0.77-1.29],0.9895966719486142
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MMP8,Neutrophil collagenase,23309,205,1.03 [0.87-1.22],0.6939438302697238
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MMP9,Matrix metalloproteinase-9,23148,202,1.15 [0.94-1.42],0.1800525779523609
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",19464,178,0.88 [0.65-1.19],0.4116340535000697
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MN1,Transcriptional activator MN1,19609,185,0.84 [0.64-1.11],0.2159861721309625
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MNAT1,CDK-activating kinase assembly factor MAT1,19789,185,0.78 [0.54-1.12],0.1732161147945439
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MNDA,Myeloid cell nuclear differentiation antigen,23128,200,0.99 [0.87-1.12],0.8421422696111711
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MOCS2,Molybdopterin synthase catalytic subunit,19723,185,1.13 [0.91-1.39],0.2605613786390762
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MOG,Myelin-oligodendrocyte glycoprotein,23353,206,0.84 [0.58-1.21],0.3473086079292639
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MORC3,MORC family CW-type zinc finger protein 3,20115,186,1.08 [0.66-1.75],0.7576054877721484
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MORF4L1,Mortality factor 4-like protein 1,19789,185,0.88 [0.60-1.29],0.5190401853044095
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MORF4L2,Mortality factor 4-like protein 2,19420,180,0.74 [0.48-1.13],0.1628392976462721
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MORN4,MORN repeat-containing protein 4,19420,180,0.93 [0.77-1.14],0.5046867700532085
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MPHOSPH8,M-phase phosphoprotein 8,22729,202,0.95 [0.80-1.13],0.5582232205986484
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MPI,Mannose-6-phosphate isomerase,23056,203,1.06 [0.91-1.22],0.4584050201060343
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,23224,203,1.07 [0.90-1.26],0.4369965369448221
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MPO,Myeloperoxidase,23193,202,1.30 [1.03-1.65],0.0283755453573936
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MPRIP,Myosin phosphatase Rho-interacting protein,20015,185,0.83 [0.60-1.16],0.2829389342378825
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MRC1,Macrophage mannose receptor 1,20164,189,1.08 [0.67-1.75],0.7584864056512619
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MRI1,Methylthioribose-1-phosphate isomerase,19609,185,0.95 [0.78-1.17],0.6541137453833217
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MRPL24,"39S ribosomal protein L24, mitochondrial",19464,178,0.99 [0.68-1.46],0.9701048219170558
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MRPL28,"39S ribosomal protein L28, mitochondrial",20106,189,0.88 [0.58-1.34],0.5560610024460813
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MRPL46,"39S ribosomal protein L46, mitochondrial",22634,201,0.76 [0.47-1.23],0.2646655705887046
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MRPL52,"39S ribosomal protein L52, mitochondrial",19376,180,0.87 [0.49-1.53],0.6164078026421687
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",20106,189,0.90 [0.73-1.11],0.3338845795074301
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MRPS16,"28S ribosomal protein S16, mitochondrial",19556,179,0.42 [0.22-0.83],0.0117764663293323
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MSLN,Mesothelin,23011,203,0.91 [0.73-1.13],0.383512788013831
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MSLNL,Mesothelin-like protein,19609,185,0.89 [0.61-1.31],0.5528672880234209
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MSMB,Beta-microseminoprotein,23124,205,1.05 [0.89-1.25],0.5671631880244585
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MSR1,Macrophage scavenger receptor types I and II,23351,205,0.90 [0.69-1.17],0.4191596970316018
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MSRA,Mitochondrial peptide methionine sulfoxide reductase,23260,204,0.99 [0.83-1.17],0.8943065234088936
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MST1,Hepatocyte growth factor-like protein,19850,186,1.01 [0.81-1.25],0.9197274161032856
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MSTN,Growth/differentiation factor 8,22729,202,0.83 [0.65-1.05],0.118434816356455
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MTDH,Protein LYRIC,19556,179,0.94 [0.80-1.10],0.4205823546433183
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",20115,186,0.88 [0.50-1.54],0.6523755943016516
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,19789,185,1.01 [0.89-1.15],0.8667165015134372
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MTIF3,"Translation initiation factor IF-3, mitochondrial",20054,186,0.99 [0.84-1.16],0.8947309646520721
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MTPN,Myotrophin,22729,202,1.16 [0.82-1.63],0.408803112757645
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MTR,Methionine synthase,19464,178,0.96 [0.77-1.20],0.7229029126862951
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MTSS1,Protein MTSS 1,20054,186,1.00 [0.88-1.13],0.9527894846750884
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MTSS2,Protein MTSS 2,20057,185,0.99 [0.86-1.15],0.932866222680046
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MTUS1,Microtubule-associated tumor suppressor 1,19789,185,1.12 [0.88-1.43],0.3454755240773901
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MUC13,Mucin-13,22634,201,0.80 [0.62-1.03],0.0874080334707608
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MUC16,Mucin-16,23056,203,0.99 [0.93-1.06],0.8095043410568981
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MUC2,Mucin-2,20163,187,0.99 [0.85-1.15],0.8600169792417296
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MUCL3,Mucin-like protein 3,19420,180,0.82 [0.56-1.21],0.3245000338913427
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MVK,Mevalonate kinase,22723,200,1.09 [0.93-1.28],0.2701109214181314
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MXRA8,Matrix remodeling-associated protein 8,19723,185,0.71 [0.45-1.13],0.1501706139918432
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYBPC1,"Myosin-binding protein C, slow-type",20148,187,1.42 [1.19-1.68],6.390508256664888e-05
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYBPC2,"Myosin-binding protein C, fast-type",19644,185,1.12 [0.97-1.30],0.1361295082128634
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,20106,189,0.98 [0.79-1.21],0.8504522105723127
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYDGF,Myeloid-derived growth factor,20148,187,0.96 [0.83-1.10],0.537271423181253
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYH4,Myosin-4,19464,178,1.18 [0.89-1.58],0.2505217183601974
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYH7B,Myosin-7B,19420,180,0.86 [0.60-1.23],0.3990008157786109
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYH9,Myosin-9,20163,187,0.96 [0.85-1.09],0.5466493658319072
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",19464,178,1.40 [1.08-1.81],0.0101326157331799
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYL3,Myosin light chain 3,19644,185,1.31 [1.09-1.58],0.0044004112097802
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYL4,Myosin light chain 4,19644,185,1.15 [0.90-1.47],0.2758682156565604
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYL6B,Myosin light chain 6B,19609,185,0.86 [0.72-1.03],0.0988459477066248
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",19609,185,1.48 [1.21-1.81],0.0001285113394474
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYO6,Unconventional myosin-VI,20106,189,0.75 [0.49-1.15],0.1857347521991139
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYO9B,Unconventional myosin-IXb,22723,200,0.90 [0.73-1.10],0.2876237367647354
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYOC,Myocilin,23193,202,0.91 [0.69-1.20],0.4955386833705912
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYOM1,Myomesin-1,19490,181,1.00 [0.74-1.35],0.9778370063739866
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYOM2,Myomesin-2,19464,178,1.45 [1.13-1.85],0.0032774903584854
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MYOM3,Myomesin-3,19723,185,1.37 [1.18-1.59],3.769306759119742e-05
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MZB1,Marginal zone B- and B1-cell-specific protein,23232,203,0.92 [0.72-1.17],0.4827754902549966
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,MZT1,Mitotic-spindle organizing protein 1,22648,194,0.96 [0.74-1.24],0.7568260926053167
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NAA10,N-alpha-acetyltransferase 10,19464,178,0.94 [0.70-1.24],0.6486452116183804
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NAA80,N-alpha-acetyltransferase 80,19609,185,0.98 [0.87-1.10],0.7350606565463544
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NAAA,N-acylethanolamine-hydrolyzing acid amidase,22860,198,1.03 [0.84-1.28],0.7565875085721272
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NACC1,Nucleus accumbens-associated protein 1,20057,185,0.98 [0.76-1.27],0.8774001681092811
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NADK,NAD kinase,23167,200,1.01 [0.81-1.25],0.9490867339872298
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NAGA,Alpha-N-acetylgalactosaminidase,19509,178,0.79 [0.58-1.06],0.1179295696168902
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NAGK,N-acetyl-D-glucosamine kinase,19608,185,1.07 [0.83-1.38],0.6031740796002749
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,19723,185,1.11 [0.57-2.17],0.7514421392304492
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NAMPT,Nicotinamide phosphoribosyltransferase,22648,194,1.05 [0.84-1.31],0.6658929246857616
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NAP1L4,Nucleosome assembly protein 1-like 4,20009,186,1.00 [0.71-1.40],0.987654299203709
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NAPRT,Nicotinate phosphoribosyltransferase,20115,186,0.82 [0.53-1.27],0.3749952968610229
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NARS1,"Asparagine--tRNA ligase, cytoplasmic",20106,189,0.98 [0.73-1.31],0.8696291818828339
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NBL1,Neuroblastoma suppressor of tumorigenicity 1,23260,204,0.97 [0.61-1.53],0.8972727646249348
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NBN,Nibrin,22723,200,1.01 [0.81-1.27],0.9257196917343028
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NCAM1,Neural cell adhesion molecule 1,23291,204,1.50 [1.01-2.22],0.0463574073525437
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NCAM2,Neural cell adhesion molecule 2,23193,202,0.86 [0.54-1.37],0.524963239333011
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NCAN,Neurocan core protein,23351,205,0.85 [0.61-1.18],0.3288719711427555
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NCF2,Neutrophil cytosol factor 2,23078,204,0.99 [0.86-1.15],0.9322513447307452
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NCK2,Cytoplasmic protein NCK2,23265,203,1.02 [0.91-1.15],0.692312936884646
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NCLN,Nicalin,22723,200,0.85 [0.64-1.14],0.2809513377872931
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NCR1,Natural cytotoxicity triggering receptor 1,23075,204,0.79 [0.57-1.11],0.1739690074785829
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,20054,186,0.92 [0.61-1.38],0.6772799140232075
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NCS1,Neuronal calcium sensor 1,23353,206,1.14 [0.74-1.75],0.5512998715610962
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NDRG1,Protein NDRG1,22634,201,0.95 [0.78-1.16],0.6240745682423463
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,20057,185,0.87 [0.68-1.12],0.287544270321827
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,19533,178,0.93 [0.62-1.41],0.7433193840295069
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,20054,186,1.00 [0.85-1.17],0.9929261002404696
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",22648,194,1.06 [0.91-1.24],0.4472588968236934
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NEB,Nebulin,19464,178,1.32 [0.97-1.79],0.0786437024559406
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NECAP2,Adaptin ear-binding coat-associated protein 2,19464,178,0.97 [0.78-1.20],0.7794438879567318
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NECTIN1,Nectin-1,19556,179,0.98 [0.63-1.52],0.92560079235432
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NECTIN2,Nectin-2,23124,200,0.95 [0.62-1.44],0.799347336769429
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NECTIN4,Nectin-4,23260,204,1.05 [0.72-1.53],0.8089078761047341
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,19556,179,0.79 [0.60-1.05],0.1016571606831019
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NEDD9,Enhancer of filamentation 1,19556,179,0.91 [0.59-1.41],0.6749221143574686
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NEFL,Neurofilament light polypeptide,22565,199,2.91 [2.52-3.37],4.667689268087161e-47
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NEK7,Serine/threonine-protein kinase Nek7,19789,185,0.90 [0.73-1.11],0.326609528220867
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NELL1,Protein kinase C-binding protein NELL1,23260,204,0.85 [0.64-1.14],0.2819214915433542
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NELL2,Protein kinase C-binding protein NELL2,23265,203,0.63 [0.41-0.97],0.0379260951193759
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NENF,Neudesin,20057,185,0.97 [0.86-1.11],0.6933499645448682
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NEO1,Neogenin,20106,189,0.85 [0.45-1.62],0.6282761038850293
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NEXN,Nexilin,20164,189,0.96 [0.78-1.18],0.6834531564215531
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NFASC,Neurofascin,23393,205,0.68 [0.44-1.07],0.0937151116359193
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NFAT5,Nuclear factor of activated T-cells 5,19556,179,0.90 [0.75-1.07],0.2408705465767865
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",23111,204,1.04 [0.91-1.18],0.5903207158274237
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",22723,200,0.93 [0.75-1.16],0.5210450844037806
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NFE2,Transcription factor NF-E2 45 kDa subunit,19644,185,1.04 [0.86-1.26],0.6668968318909494
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NFIC,Nuclear factor 1 C-type,20106,189,0.84 [0.58-1.22],0.3533373142597713
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NFKB1,Nuclear factor NF-kappa-B p105 subunit,19464,178,1.04 [0.85-1.26],0.7210917855040284
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NFKB2,Nuclear factor NF-kappa-B p100 subunit,19789,185,1.08 [0.86-1.36],0.5087626372522204
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NFKBIE,NF-kappa-B inhibitor epsilon,22648,194,0.94 [0.72-1.23],0.6487568970422026
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",20054,186,1.01 [0.88-1.16],0.8853411269349925
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NFX1,Transcriptional repressor NF-X1,19464,178,1.07 [0.87-1.32],0.5214380657631561
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NFYA,Nuclear transcription factor Y subunit alpha,19464,178,1.03 [0.72-1.47],0.8898109123465748
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NGF,Beta-nerve growth factor,22961,199,1.48 [0.54-4.08],0.4449155044915701
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NGFR,Tumor necrosis factor receptor superfamily member 16,20148,187,0.50 [0.29-0.87],0.0135829433767335
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NGRN,Neugrin,20115,186,1.63 [0.99-2.67],0.0536890214778016
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NHLRC3,NHL repeat-containing protein 3,19221,183,1.18 [0.75-1.87],0.4786135641304987
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NID1,Nidogen-1,23204,204,1.20 [0.87-1.65],0.2769811817268109
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NID2,Nidogen-2,23193,202,1.04 [0.88-1.23],0.6338853417506827
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NINJ1,Ninjurin-1,22648,194,0.84 [0.64-1.10],0.2104539572978034
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NIT1,Deaminated glutathione amidase,19644,185,1.09 [0.80-1.48],0.5791238255881273
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NIT2,Omega-amidase NIT2,20072,185,1.02 [0.84-1.24],0.8479422003272828
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NLGN1,Neuroligin-1,19609,185,1.04 [0.85-1.27],0.7179735654001168
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NLGN2,Neuroligin-2,19490,181,0.72 [0.50-1.04],0.0819540560039579
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NME1,Nucleoside diphosphate kinase A,19556,179,0.69 [0.34-1.36],0.2827346071212242
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NME3,Nucleoside diphosphate kinase 3,23191,203,1.04 [0.62-1.76],0.874792615722153
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NMI,N-myc-interactor,19992,185,1.00 [0.82-1.22],0.9750948634594244
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,22961,199,1.05 [0.89-1.23],0.5723930043931011
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NMRK2,Nicotinamide riboside kinase 2,19420,180,0.93 [0.64-1.35],0.6978540530922008
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,20106,189,0.94 [0.75-1.17],0.5786563286880835
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NOMO1,Nodal modulator 1,23193,202,0.73 [0.43-1.26],0.2648237624977348
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NOP56,Nucleolar protein 56,19464,178,1.03 [0.91-1.16],0.670296532900226
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NOS1,"Nitric oxide synthase, brain",22634,201,1.27 [1.02-1.59],0.0353048988719822
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NOS2,"Nitric oxide synthase, inducible",19464,178,0.94 [0.65-1.36],0.7407608554673749
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NOS3,"Nitric oxide synthase, endothelial",22634,201,1.06 [0.84-1.33],0.6275876073826874
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NOTCH1,Neurogenic locus notch homolog protein 1,23453,207,0.77 [0.35-1.68],0.5086120726828429
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NOTCH2,Neurogenic locus notch homolog protein 2,20163,187,1.08 [0.55-2.12],0.8182627957104981
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NOTCH3,Neurogenic locus notch homolog protein 3,23453,207,0.78 [0.54-1.13],0.1849167712043245
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NPC2,NPC intracellular cholesterol transporter 2,19814,184,0.99 [0.64-1.53],0.9514713427570984
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NPDC1,Neural proliferation differentiation and control protein 1,23167,200,1.13 [0.78-1.64],0.5246799246857288
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NPHS1,Nephrin,19556,179,0.88 [0.57-1.36],0.5610418598440992
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NPHS2,Podocin,19556,179,0.99 [0.86-1.14],0.8919062153377065
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NPL,N-acetylneuraminate lyase,20148,187,0.87 [0.64-1.19],0.3732594183126414
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NPPB,Natriuretic peptides B,22729,202,0.93 [0.85-1.01],0.103151482805281
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NPPC,C-type natriuretic peptide,23111,204,1.04 [0.81-1.34],0.7515374863237048
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NPR1,Atrial natriuretic peptide receptor 1,19464,178,0.70 [0.46-1.07],0.1016915779660729
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NPTN,Neuroplastin,22648,194,1.13 [0.99-1.30],0.0742699581140429
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NPTX1,Neuronal pentraxin-1,23193,202,1.00 [0.73-1.37],0.9990765364083316
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NPTX2,Neuronal pentraxin-2,20163,187,1.10 [0.71-1.69],0.6710127571006945
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NPTXR,Neuronal pentraxin receptor,23167,200,0.70 [0.47-1.03],0.0705582777412858
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NPY,Pro-neuropeptide Y,23353,206,0.97 [0.80-1.17],0.7386738821945518
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NRCAM,Neuronal cell adhesion molecule,23167,200,1.39 [0.91-2.13],0.1297046405684642
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NRGN,Neurogranin,20164,189,0.99 [0.85-1.16],0.937857286947154
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NRN1,Neuritin,20106,189,1.06 [0.74-1.53],0.7425459200967564
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NRP1,Neuropilin-1,23320,204,1.22 [0.78-1.92],0.3817387138333771
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NRP2,Neuropilin-2,23193,202,0.85 [0.55-1.33],0.4826506163044978
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NRTN,Neurturin,22723,200,1.08 [0.85-1.38],0.5143721361841405
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NRXN3,Neurexin-3,19609,185,0.86 [0.56-1.33],0.4996359932140743
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NSFL1C,NSFL1 cofactor p47,23351,205,1.01 [0.84-1.22],0.8921504402516346
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",20148,187,1.00 [0.83-1.21],0.9918245161752216
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NT5C1A,Cytosolic 5'-nucleotidase 1A,20115,186,1.22 [0.82-1.84],0.3271451618194199
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NT5C3A,Cytosolic 5'-nucleotidase 3A,23080,204,1.02 [0.88-1.18],0.789707424289609
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NT5E,5'-nucleotidase,23260,204,0.98 [0.78-1.22],0.8283406305004564
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NTF3,Neurotrophin-3,23111,204,0.79 [0.55-1.12],0.1894902918345254
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NTF4,Neurotrophin-4,22648,194,0.96 [0.68-1.35],0.8020385864999745
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NTRK2,BDNF/NT-3 growth factors receptor,23167,200,0.91 [0.55-1.49],0.7028214483908394
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NTRK3,NT-3 growth factor receptor,23351,205,1.11 [0.62-1.98],0.7206974813108507
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NTproBNP,N-terminal prohormone of brain natriuretic peptide,23167,200,0.90 [0.80-1.01],0.0696879472890665
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NUB1,NEDD8 ultimate buster 1,23111,204,1.00 [0.86-1.16],0.9680094902917976
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,20057,185,1.01 [0.87-1.16],0.9191786131905648
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NUCB2,Nucleobindin-2,23307,206,1.06 [0.76-1.49],0.714551137466809
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NUDC,Nuclear migration protein nudC,23393,205,0.99 [0.81-1.20],0.913886555169599
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,19644,185,0.93 [0.52-1.64],0.7980402839684028
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,19464,178,0.80 [0.57-1.11],0.176224406684906
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NUDT16,U8 snoRNA-decapping enzyme,20015,186,0.99 [0.84-1.16],0.8872094143033581
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],23056,203,1.04 [0.84-1.29],0.719484715095404
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NUDT5,ADP-sugar pyrophosphatase,23193,202,1.05 [0.82-1.34],0.6928891105926105
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NUMB,Protein numb homolog,19556,179,0.91 [0.76-1.08],0.2697759098045948
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NUP50,Nuclear pore complex protein Nup50,19464,178,0.87 [0.54-1.39],0.5480252917619722
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NXPE4,NXPE family member 4,19464,178,1.40 [1.01-1.96],0.046313822631227
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NXPH1,Neurexophilin-1,22634,201,1.01 [0.73-1.40],0.9339276411283012
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,NXPH3,Neurexophilin-3,19556,179,0.64 [0.40-1.02],0.0633069496661221
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OBP2B,Odorant-binding protein 2b,22892,199,0.94 [0.76-1.15],0.5511302169833883
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OCLN,Occludin,20106,189,0.77 [0.55-1.08],0.1353275011366901
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ODAM,Odontogenic ameloblast-associated protein,22600,200,0.97 [0.77-1.22],0.8170933680426578
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OFD1,Oral-facial-digital syndrome 1 protein,19789,185,0.92 [0.73-1.16],0.4829403052220449
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OGA,Protein O-GlcNAcase,20054,186,1.00 [0.81-1.22],0.9706054710659632
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OGFR,Opioid growth factor receptor,23056,203,1.00 [0.68-1.47],0.9972647671431004
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OGN,Mimecan,23193,202,1.33 [1.00-1.75],0.04816729209007
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,19789,185,0.95 [0.75-1.19],0.6376093035028162
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OLFM4,Olfactomedin-4,18982,174,1.02 [0.90-1.15],0.767186588686684
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OLR1,Oxidized low-density lipoprotein receptor 1,22939,199,1.07 [0.87-1.31],0.5310738409067226
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OMD,Osteomodulin,23265,203,0.95 [0.71-1.28],0.7468844369400327
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OMG,Oligodendrocyte-myelin glycoprotein,23056,203,0.92 [0.77-1.11],0.4036706005263453
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OMP,Olfactory marker protein,19490,181,1.03 [0.77-1.37],0.84762096628475
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OPHN1,Oligophrenin-1,20115,186,0.97 [0.85-1.11],0.6578759085806558
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OPLAH,5-oxoprolinase,19644,185,1.00 [0.81-1.23],0.9937226165123008
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OPTC,Opticin,23056,203,0.83 [0.62-1.11],0.2155044086501919
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ORM1,Alpha-1-acid glycoprotein 1,20107,187,1.33 [0.67-2.67],0.4178511480022862
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OSBPL2,Oxysterol-binding protein-related protein 2,20115,186,1.05 [0.75-1.48],0.7675023316579269
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OSCAR,Osteoclast-associated immunoglobulin-like receptor,23191,203,1.13 [0.79-1.62],0.5108529318105685
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OSM,Oncostatin-M,23010,204,1.09 [0.91-1.30],0.3324088816584608
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OSMR,Oncostatin-M-specific receptor subunit beta,23320,204,1.51 [0.81-2.81],0.1905854536816211
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OSTN,Osteocrin,19609,185,0.84 [0.57-1.23],0.3704273715720686
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OTOA,Otoancorin,19490,181,0.74 [0.53-1.03],0.0741073257323368
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OTUD6B,Deubiquitinase OTUD6B,20054,186,1.00 [0.79-1.28],0.9728944591872948
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OTUD7B,OTU domain-containing protein 7B,20106,189,1.05 [0.84-1.32],0.662625799976768
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",19644,185,1.00 [0.81-1.22],0.9703169340177152
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,OXT,Oxytocin-neurophysin 1,23351,205,0.92 [0.84-1.01],0.0745305080740026
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,P4HB,Protein disulfide-isomerase,23070,204,0.81 [0.59-1.13],0.221058635275405
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PACS2,Phosphofurin acidic cluster sorting protein 2,19464,178,1.08 [0.86-1.37],0.504738833955664
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PADI2,Protein-arginine deiminase type-2,22723,200,0.95 [0.75-1.20],0.6706103714930471
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PADI4,Protein-arginine deiminase type-4,22600,200,1.05 [0.90-1.23],0.5291896984838804
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PAEP,Glycodelin,22961,199,1.05 [0.92-1.20],0.4422793739314292
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,20106,189,0.98 [0.87-1.11],0.7998782365636055
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",19789,185,0.94 [0.70-1.25],0.6587557529806325
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,22729,202,0.95 [0.76-1.19],0.6483163876974702
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PAGR1,PAXIP1-associated glutamate-rich protein 1,19644,185,0.81 [0.57-1.15],0.2320413717398103
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,19390,180,0.91 [0.68-1.20],0.4983042726218655
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PAK4,Serine/threonine-protein kinase PAK 4,22634,201,0.92 [0.74-1.14],0.4541536350894219
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PALLD,Palladin,19556,179,0.54 [0.33-0.86],0.0090654682938491
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PALM,Paralemmin-1,19939,186,0.67 [0.44-1.02],0.0647190054709115
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PALM2,Paralemmin-2,20115,186,0.99 [0.67-1.46],0.9687695852093492
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PALM3,Paralemmin-3,19464,178,0.94 [0.77-1.16],0.5827889831905033
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PAM,Peptidyl-glycine alpha-amidating monooxygenase,23343,206,0.83 [0.55-1.27],0.3912229802799657
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PAMR1,Inactive serine protease PAMR1,23193,202,1.02 [0.64-1.62],0.9439076910645646
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PAPPA,Pappalysin-1,22723,200,0.83 [0.63-1.09],0.1759521094828496
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PARD3,Partitioning defective 3 homolog,19789,185,0.93 [0.76-1.13],0.4640813101136255
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PARK7,Parkinson disease protein 7,23193,202,1.12 [0.88-1.42],0.3648348678114179
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PARP1,Poly [ADP-ribose] polymerase 1,23111,204,0.85 [0.66-1.09],0.1908156805783465
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PAXX,Protein PAXX,19723,185,0.78 [0.57-1.08],0.1357813553524416
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PBK,Lymphokine-activated killer T-cell-originated protein kinase,19420,180,0.73 [0.46-1.16],0.186181682118819
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PBLD,Phenazine biosynthesis-like domain-containing protein,22634,201,1.00 [0.78-1.29],0.9700824093833323
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,20054,186,0.65 [0.39-1.09],0.1023487062674297
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PCARE,Photoreceptor cilium actin regulator,19490,181,0.98 [0.83-1.17],0.8554748824523037
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,19693,185,1.11 [0.81-1.50],0.5187155494665207
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PCBP2,Poly(rC)-binding protein 2,20106,189,0.98 [0.81-1.19],0.8445779892827437
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PCDH1,Protocadherin-1,23318,205,0.90 [0.50-1.63],0.7343311351005457
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PCDH12,Protocadherin-12,20106,189,1.06 [0.61-1.83],0.8455583095085349
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PCDH17,Protocadherin-17,23167,200,1.21 [0.87-1.70],0.2624229301569488
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PCDH7,Protocadherin-7,20054,186,1.18 [0.83-1.67],0.3596772591004905
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PCDH9,Protocadherin-9,20054,186,1.04 [0.69-1.58],0.8460239602880717
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PCDHB15,Protocadherin beta-15,20057,185,0.93 [0.65-1.33],0.7012643953313891
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PCNA,Proliferating cell nuclear antigen,19420,180,0.90 [0.70-1.17],0.439071073355556
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PCSK7,Proprotein convertase subtilisin/kexin type 7,20057,185,0.92 [0.66-1.27],0.6020539998075733
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PCSK9,Proprotein convertase subtilisin/kexin type 9,23453,207,1.00 [0.73-1.36],0.9924253019476348
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PCYT2,Ethanolamine-phosphate cytidylyltransferase,20054,186,0.97 [0.80-1.17],0.7490046859922512
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDAP1,28 kDa heat- and acid-stable phosphoprotein,20148,187,0.96 [0.83-1.10],0.5395193525344729
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDCD1,Programmed cell death protein 1,23311,205,1.15 [0.87-1.51],0.3247957714791504
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDCD1LG2,Programmed cell death 1 ligand 2,23056,203,1.24 [0.84-1.82],0.2768796737647384
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDCD5,Programmed cell death protein 5,23351,205,1.10 [0.89-1.36],0.3707608908514624
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDCD6,Programmed cell death protein 6,23167,200,0.97 [0.82-1.15],0.7099706546597613
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDCL2,Phosducin-like protein 2,19420,180,1.01 [0.78-1.32],0.9251369817990562
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",19420,180,1.00 [0.77-1.30],0.978325362525434
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",19464,178,0.83 [0.63-1.11],0.2105567081782763
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",19723,185,0.99 [0.86-1.13],0.8615487024559241
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDGFA,Platelet-derived growth factor subunit A,23453,207,0.95 [0.80-1.12],0.5529865092474875
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDGFB,Platelet-derived growth factor subunit B,23265,203,1.01 [0.87-1.17],0.89204779153883
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDGFC,Platelet-derived growth factor C,22648,194,1.19 [0.76-1.85],0.4451292546348089
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDGFRA,Platelet-derived growth factor receptor alpha,23167,200,0.92 [0.59-1.43],0.713923173809795
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDGFRB,Platelet-derived growth factor receptor beta,23453,207,0.82 [0.58-1.17],0.2791021379777216
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDIA2,Protein disulfide-isomerase A2,19420,180,1.09 [0.78-1.51],0.6243682844274983
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDIA3,Protein disulfide-isomerase A3,19723,185,0.97 [0.55-1.73],0.9237260698231278
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDIA4,Protein disulfide-isomerase A4,20163,187,0.92 [0.72-1.16],0.4721445597049718
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDIA5,Protein disulfide-isomerase A5,19420,180,0.86 [0.67-1.12],0.2594915649247185
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDLIM5,PDZ and LIM domain protein 5,20106,189,1.02 [0.91-1.15],0.7026570907260999
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDLIM7,PDZ and LIM domain protein 7,23265,203,1.00 [0.90-1.10],0.973734120709088
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",22648,194,0.93 [0.71-1.22],0.581787727645869
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDRG1,p53 and DNA damage-regulated protein 1,19609,185,0.83 [0.61-1.13],0.2420224754426794
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,19420,180,0.91 [0.67-1.22],0.5083780600919444
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDZD2,PDZ domain-containing protein 2,19464,178,1.02 [0.80-1.30],0.8889222358199332
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,19556,179,0.77 [0.54-1.11],0.1667842062208432
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PEAR1,Platelet endothelial aggregation receptor 1,23453,207,1.09 [0.63-1.87],0.7592409773631884
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PEBP1,Phosphatidylethanolamine-binding protein 1,23193,202,1.09 [0.88-1.35],0.4376880866789554
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PECAM1,Platelet endothelial cell adhesion molecule,23193,202,1.01 [0.67-1.53],0.9505562998400484
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PECR,Peroxisomal trans-2-enoyl-CoA reductase,19644,185,1.30 [0.84-2.01],0.2317231685397191
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PENK,Proenkephalin-A,19723,185,0.79 [0.49-1.25],0.3100226662260276
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PEPD,Xaa-Pro dipeptidase,20164,189,0.70 [0.41-1.19],0.1871284953644058
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PER3,Period circadian protein homolog 3,19556,179,0.95 [0.85-1.07],0.4268068637367324
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PF4,Platelet factor 4,20031,187,0.93 [0.80-1.07],0.3245009706901025
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PFDN2,Prefoldin subunit 2,22634,201,1.00 [0.80-1.25],0.985387107345736
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PFDN4,Prefoldin subunit 4,19420,180,1.01 [0.76-1.33],0.947257406429101
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PFDN6,Prefoldin subunit 6,19609,185,1.19 [1.00-1.42],0.0504649300369766
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",23012,202,1.03 [0.88-1.21],0.7090349584108744
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PGA4,Pepsin A-4,20164,189,1.03 [0.86-1.23],0.767773470095193
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",20148,187,1.12 [0.86-1.45],0.4021639555230883
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PGF,Placenta growth factor,23393,205,0.95 [0.58-1.56],0.8535217477077054
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PGLYRP1,Peptidoglycan recognition protein 1,23357,206,1.04 [0.78-1.38],0.8069994914524836
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,19936,185,0.86 [0.54-1.37],0.5235306023300663
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PGLYRP4,Peptidoglycan recognition protein 4,19464,178,1.11 [0.89-1.38],0.3503919667841207
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PGM2,Phosphoglucomutase-2,19609,185,1.25 [1.05-1.50],0.0141422961443919
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PGR,Progesterone receptor,19556,179,0.90 [0.76-1.07],0.2357849667841938
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PHACTR2,Phosphatase and actin regulator 2,20106,189,1.01 [0.90-1.15],0.8360319101232518
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PHLDB1,Pleckstrin homology-like domain family B member 1,20054,186,1.00 [0.76-1.31],0.979864172482808
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PHLDB2,Pleckstrin homology-like domain family B member 2,19420,180,0.89 [0.75-1.06],0.1797293720897353
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,22961,199,1.58 [1.05-2.36],0.0281258208542693
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,19723,185,0.91 [0.65-1.28],0.5837703134731385
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PI16,Peptidase inhibitor 16,20164,189,0.86 [0.49-1.51],0.6027539994143405
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PI3,Elafin,22883,203,1.25 [1.02-1.54],0.0344997619938165
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",20106,189,1.00 [0.83-1.20],0.9783996865791288
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PIGR,Polymeric immunoglobulin receptor,22883,202,0.88 [0.62-1.27],0.5021417033265247
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,23111,204,1.04 [0.85-1.27],0.7004589353942543
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,23193,202,0.96 [0.62-1.49],0.8548751202863311
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,19556,179,0.84 [0.63-1.12],0.2325500822601458
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PILRA,Paired immunoglobulin-like type 2 receptor alpha,23193,202,0.84 [0.63-1.12],0.2388997534218423
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PILRB,Paired immunoglobulin-like type 2 receptor beta,23167,200,0.92 [0.74-1.14],0.4403384037360067
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,19723,185,1.05 [0.85-1.28],0.6622635436417615
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PITHD1,PITH domain-containing protein 1,19390,180,1.03 [0.87-1.23],0.7073591644093394
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PKD1,Polycystin-1,20148,187,1.21 [0.71-2.07],0.4767129039712864
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PKD2,Polycystin-2,19464,178,0.88 [0.67-1.14],0.3279957168722382
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PKLR,Pyruvate kinase PKLR,23195,203,1.06 [0.89-1.28],0.5071505506771375
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PKN3,Serine/threonine-protein kinase N3,19789,185,1.01 [0.84-1.22],0.8956245408350949
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLA2G10,Group 10 secretory phospholipase A2,22961,199,1.00 [0.81-1.25],0.977244137099015
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLA2G15,Phospholipase A2 group XV,23260,204,1.39 [0.88-2.20],0.1607463550411658
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLA2G1B,Phospholipase A2,23422,207,0.99 [0.75-1.30],0.9274931804800072
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLA2G2A,"Phospholipase A2, membrane associated",23127,202,0.90 [0.71-1.15],0.4004294673948401
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLA2G4A,Cytosolic phospholipase A2,23265,203,1.00 [0.86-1.15],0.9482132556528144
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLA2G7,Platelet-activating factor acetylhydrolase,23193,202,1.06 [0.72-1.55],0.7611271687645554
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLAT,Tissue-type plasminogen activator,23385,207,0.91 [0.71-1.16],0.4243772122422824
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLAU,Urokinase-type plasminogen activator,23193,202,0.92 [0.60-1.43],0.7183724956745774
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLAUR,Urokinase plasminogen activator surface receptor,23010,202,1.13 [0.72-1.78],0.591294006717393
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLB1,"Phospholipase B1, membrane-associated",20115,186,0.97 [0.76-1.22],0.779135639354089
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",19556,179,0.86 [0.60-1.25],0.4289260859317609
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",20115,186,0.94 [0.81-1.09],0.4059765511756633
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLEKHO1,Pleckstrin homology domain-containing family O member 1,20115,186,0.97 [0.79-1.19],0.7578681897356722
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLG,Plasminogen,19681,182,0.77 [0.40-1.50],0.4461714627018531
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLIN1,Perilipin-1,22634,201,0.89 [0.61-1.30],0.549377002042237
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLIN3,Perilipin-3,23167,200,0.86 [0.64-1.17],0.3383454565475888
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLPBP,Pyridoxal phosphate homeostasis protein,23167,200,1.00 [0.83-1.20],0.967522086359892
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLSCR3,Phospholipid scramblase 3,20071,186,0.96 [0.75-1.23],0.7376771165375475
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLTP,Phospholipid transfer protein,23390,206,1.01 [0.71-1.43],0.9600645424077302
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLXDC1,Plexin domain-containing protein 1,22648,194,0.50 [0.31-0.81],0.0046401354739056
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLXDC2,Plexin domain-containing protein 2,20115,186,0.83 [0.48-1.42],0.5006745793185006
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLXNA4,Plexin-A4,23111,204,0.96 [0.82-1.12],0.5848235797227453
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLXNB2,Plexin-B2,23335,207,0.95 [0.57-1.59],0.8419610926468912
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PLXNB3,Plexin-B3,23102,199,0.96 [0.74-1.26],0.7940334652174823
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,23036,199,1.04 [0.97-1.12],0.2571504528829059
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PMCH,Pro-MCH,19464,178,1.07 [0.92-1.25],0.3936780275032802
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PMM2,Phosphomannomutase 2,19464,178,1.12 [0.88-1.42],0.3703795788466496
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PMS1,PMS1 protein homolog 1,19609,185,0.84 [0.62-1.14],0.2585764998740214
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PMVK,Phosphomevalonate kinase,22595,201,1.00 [0.89-1.13],0.945876818948684
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PNLIP,Pancreatic triacylglycerol lipase,20164,189,0.93 [0.75-1.16],0.5388223713939413
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PNLIPRP1,Inactive pancreatic lipase-related protein 1,20115,186,0.90 [0.76-1.07],0.2462045857042684
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PNLIPRP2,Pancreatic lipase-related protein 2,23156,203,0.97 [0.93-1.01],0.1286110225132922
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PNMA1,Paraneoplastic antigen Ma1,19644,185,0.98 [0.76-1.27],0.877861757126165
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PNMA2,Paraneoplastic antigen Ma2,19490,181,1.07 [0.79-1.46],0.6496529494733965
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",22723,200,0.96 [0.86-1.08],0.5319967331915674
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PODXL,Podocalyxin,23056,203,0.48 [0.21-1.08],0.0764366424312989
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PODXL2,Podocalyxin-like protein 2,23260,204,0.64 [0.41-1.00],0.0508427248978858
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,POF1B,Protein POF1B,19556,179,0.91 [0.65-1.26],0.5571542283331252
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,POLR2A,DNA-directed RNA polymerase II subunit RPB1,19556,179,0.80 [0.48-1.34],0.3986638709258832
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",23056,203,0.93 [0.64-1.35],0.7003517716854287
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,POMC,Pro-opiomelanocortin,19644,185,1.06 [0.86-1.29],0.5952026016784031
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PON1,Serum paraoxonase/arylesterase 1,20164,189,0.64 [0.40-1.02],0.0615221338126631
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PON2,Serum paraoxonase/arylesterase 2,22729,202,0.91 [0.64-1.31],0.6233738808862925
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PON3,Serum paraoxonase/lactonase 3,23265,203,0.69 [0.47-0.99],0.0458415188163718
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,POSTN,Periostin,20163,187,0.99 [0.68-1.44],0.9490899220267578
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPBP,Platelet basic protein,20042,187,0.94 [0.80-1.11],0.4722695574889046
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPCDC,Phosphopantothenoylcysteine decarboxylase,23351,205,1.09 [0.84-1.42],0.5346800940438037
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPIB,Peptidyl-prolyl cis-trans isomerase B,23215,203,1.00 [0.88-1.14],0.9911690729024858
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPIE,Peptidyl-prolyl cis-trans isomerase E,19789,185,1.07 [0.86-1.32],0.5444381964785121
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",20163,187,1.00 [0.80-1.25],0.9933029288297937
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPL,Periplakin,19556,179,1.01 [0.64-1.57],0.9795827211501292
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPM1A,Protein phosphatase 1A,22648,194,1.02 [0.68-1.52],0.931912364336644
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPM1B,Protein phosphatase 1B,19556,179,0.93 [0.73-1.20],0.5940937994654787
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPM1F,Protein phosphatase 1F,20148,187,0.98 [0.75-1.28],0.8861570905620929
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPME1,Protein phosphatase methylesterase 1,23056,203,1.04 [0.85-1.27],0.7234324013764022
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,20057,185,1.02 [0.86-1.21],0.8168779783930916
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,23260,204,0.94 [0.83-1.07],0.3772937398098124
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,19789,185,0.84 [0.67-1.05],0.1327120056592206
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,20106,189,0.93 [0.78-1.12],0.4639004677103022
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,20106,189,0.81 [0.55-1.19],0.2830276157851376
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPP1R2,Protein phosphatase inhibitor 2,23167,200,0.98 [0.84-1.15],0.7952382149730765
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPP1R9B,Neurabin-2,23393,205,1.00 [0.88-1.14],0.9760444457590104
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,20054,186,1.01 [0.89-1.13],0.9218664631079138
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPP3R1,Calcineurin subunit B type 1,22961,199,1.00 [0.73-1.36],0.9770618498396436
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPT1,Palmitoyl-protein thioesterase 1,19609,185,0.92 [0.75-1.13],0.4077714206546422
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PPY,Pancreatic prohormone,23161,204,0.96 [0.85-1.08],0.5264846719041485
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PQBP1,Polyglutamine-binding protein 1,22648,194,0.87 [0.68-1.11],0.2624640627416134
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRAME,Melanoma antigen preferentially expressed in tumors,19420,180,0.76 [0.43-1.36],0.3619351701735152
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRAP1,Proline-rich acidic protein 1,20163,187,1.03 [0.73-1.46],0.8784182413904641
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRC1,Protein regulator of cytokinesis 1,20057,185,1.01 [0.74-1.38],0.9341702856560252
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRCP,Lysosomal Pro-X carboxypeptidase,23326,207,0.94 [0.63-1.39],0.7517770841186421
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRDX1,Peroxiredoxin-1,22489,198,1.06 [0.92-1.22],0.4156263880322356
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRDX2,Peroxiredoxin-2,19807,179,1.04 [0.83-1.31],0.7077206502692399
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",22723,200,1.03 [0.87-1.23],0.7055239549814394
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRDX5,"Peroxiredoxin-5, mitochondrial",23393,205,1.15 [0.95-1.39],0.1587888620095105
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRDX6,Peroxiredoxin-6,23353,206,1.10 [0.90-1.34],0.341023307442448
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PREB,Prolactin regulatory element-binding protein,22723,200,1.31 [0.88-1.93],0.1814982926437487
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRELP,Prolargin,23156,203,1.55 [0.91-2.65],0.1079862002091258
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRG2,Bone marrow proteoglycan,20163,187,1.00 [0.77-1.31],0.9748920629293238
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRG3,Proteoglycan 3,20163,187,0.87 [0.65-1.15],0.3247481106389644
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,22723,200,1.03 [0.81-1.30],0.8154103376455575
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,19609,185,1.02 [0.66-1.57],0.937132702439529
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,23167,200,0.92 [0.79-1.07],0.2913698220891436
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,20078,186,1.03 [0.87-1.23],0.700962900175284
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRKCQ,Protein kinase C theta type,22723,200,1.02 [0.77-1.36],0.8703625313048877
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRKD2,Serine/threonine-protein kinase D2,19464,178,0.95 [0.68-1.33],0.7522759432016136
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRKG1,cGMP-dependent protein kinase 1,19723,185,0.98 [0.88-1.10],0.7484784473983188
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,22648,194,0.96 [0.79-1.16],0.6616100895834802
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRL,Prolactin,23351,205,1.01 [0.85-1.19],0.9071132225033324
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRND,Prion-like protein doppel,20115,186,0.84 [0.63-1.11],0.2224089452565486
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PROC,Vitamin K-dependent protein C,23243,204,1.85 [1.12-3.03],0.0155430246957364
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PROCR,Endothelial protein C receptor,19464,178,1.01 [0.66-1.54],0.979734820439333
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PROK1,Prokineticin-1,23111,204,1.09 [0.87-1.37],0.4480916884020084
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PROS1,Vitamin K-dependent protein S,20182,187,0.97 [0.56-1.67],0.9005453294800445
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRR4,Proline-rich protein 4,19560,184,0.74 [0.60-0.93],0.0089035411194859
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRR5,Proline-rich protein 5,19556,179,0.71 [0.50-1.01],0.0559939946578907
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRRT3,Proline-rich transmembrane protein 3,19644,185,0.71 [0.49-1.04],0.0791270285005675
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRSS2,Trypsin-2,23291,204,1.10 [0.88-1.38],0.406374120465649
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRSS22,Brain-specific serine protease 4,19556,179,0.75 [0.47-1.17],0.2026734552174853
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRSS27,Serine protease 27,23101,200,1.02 [0.74-1.39],0.922881804063737
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRSS53,Serine protease 53,20115,186,0.84 [0.58-1.23],0.3821985917739287
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRSS8,Prostasin,23080,203,0.92 [0.68-1.25],0.5888075858017425
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,22634,201,1.02 [0.91-1.14],0.7423474979304123
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRTG,Protogenin,23353,206,1.14 [0.69-1.88],0.6092624096394609
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRTN3,Myeloblastin,22584,197,1.14 [0.90-1.45],0.2702371531929862
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PRUNE2,Protein prune homolog 2,19789,185,0.69 [0.40-1.18],0.1731036025950605
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSAP,Prosaposin,19966,185,0.77 [0.46-1.30],0.3326461245283518
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSAPL1,Proactivator polypeptide-like 1,20054,186,0.73 [0.55-0.97],0.0310142354050552
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSCA,Prostate stem cell antigen,20054,186,0.98 [0.93-1.04],0.5241296236587883
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSG1,Pregnancy-specific beta-1-glycoprotein 1,22961,199,1.03 [0.92-1.14],0.629041551952667
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSIP1,PC4 and SFRS1-interacting protein,23111,204,0.98 [0.81-1.19],0.8182090541224198
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSMA1,Proteasome subunit alpha type-1,22648,194,1.10 [0.84-1.44],0.4805385391990387
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSMC3,26S proteasome regulatory subunit 6A,19420,180,0.76 [0.47-1.23],0.2589749286548957
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSMD1,26S proteasome non-ATPase regulatory subunit 1,20106,189,0.97 [0.73-1.29],0.8405284879880619
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSMD5,26S proteasome non-ATPase regulatory subunit 5,19609,185,0.94 [0.72-1.23],0.6665642308328839
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSMD9,26S proteasome non-ATPase regulatory subunit 9,23056,203,1.08 [0.87-1.34],0.4901361481945226
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSME1,Proteasome activator complex subunit 1,22911,199,1.19 [0.86-1.66],0.29801799810701
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSME2,Proteasome activator complex subunit 2,22846,199,1.20 [0.85-1.68],0.2987483273639097
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSMG3,Proteasome assembly chaperone 3,23111,204,1.06 [0.84-1.35],0.6069778715211844
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSMG4,Proteasome assembly chaperone 4,19556,179,1.04 [0.82-1.33],0.7439819176683342
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSPN,Persephin,23111,204,0.95 [0.83-1.09],0.4467364559699643
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSRC1,Proline/serine-rich coiled-coil protein 1,22648,194,0.97 [0.78-1.21],0.7910103003766977
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,19042,181,0.97 [0.85-1.11],0.6261938718155367
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",22634,201,1.00 [0.66-1.51],0.9959712162867232
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTGDS,Prostaglandin-H2 D-isomerase,23008,204,1.27 [0.87-1.86],0.2152336321741054
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTGES2,Prostaglandin E synthase 2,19410,177,1.09 [0.83-1.42],0.535926531789026
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTGR1,Prostaglandin reductase 1,20148,187,0.88 [0.74-1.05],0.1470456724742548
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTH,Parathyroid hormone,19609,185,1.06 [0.89-1.27],0.4964937974066203
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,23111,204,1.05 [0.77-1.43],0.7429619782059738
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTK7,Inactive tyrosine-protein kinase 7,22634,201,1.20 [0.86-1.67],0.2883781855575356
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTN,Pleiotrophin,22729,202,1.15 [0.90-1.48],0.2704945423862058
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTP4A3,Protein tyrosine phosphatase type IVA 3,19556,179,0.90 [0.67-1.20],0.4817712697509307
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,22961,199,0.97 [0.82-1.14],0.6920219048805888
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,23224,203,1.01 [0.88-1.16],0.8578830029441268
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,19526,179,1.17 [0.83-1.65],0.381885880815861
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTPRB,Receptor-type tyrosine-protein phosphatase beta,20148,187,0.92 [0.57-1.50],0.7521780543609731
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTPRC,Receptor-type tyrosine-protein phosphatase C,20163,187,0.69 [0.37-1.28],0.2386787419403873
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTPRF,Receptor-type tyrosine-protein phosphatase F,23453,207,0.51 [0.34-0.78],0.0020118458147651
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTPRH,Receptor-type tyrosine-protein phosphatase H,20054,186,1.23 [0.93-1.64],0.1494795148160457
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,20054,186,0.57 [0.28-1.18],0.1285963547541639
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTPRM,Receptor-type tyrosine-protein phosphatase mu,23080,203,0.96 [0.57-1.60],0.8757447813269006
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,22893,199,0.78 [0.53-1.14],0.2005207203547928
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTPRR,Receptor-type tyrosine-protein phosphatase R,20115,186,0.80 [0.54-1.18],0.2625211967928079
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTPRS,Receptor-type tyrosine-protein phosphatase S,23453,207,0.90 [0.55-1.47],0.666608611666399
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,20148,187,0.87 [0.56-1.35],0.5228356617801115
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,19723,185,1.00 [0.79-1.27],0.9929853013639136
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTS,6-pyruvoyl tetrahydrobiopterin synthase,22522,200,1.08 [0.85-1.35],0.5327940822307753
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTTG1,Securin,19789,185,1.16 [0.84-1.60],0.3717992233854673
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PTX3,Pentraxin-related protein PTX3,23111,204,1.05 [0.81-1.35],0.7296150939578887
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PVALB,Parvalbumin alpha,23228,203,1.08 [0.96-1.21],0.1969469869047037
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PVR,Poliovirus receptor,23351,205,1.18 [0.85-1.65],0.3220080964699433
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PXDNL,Peroxidasin-like protein,20057,185,1.03 [0.81-1.31],0.8116360974098624
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PXN,Paxillin,22634,201,0.97 [0.76-1.24],0.8123365491087466
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PYDC1,Pyrin domain-containing protein 1,19644,185,0.70 [0.48-1.02],0.0623748744948054
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PYY,Peptide YY,19464,178,1.00 [0.87-1.16],0.9823981799238308
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,PZP,Pregnancy zone protein,20182,187,0.98 [0.73-1.30],0.8662779277799166
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,QDPR,Dihydropteridine reductase,23054,199,1.02 [0.76-1.37],0.9129314924873204
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,QPCT,Glutaminyl-peptide cyclotransferase,23221,207,0.67 [0.42-1.05],0.0827391197841587
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,QSOX1,Sulfhydryl oxidase 1,19787,184,0.69 [0.42-1.11],0.1260874045802181
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RAB10,Ras-related protein Rab-10,20148,187,0.98 [0.75-1.28],0.8816503688407811
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RAB11FIP3,Rab11 family-interacting protein 3,20148,187,0.97 [0.85-1.10],0.5971491707144885
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RAB27B,Ras-related protein Rab-27B,20148,187,0.93 [0.79-1.10],0.3976738155817151
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RAB2B,Ras-related protein Rab-2B,20057,185,1.04 [0.83-1.32],0.7127822454341569
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RAB33A,Ras-related protein Rab-33A,19464,178,1.08 [0.87-1.35],0.4603241551626619
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RAB37,Ras-related protein Rab-37,22723,200,0.91 [0.77-1.07],0.258340004122683
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RAB39B,Ras-related protein Rab-39B,19464,178,0.86 [0.70-1.05],0.1330451632027182
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,19490,181,0.83 [0.62-1.12],0.2225748844146527
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RAB44,Ras-related protein Rab-44,20057,185,0.96 [0.69-1.32],0.7918159594789522
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RAB6A,Ras-related protein Rab-6A,23111,204,0.87 [0.66-1.14],0.3084915731166234
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RAB6B,Ras-related protein Rab-6B,22634,201,1.09 [0.85-1.39],0.5003660823151606
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RABEP1,Rab GTPase-binding effector protein 1,19723,185,0.99 [0.83-1.19],0.9356744624167764
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RABEPK,Rab9 effector protein with kelch motifs,22648,194,0.89 [0.70-1.13],0.3201521504695934
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RABGAP1L,Rab GTPase-activating protein 1-like,22723,200,1.14 [0.93-1.39],0.2203556110937594
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RAC3,Ras-related C3 botulinum toxin substrate 3,19609,185,1.15 [0.97-1.37],0.1079873927971416
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RAD23B,UV excision repair protein RAD23 homolog B,22648,194,1.15 [0.89-1.50],0.2868555708205534
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RAD51,DNA repair protein RAD51 homolog 1,19789,185,1.02 [0.79-1.32],0.8849630615801812
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RALB,Ras-related protein Ral-B,19556,179,0.76 [0.47-1.23],0.2563643307635684
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RALY,RNA-binding protein Raly,20057,185,0.98 [0.73-1.32],0.9114745025164784
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RANBP1,Ran-specific GTPase-activating protein,19644,185,0.96 [0.74-1.26],0.7918934171780283
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RANBP2,E3 SUMO-protein ligase RanBP2,19490,181,0.79 [0.50-1.24],0.298361183638139
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RANGAP1,Ran GTPase-activating protein 1,22648,194,1.04 [0.80-1.35],0.7636454821993949
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RAP1A,Ras-related protein Rap-1A,19556,179,1.12 [0.94-1.34],0.2150867833947977
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RAPGEF2,Rap guanine nucleotide exchange factor 2,19789,185,0.95 [0.72-1.25],0.721124154231544
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RARRES1,Retinoic acid receptor responder protein 1,22648,194,1.09 [0.75-1.58],0.6539630137683605
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RARRES2,Retinoic acid receptor responder protein 2,23320,204,1.14 [0.88-1.46],0.315173318330433
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RASA1,Ras GTPase-activating protein 1,22634,201,0.87 [0.59-1.28],0.4728908857901838
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,19420,180,1.01 [0.73-1.39],0.9746596634312632
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RASSF2,Ras association domain-containing protein 2,22648,194,0.94 [0.75-1.19],0.6128357666259632
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RBFOX3,RNA binding protein fox-1 homolog 3,20106,189,1.53 [1.16-2.03],0.0029459323887565
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RBKS,Ribokinase,22613,197,1.12 [0.87-1.44],0.3919081650466723
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RBM17,Splicing factor 45,20106,189,0.96 [0.80-1.16],0.6834270766597741
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RBM19,Probable RNA-binding protein 19,19464,178,1.02 [0.75-1.38],0.9058700215630412
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RBM25,RNA-binding protein 25,19420,180,0.85 [0.61-1.17],0.3105365190078267
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RBP1,Retinol-binding protein 1,19609,185,0.99 [0.80-1.21],0.9064997294501108
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RBP2,Retinol-binding protein 2,23056,203,0.86 [0.73-1.01],0.0728175638911543
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RBP5,Retinol-binding protein 5,23056,203,1.23 [0.99-1.53],0.0587113655967435
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RBP7,Retinoid-binding protein 7,20054,186,0.83 [0.65-1.06],0.1415166753935728
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RBPMS,RNA-binding protein with multiple splicing,19556,179,0.68 [0.50-0.93],0.0139306156358778
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RBPMS2,RNA-binding protein with multiple splicing 2,19644,185,0.96 [0.83-1.10],0.5719866205418527
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RCC1,Regulator of chromosome condensation,20057,185,0.95 [0.71-1.26],0.6969376757869866
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RCOR1,REST corepressor 1,22729,202,1.01 [0.76-1.34],0.938635151439935
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,19644,185,1.04 [0.52-2.06],0.9195869507913343
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,REEP4,Receptor expression-enhancing protein 4,20106,189,0.97 [0.77-1.21],0.7646754489354984
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,REG1A,Lithostathine-1-alpha,23036,203,1.17 [0.92-1.47],0.1961713185494834
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,REG1B,Lithostathine-1-beta,23453,207,1.16 [0.95-1.42],0.1369101365628566
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,REG3A,Regenerating islet-derived protein 3-alpha,23453,207,0.97 [0.80-1.18],0.7647347575126701
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,REG3G,Regenerating islet-derived protein 3-gamma,20057,185,1.06 [0.75-1.50],0.7473519878663624
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,REG4,Regenerating islet-derived protein 4,23191,203,0.88 [0.68-1.12],0.2971534763842021
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RELB,Transcription factor RelB,19556,179,1.00 [0.75-1.34],0.9921043018693853
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RELT,Tumor necrosis factor receptor superfamily member 19L,23193,202,0.77 [0.49-1.19],0.2350309887221079
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,REN,Renin,23167,200,0.92 [0.79-1.08],0.3264208511687339
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,REPS1,RalBP1-associated Eps domain-containing protein 1,19556,179,0.79 [0.54-1.18],0.252502465019594
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,REST,RE1-silencing transcription factor,19420,180,0.91 [0.59-1.39],0.6496294492131535
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,23056,203,0.84 [0.61-1.15],0.2709578894618391
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RETN,Resistin,23127,205,0.99 [0.74-1.32],0.9451657295808696
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,REXO2,"Oligoribonuclease, mitochondrial",19464,178,0.95 [0.70-1.28],0.725252933431394
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RFC4,Replication factor C subunit 4,20057,185,0.66 [0.33-1.34],0.251593751293894
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RGCC,Regulator of cell cycle RGCC,20106,189,0.98 [0.82-1.18],0.8602379428267096
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,19789,185,0.96 [0.77-1.21],0.75461892563041
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RGMA,Repulsive guidance molecule A,23351,205,0.79 [0.54-1.17],0.2368949305453021
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RGMB,RGM domain family member B,23351,205,0.83 [0.53-1.31],0.4293161602208393
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RGS10,Regulator of G-protein signaling 10,20106,189,0.95 [0.75-1.20],0.6636787396514426
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RGS8,Regulator of G-protein signaling 8,22723,200,1.01 [0.84-1.23],0.8846374831063658
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RHOC,Rho-related GTP-binding protein RhoC,22825,198,1.02 [0.92-1.14],0.6622828070784768
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RICTOR,Rapamycin-insensitive companion of mTOR,19556,179,1.06 [0.80-1.40],0.6908679148781007
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,19723,185,1.09 [0.82-1.45],0.5580336885208252
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RILP,Rab-interacting lysosomal protein,23276,203,1.15 [0.94-1.41],0.1823661525233491
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RILPL2,RILP-like protein 2,20148,187,0.96 [0.83-1.10],0.5445631441921686
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,19464,178,0.80 [0.62-1.03],0.0898710537675033
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RLN1,Prorelaxin H1,20106,189,0.81 [0.55-1.19],0.2784651736964715
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RLN2,Prorelaxin H2,19682,185,1.01 [0.76-1.34],0.9517807417499354
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RNASE1,Ribonuclease pancreatic,20164,189,1.20 [0.71-2.01],0.4963090293086244
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RNASE10,Inactive ribonuclease-like protein 10,19644,185,0.87 [0.64-1.18],0.3696708971197433
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RNASE3,Eosinophil cationic protein,23062,200,0.94 [0.83-1.05],0.2675099007866972
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RNASE4,Ribonuclease 4,19468,183,0.92 [0.55-1.54],0.7504388900104125
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RNASE6,Ribonuclease K6,20018,189,1.15 [0.76-1.73],0.5093959445086478
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RNASEH2A,Ribonuclease H2 subunit A,20106,189,0.90 [0.67-1.21],0.4888862980513258
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RNASET2,Ribonuclease T2,23356,207,1.02 [0.65-1.60],0.9465562058129556
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RNF149,E3 ubiquitin-protein ligase RNF149,19644,185,1.05 [0.67-1.63],0.8464438390250797
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RNF168,E3 ubiquitin-protein ligase RNF168,19556,179,0.68 [0.45-1.02],0.0654667656758805
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RNF31,E3 ubiquitin-protein ligase RNF31,19556,179,0.48 [0.29-0.80],0.0045635231833229
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RNF4,E3 ubiquitin-protein ligase RNF4,19789,185,0.89 [0.71-1.12],0.3316486197817455
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RNF41,E3 ubiquitin-protein ligase NRDP1,22648,194,0.95 [0.78-1.15],0.6026111508186285
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RNF43,E3 ubiquitin-protein ligase RNF43,19789,185,1.21 [0.99-1.48],0.0569169647254803
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RNF5,E3 ubiquitin-protein ligase RNF5,19644,185,1.04 [0.85-1.27],0.6901872524715111
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ROBO1,Roundabout homolog 1,23191,203,1.10 [0.66-1.83],0.7194776905726478
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ROBO2,Roundabout homolog 2,23351,205,1.18 [0.69-2.01],0.5453341023630098
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ROBO4,Roundabout homolog 4,19644,185,0.87 [0.39-1.94],0.7353581446098907
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,23167,200,1.08 [0.73-1.59],0.7032254471985251
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RP2,Protein XRP2,23056,203,0.87 [0.65-1.18],0.3850783503195096
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RPA2,Replication protein A 32 kDa subunit,19556,179,0.97 [0.60-1.55],0.8832481218729218
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RPE,Ribulose-phosphate 3-epimerase,19789,185,0.94 [0.77-1.15],0.5531975151953338
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RPGR,X-linked retinitis pigmentosa GTPase regulator,19609,185,0.85 [0.58-1.23],0.3784823830081975
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RPL14,60S ribosomal protein L14,19644,185,0.97 [0.68-1.40],0.885855670884719
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RPS10,40S ribosomal protein S10,19464,178,1.11 [0.80-1.55],0.5328194923242828
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RRAS,Ras-related protein R-Ras,19609,185,0.98 [0.87-1.09],0.6658821387463179
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RRM2,Ribonucleoside-diphosphate reductase subunit M2,22648,194,1.09 [0.86-1.37],0.4896995180234732
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,22648,194,0.97 [0.80-1.18],0.7639273183268845
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RRP15,RRP15-like protein,19490,181,0.97 [0.83-1.14],0.7204638879221675
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RSPO1,R-spondin-1,22961,199,1.10 [0.76-1.60],0.5994618606220035
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RSPO3,R-spondin-3,23353,206,0.76 [0.49-1.19],0.2297356493140641
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RTBDN,Retbindin,23056,203,0.65 [0.42-1.01],0.0539384369396851
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RTKN2,Rhotekin-2,19464,178,0.83 [0.60-1.15],0.2674045250833229
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",20106,189,0.99 [0.85-1.15],0.8587577528750071
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RTN4R,Reticulon-4 receptor,23353,206,0.91 [0.63-1.31],0.6167130922804283
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RUVBL1,RuvB-like 1,22648,194,1.10 [0.98-1.22],0.1061755457964125
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RWDD1,RWD domain-containing protein 1,23351,205,1.01 [0.83-1.23],0.8993566269904291
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,RYR1,Ryanodine receptor 1,19464,178,1.15 [0.79-1.66],0.4662707787028094
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,S100A11,Protein S100-A11,22992,200,0.82 [0.61-1.10],0.1801206708877155
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,S100A12,Protein S100-A12,22837,201,1.11 [0.95-1.31],0.1933277530373257
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,S100A13,Protein S100-A13,19556,179,0.86 [0.57-1.31],0.4896866634938885
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,S100A14,Protein S100-A14,20106,189,0.97 [0.75-1.26],0.8304469983307275
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,S100A16,Protein S100-A16,22600,200,0.93 [0.75-1.14],0.4701576523112933
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,S100A3,Protein S100-A3,20057,185,0.93 [0.66-1.30],0.6748210151660352
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,S100A4,Protein S100-A4,23260,204,1.10 [0.88-1.37],0.3907486392260305
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,S100G,Protein S100-G,20106,189,0.84 [0.62-1.14],0.2718906490151245
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,S100P,Protein S100-P,22729,202,0.98 [0.78-1.22],0.8519311115626278
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SAA4,Serum amyloid A-4 protein,20182,187,0.43 [0.17-1.07],0.0702066497266359
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SAFB2,Scaffold attachment factor B2,20106,189,0.96 [0.58-1.58],0.8580646620101516
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SAG,S-arrestin,19490,181,0.79 [0.59-1.07],0.1248780075557579
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SAMD9L,Sterile alpha motif domain-containing protein 9-like,23111,204,1.03 [0.87-1.23],0.7076534329187889
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SAP18,Histone deacetylase complex subunit SAP18,19789,185,0.85 [0.69-1.06],0.1500537714355403
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SARG,Specifically androgen-regulated gene protein,20058,187,0.97 [0.86-1.11],0.6878739919720502
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SART1,U4/U6.U5 tri-snRNP-associated protein 1,19464,178,1.25 [0.91-1.70],0.1625762802651797
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SAT1,Diamine acetyltransferase 1,19464,178,0.72 [0.51-1.02],0.0670198401140614
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SAT2,Thialysine N-epsilon-acetyltransferase,19789,185,0.85 [0.67-1.08],0.1878560641784351
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SATB1,DNA-binding protein SATB1,20106,189,1.14 [0.74-1.76],0.5467662268498316
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SBSN,Suprabasin,20124,187,0.81 [0.54-1.21],0.302793928692126
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCAMP3,Secretory carrier-associated membrane protein 3,23056,203,0.98 [0.84-1.13],0.7409623561857253
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCARA5,Scavenger receptor class A member 5,23351,205,1.22 [0.81-1.84],0.3392514748958452
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCARB1,Scavenger receptor class B member 1,22634,201,0.88 [0.68-1.13],0.2995119195371664
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCARB2,Lysosome membrane protein 2,22528,198,1.13 [0.77-1.66],0.5160620352124727
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCARF1,Scavenger receptor class F member 1,23453,207,1.02 [0.76-1.36],0.9085793685928732
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCARF2,Scavenger receptor class F member 2,23351,205,1.18 [0.77-1.81],0.4431381806642331
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCG2,Secretogranin-2,23230,203,0.61 [0.41-0.90],0.0119330562094244
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCG3,Secretogranin-3,23191,203,0.74 [0.51-1.06],0.0981283713214914
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCGB1A1,Uteroglobin,23174,203,0.87 [0.70-1.09],0.2346630084594608
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCGB2A2,Mammaglobin-A,19464,178,1.17 [0.76-1.80],0.4635693051036255
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCGB3A1,Secretoglobin family 3A member 1,19723,185,0.72 [0.42-1.24],0.2355777461314477
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCGB3A2,Secretoglobin family 3A member 2,23224,203,0.91 [0.78-1.07],0.2573503386341594
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCGN,Secretagogin,22723,200,0.79 [0.60-1.06],0.1174438182668971
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCIN,Adseverin,19490,181,0.78 [0.63-0.98],0.0292839245251561
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCLY,Selenocysteine lyase,23276,203,1.09 [0.84-1.43],0.5093607910401122
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCN2A,Sodium channel protein type 2 subunit alpha,19490,181,1.23 [0.95-1.57],0.1109128943273807
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCN2B,Sodium channel subunit beta-2,19609,185,0.59 [0.34-1.02],0.0609858069284218
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCN3A,Sodium channel protein type 3 subunit alpha,19609,185,0.81 [0.53-1.25],0.3447968749878503
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCN3B,Sodium channel subunit beta-3,19490,181,0.91 [0.66-1.25],0.5565384466091574
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCN4B,Sodium channel subunit beta-4,19644,185,0.83 [0.59-1.15],0.2610724899120674
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCP2,Non-specific lipid-transfer protein,22648,194,0.89 [0.74-1.08],0.2468200351724965
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCPEP1,Retinoid-inducible serine carboxypeptidase,19565,184,1.02 [0.77-1.37],0.8682901019743827
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCRG1,Scrapie-responsive protein 1,20148,187,0.60 [0.35-1.02],0.0595088683212213
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCRIB,Protein scribble homolog,19644,185,0.97 [0.82-1.13],0.6724000544802995
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCRN1,Secernin-1,23111,204,1.05 [0.84-1.32],0.6527476450703174
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SCT,Secretin,19609,185,0.79 [0.59-1.07],0.1266239332868623
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SDC1,Syndecan-1,23167,200,0.96 [0.70-1.33],0.8041651930795848
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SDC4,Syndecan-4,23167,200,0.89 [0.68-1.16],0.3831908112875488
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SDCCAG8,Serologically defined colon cancer antigen 8,20057,185,1.00 [0.88-1.13],0.9719824106488224
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SDHB,Succinate dehydrogenase,20054,186,0.92 [0.73-1.15],0.4599558885203555
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SDK2,Protein sidekick-2,19723,185,0.73 [0.49-1.07],0.1037033508060537
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SEC31A,Protein transport protein Sec31A,19644,185,0.97 [0.80-1.16],0.7177288854209933
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SEL1L,Protein sel-1 homolog 1,19644,185,0.89 [0.54-1.44],0.6299743549545505
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SELE,E-selectin,23453,207,0.76 [0.59-0.96],0.0219936185094627
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SELENOP,Selenoprotein P,20182,187,0.50 [0.27-0.93],0.0287292287831569
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SELL,L-selectin,20182,187,0.84 [0.46-1.54],0.5821544581151258
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SELP,P-selectin,23291,204,0.97 [0.78-1.21],0.7713780562027703
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SELPLG,P-selectin glycoprotein ligand 1,23111,204,0.89 [0.56-1.41],0.6159359290007553
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SEMA3F,Semaphorin-3F,23167,200,1.48 [0.93-2.36],0.0965708057453841
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SEMA3G,Semaphorin-3G,19723,185,0.91 [0.66-1.26],0.5606066727457468
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SEMA4C,Semaphorin-4C,23056,203,1.13 [0.74-1.73],0.5714738168643428
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SEMA4D,Semaphorin-4D,23351,205,1.07 [0.71-1.61],0.7585331536677125
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SEMA6C,Semaphorin-6C,19556,179,0.80 [0.45-1.44],0.4540030899357083
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SEMA7A,Semaphorin-7A,23385,207,1.01 [0.65-1.55],0.9818535640924004
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SEPTIN3,Neuronal-specific septin-3,20106,189,0.90 [0.75-1.09],0.3020940946809826
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SEPTIN7,Septin-7,19789,185,0.79 [0.57-1.08],0.137503180974457
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SEPTIN8,Septin-8,20086,186,0.97 [0.62-1.52],0.9072873800066994
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SEPTIN9,Septin-9,23056,203,1.04 [0.68-1.59],0.8526844064590883
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINA1,Alpha-1-antitrypsin,19783,182,0.47 [0.08-2.91],0.4174413879982067
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINA11,Serpin A11,23453,207,1.26 [0.93-1.71],0.1336117757536813
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINA12,Serpin A12,22472,198,1.04 [0.92-1.17],0.5557760137633745
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINA3,Alpha-1-antichymotrypsin,20096,186,1.92 [0.86-4.30],0.1111179109513254
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINA4,Kallistatin,19807,185,1.01 [0.56-1.84],0.968625592277346
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINA5,Plasma serine protease inhibitor,19885,186,0.70 [0.43-1.14],0.1546634577142021
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINA6,Corticosteroid-binding globulin,20182,187,0.34 [0.14-0.83],0.0176960633758456
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINA7,Thyroxine-binding globulin,20182,187,0.48 [0.22-1.02],0.0554973616373395
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINA9,Serpin A9,22946,202,0.94 [0.78-1.12],0.4694424826217094
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINB1,Leukocyte elastase inhibitor,23112,202,1.01 [0.88-1.16],0.871713909300927
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINB5,Serpin B5,22729,202,0.88 [0.68-1.13],0.3103999355396284
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINB6,Serpin B6,23278,205,1.05 [0.85-1.29],0.6748253297136109
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINB8,Serpin B8,23393,205,0.89 [0.71-1.11],0.2976086848957333
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINB9,Serpin B9,22961,199,1.12 [0.77-1.64],0.5519191593957148
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINC1,Antithrombin-III,20148,187,0.87 [0.34-2.25],0.7741871354992615
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPIND1,Heparin cofactor 2,20148,187,1.13 [0.68-1.87],0.6336961672045338
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINE1,Plasminogen activator inhibitor 1,23453,207,0.97 [0.81-1.16],0.7432633672115938
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINE2,Glia-derived nexin,20148,187,0.93 [0.75-1.16],0.5071930215770966
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINF1,Pigment epithelium-derived factor,19868,179,1.01 [0.59-1.74],0.9708816205196622
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINF2,Alpha-2-antiplasmin,19796,182,0.61 [0.21-1.74],0.3502068322232408
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPING1,Plasma protease C1 inhibitor,20148,187,1.02 [0.48-2.19],0.9522264450344948
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINH1,Serpin H1,19789,185,0.92 [0.83-1.03],0.1523851031026423
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINI1,Neuroserpin,19695,185,1.00 [0.62-1.61],0.992393335849702
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SERPINI2,Serpin I2,20054,186,1.00 [0.78-1.29],0.9813608311292766
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,22634,201,0.99 [0.81-1.20],0.9142803554529148
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SETMAR,Histone-lysine N-methyltransferase SETMAR,22882,198,1.08 [0.71-1.64],0.734144120825067
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SEZ6,Seizure protein 6 homolog,19609,185,0.63 [0.39-1.02],0.0595375012820061
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SEZ6L,Seizure 6-like protein,23260,204,0.83 [0.53-1.31],0.4256517588157207
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SEZ6L2,Seizure 6-like protein 2,23056,203,0.96 [0.56-1.64],0.8696070295614774
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SF3B4,Splicing factor 3B subunit 4,23056,203,1.03 [0.87-1.22],0.6935233356459536
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SFRP1,Secreted frizzled-related protein 1,22892,199,1.37 [1.05-1.79],0.0184070570907959
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SFRP4,Secreted frizzled-related protein 4,19723,185,1.33 [0.93-1.90],0.1227943310487682
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SFTPA1,Pulmonary surfactant-associated protein A1,22648,194,1.03 [0.83-1.29],0.7704399357244693
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SFTPA2,Pulmonary surfactant-associated protein A2,22648,194,0.99 [0.77-1.27],0.9102368277537872
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SFTPD,Pulmonary surfactant-associated protein D,23167,200,1.05 [0.87-1.26],0.6080398495725108
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SGSH,N-sulphoglucosamine sulphohydrolase,19783,186,1.07 [0.84-1.37],0.5643283140053912
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SH2B3,SH2B adapter protein 3,22648,194,1.00 [0.88-1.14],0.9746897608515892
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SH2D1A,SH2 domain-containing protein 1A,23111,204,1.07 [0.88-1.31],0.4913928666976179
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,19490,181,0.99 [0.78-1.26],0.9500073509708024
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SH3BP1,SH3 domain-binding protein 1,20054,186,0.93 [0.69-1.25],0.6238974362462553
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SH3GL3,Endophilin-A3,19694,184,0.91 [0.78-1.07],0.256455666981201
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SH3GLB2,Endophilin-B2,20115,186,1.02 [0.82-1.25],0.8826128934513531
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SHBG,Sex hormone-binding globulin,20164,189,0.75 [0.58-0.99],0.0411343371880977
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SHC1,SHC-transforming protein 1,19420,180,0.97 [0.86-1.10],0.6694332931630086
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SHD,SH2 domain-containing adapter protein D,19417,177,0.92 [0.76-1.11],0.3820198296204623
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SHH,Sonic hedgehog protein,19556,179,0.96 [0.68-1.35],0.8086633843066298
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SHISA5,Protein shisa-5,20163,187,0.72 [0.41-1.26],0.246076805249771
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SHMT1,"Serine hydroxymethyltransferase, cytosolic",23224,203,1.13 [0.97-1.30],0.1108284180698299
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SHPK,Sedoheptulokinase,19789,185,0.96 [0.67-1.37],0.8221607197390188
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SIAE,Sialate O-acetylesterase,23225,204,0.97 [0.74-1.27],0.8234771200030804
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SIGLEC1,Sialoadhesin,23265,203,1.00 [0.75-1.34],0.9898233845566818
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SIGLEC10,Sialic acid-binding Ig-like lectin 10,23111,204,1.04 [0.72-1.48],0.8463971446496674
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SIGLEC15,Sialic acid-binding Ig-like lectin 15,22634,201,1.06 [0.90-1.23],0.4860933332781374
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SIGLEC5,Sialic acid-binding Ig-like lectin 5,23193,202,1.00 [0.90-1.11],0.9416647123134724
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SIGLEC6,Sialic acid-binding Ig-like lectin 6,23353,206,0.99 [0.69-1.43],0.9656306483396208
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SIGLEC7,Sialic acid-binding Ig-like lectin 7,23167,200,0.99 [0.63-1.57],0.9797362845689656
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SIGLEC8,Sialic acid-binding Ig-like lectin 8,19644,185,1.24 [0.91-1.69],0.1810955489364435
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SIGLEC9,Sialic acid-binding Ig-like lectin 9,23316,205,1.08 [0.71-1.65],0.7247128825128404
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SIL1,Nucleotide exchange factor SIL1,19644,185,0.89 [0.55-1.44],0.6380733689849891
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,23237,205,0.95 [0.77-1.17],0.5998963786040696
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SIRPB1,Signal-regulatory protein beta-1,23127,203,1.05 [0.81-1.36],0.73647071594378
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SIRT1,NAD-dependent protein deacetylase sirtuin-1,19556,179,0.91 [0.75-1.10],0.3447600503946857
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SIRT2,NAD-dependent protein deacetylase sirtuin-2,23056,203,1.02 [0.88-1.17],0.7924967225428026
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",22634,201,1.13 [0.91-1.39],0.2729652267101771
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SIT1,Signaling threshold-regulating transmembrane adapter 1,22723,200,1.02 [0.81-1.28],0.8639239156884126
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SKAP1,Src kinase-associated phosphoprotein 1,22926,199,0.99 [0.84-1.18],0.9332328473083912
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SKAP2,Src kinase-associated phosphoprotein 2,23265,203,0.96 [0.85-1.08],0.5284768134484966
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SKIV2L,Helicase SKI2W,19464,178,0.89 [0.61-1.32],0.5692171003869324
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLA2,Src-like-adapter 2,20106,189,1.01 [0.88-1.16],0.873229699056453
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLAMF1,Signaling lymphocytic activation molecule,22723,200,1.00 [0.81-1.24],0.9764098355641734
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLAMF6,SLAM family member 6,22648,194,0.80 [0.57-1.14],0.2174132216464746
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLAMF7,SLAM family member 7,23111,204,0.98 [0.79-1.21],0.8453983662283054
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLAMF8,SLAM family member 8,22648,194,0.90 [0.72-1.14],0.3799338744286173
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLC12A2,Solute carrier family 12 member 2,19464,178,0.82 [0.47-1.44],0.4844683133728106
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLC13A1,Solute carrier family 13 member 1,20057,185,0.90 [0.69-1.17],0.4308662427596281
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLC16A1,Monocarboxylate transporter 1,22634,201,1.02 [0.82-1.27],0.8470949625871564
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLC1A4,Neutral amino acid transporter A,19609,185,0.97 [0.73-1.29],0.8360836496937307
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLC27A4,Long-chain fatty acid transport protein 4,22634,201,1.09 [0.91-1.31],0.3275983963172828
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLC28A1,Sodium/nucleoside cotransporter 1,19420,180,1.00 [0.78-1.27],0.981786369334456
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLC34A3,Sodium-dependent phosphate transport protein 2C,19420,180,0.92 [0.68-1.26],0.6209230142489235
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLC39A14,Zinc transporter ZIP14,22634,201,0.88 [0.60-1.29],0.5139126617063124
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLC39A5,Zinc transporter ZIP5,23111,204,1.02 [0.81-1.29],0.8588647754923091
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLC44A4,Choline transporter-like protein 4,19609,185,0.96 [0.77-1.19],0.6870649639174389
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLC4A1,Band 3 anion transport protein,20163,187,0.99 [0.73-1.32],0.9204185917520036
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLC51B,Organic solute transporter subunit beta,19464,178,0.93 [0.77-1.14],0.4982171966899699
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,19723,185,0.95 [0.80-1.13],0.5617478102798192
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,20054,186,1.01 [0.76-1.33],0.9608057262486296
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",19420,180,1.05 [0.82-1.34],0.7099522272133194
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLIT2,Slit homolog 2 protein,22634,201,1.08 [0.86-1.36],0.5205188407575615
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLITRK1,SLIT and NTRK-like protein 1,19556,179,0.56 [0.36-0.88],0.0126673114081005
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLITRK2,SLIT and NTRK-like protein 2,23353,206,1.11 [0.82-1.52],0.4979304018174671
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLITRK6,SLIT and NTRK-like protein 6,22729,202,0.86 [0.60-1.24],0.4157447922928385
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLK,STE20-like serine/threonine-protein kinase,19789,185,1.08 [0.92-1.26],0.3430201115849957
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLMAP,Sarcolemmal membrane-associated protein,20054,186,1.02 [0.86-1.21],0.854282580870693
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SLURP1,Secreted Ly-6/uPAR-related protein 1,20013,187,0.64 [0.41-0.99],0.0456111226785392
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SMAD1,Mothers against decapentaplegic homolog 1,22648,194,1.00 [0.86-1.17],0.9665845164475017
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SMAD2,Mothers against decapentaplegic homolog 2,20057,185,1.03 [0.84-1.26],0.770674497981818
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SMAD3,Mothers against decapentaplegic homolog 3,20057,185,0.98 [0.75-1.29],0.8968025530378602
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SMAD5,Mothers against decapentaplegic homolog 5,23056,203,1.05 [0.56-1.97],0.8790154608221254
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SMARCA2,Probable global transcription activator SNF2L2,22634,201,1.17 [1.00-1.37],0.0563788539108914
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SMC3,Structural maintenance of chromosomes protein 3,19420,180,0.95 [0.73-1.25],0.7296860948584749
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SMNDC1,Survival of motor neuron-related-splicing factor 30,20054,186,0.89 [0.69-1.14],0.3517043273097908
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SMOC1,SPARC-related modular calcium-binding protein 1,23353,206,1.11 [0.76-1.62],0.5845546200422951
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SMOC2,SPARC-related modular calcium-binding protein 2,23265,203,1.38 [1.01-1.88],0.041852974852964
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SMPD1,Sphingomyelin phosphodiesterase,23237,202,0.99 [0.77-1.28],0.935509235892368
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SMPD3,Sphingomyelin phosphodiesterase 3,19556,179,0.75 [0.54-1.04],0.0880562470189385
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,23236,203,0.95 [0.79-1.14],0.5862218382062072
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,20057,185,1.16 [1.00-1.35],0.0549626684124758
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SMS,Spermine synthase,19490,181,0.83 [0.65-1.07],0.1512870892499764
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SMTN,Smoothelin,20086,185,1.02 [0.88-1.19],0.7581751000524817
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SNAP23,Synaptosomal-associated protein 23,23167,200,0.96 [0.83-1.10],0.5478234176633269
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SNAP25,Synaptosomal-associated protein 25,19490,181,1.00 [0.74-1.36],0.98049377381452
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SNAP29,Synaptosomal-associated protein 29,23260,204,0.97 [0.85-1.12],0.7040434676677103
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SNAPIN,SNARE-associated protein Snapin,20106,189,1.05 [0.83-1.34],0.6760317700585462
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SNCA,Alpha-synuclein,19723,185,0.99 [0.88-1.12],0.8949367143872197
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SNCG,Gamma-synuclein,22961,199,0.93 [0.78-1.12],0.4745783857242854
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",19644,185,1.08 [0.71-1.64],0.7292722746991611
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SNRPB2,U2 small nuclear ribonucleoprotein B'',20115,186,0.89 [0.63-1.26],0.5192022657204296
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SNU13,NHP2-like protein 1,19464,178,0.79 [0.59-1.04],0.0903625547788676
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SNX15,Sorting nexin-15,19723,185,1.06 [0.82-1.38],0.6548040471835688
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SNX18,Sorting nexin-18,20054,186,0.95 [0.68-1.33],0.7641953601418271
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SNX2,Sorting nexin-2,20057,185,1.00 [0.84-1.18],0.9736014299428122
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SNX5,Sorting nexin-5,19644,185,1.00 [0.62-1.63],0.99221085288082
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SNX9,Sorting nexin-9,23167,200,0.97 [0.80-1.17],0.7360428578551048
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SOD1,Superoxide dismutase [Cu-Zn],22746,199,1.14 [0.88-1.47],0.3267508334316578
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SOD2,"Superoxide dismutase [Mn], mitochondrial",23193,202,1.06 [0.76-1.48],0.7229052918827384
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SOD3,Extracellular superoxide dismutase,20164,189,1.16 [0.95-1.41],0.1499955640374127
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SORBS1,Sorbin and SH3 domain-containing protein 1,20106,189,1.44 [1.14-1.80],0.0018299684315067
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SORCS2,VPS10 domain-containing receptor SorCS2,22648,194,0.95 [0.67-1.36],0.7989121841991813
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SORD,Sorbitol dehydrogenase,23244,202,1.08 [0.89-1.30],0.4532753910155727
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SORT1,Sortilin,23124,200,0.92 [0.65-1.29],0.6235655440613389
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SOST,Sclerostin,23124,200,0.73 [0.53-1.01],0.0557289365037259
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,19609,185,0.92 [0.68-1.23],0.5635191934003372
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SOX2,Transcription factor SOX-2,20062,189,0.97 [0.54-1.75],0.9192741882409738
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SOX9,Transcription factor SOX-9,19609,185,0.88 [0.52-1.49],0.6458967828697666
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,20106,189,0.97 [0.60-1.56],0.8949059189617408
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPAG1,Sperm-associated antigen 1,20106,189,1.16 [0.93-1.44],0.1908014392090666
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPARC,SPARC,23260,204,0.97 [0.81-1.15],0.6928646324092075
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPARCL1,SPARC-like protein 1,23213,202,1.36 [0.91-2.04],0.129479601174435
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPART,Spartin,19723,185,0.96 [0.79-1.15],0.6313298991973961
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPESP1,Sperm equatorial segment protein 1,20148,187,1.04 [0.67-1.60],0.85740472913496
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPINK1,Serine protease inhibitor Kazal-type 1,23193,202,0.92 [0.68-1.23],0.5598027939846166
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPINK2,Serine protease inhibitor Kazal-type 2,19723,185,1.04 [0.71-1.54],0.8285490596253191
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPINK4,Serine protease inhibitor Kazal-type 4,23111,204,0.99 [0.83-1.20],0.9536858142886306
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPINK5,Serine protease inhibitor Kazal-type 5,23193,202,1.31 [0.92-1.88],0.1392487986740289
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPINK6,Serine protease inhibitor Kazal-type 6,23353,206,0.96 [0.76-1.21],0.7418900439249616
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPINK8,Serine protease inhibitor Kazal-type 8,19464,178,1.19 [0.86-1.67],0.2944989467748005
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPINT1,Kunitz-type protease inhibitor 1,23123,202,1.20 [0.74-1.96],0.4633620735983901
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPINT2,Kunitz-type protease inhibitor 2,23265,203,0.99 [0.72-1.35],0.9427604636149512
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPINT3,Kunitz-type protease inhibitor 3,20054,186,1.02 [0.93-1.12],0.7002638758149025
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPOCK1,Testican-1,22961,199,0.93 [0.57-1.51],0.7622175264025622
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPON1,Spondin-1,23191,203,0.99 [0.68-1.45],0.9727001165403488
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPON2,Spondin-2,23058,200,1.05 [0.73-1.50],0.8055477514243006
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPP1,Osteopontin,23425,206,0.95 [0.73-1.24],0.7048991833641747
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",19556,179,0.70 [0.48-1.01],0.0594893435142801
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPRING1,SREBP regulating gene protein,19420,180,0.80 [0.60-1.07],0.1335989063304357
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPRR1B,Cornifin-B,19789,185,1.05 [0.90-1.24],0.5253926829604953
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPRR3,Small proline-rich protein 3,20115,186,1.14 [0.93-1.40],0.1967136181340915
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPRY2,Protein sprouty homolog 2,22723,200,1.00 [0.87-1.15],0.9999344826926032
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",19490,181,0.77 [0.48-1.24],0.284269188068063
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SPTLC1,Serine palmitoyltransferase 1,20115,186,0.84 [0.56-1.26],0.4112161563830833
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SRC,Proto-oncogene tyrosine-protein kinase Src,23219,203,0.98 [0.89-1.09],0.7638833744016748
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SRP14,Signal recognition particle 14 kDa protein,23056,203,0.94 [0.77-1.16],0.5816042066603373
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SRPK2,SRSF protein kinase 2,23111,204,0.99 [0.85-1.15],0.8684658991412232
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SRPX,Sushi repeat-containing protein SRPX,20148,187,1.01 [0.69-1.47],0.9679926838458068
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SSB,Lupus La protein,22634,201,0.91 [0.72-1.15],0.420907413622733
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",19556,179,0.69 [0.44-1.10],0.1225013032004558
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,23124,200,0.97 [0.87-1.09],0.6545576363519443
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,23291,204,1.30 [0.97-1.74],0.0831280745303991
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SSH3,Protein phosphatase Slingshot homolog 3,19420,180,0.53 [0.30-0.91],0.022412367046554
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SSNA1,Sjoegren syndrome nuclear autoantigen 1,20054,186,0.94 [0.71-1.24],0.6507700531762419
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ST13,Hsc70-interacting protein,19723,185,1.00 [0.78-1.28],0.9883948341053224
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",23056,203,0.96 [0.70-1.30],0.7770459852357525
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",23453,207,0.96 [0.64-1.46],0.8640067248481169
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",19556,179,0.67 [0.45-1.01],0.0555131197033721
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STAB2,Stabilin-2,20163,187,0.88 [0.53-1.44],0.6062789652149772
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STAM,Signal transducing adapter molecule 1,20057,185,1.00 [0.68-1.46],0.9848291228112416
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STAMBP,STAM-binding protein,22926,199,1.10 [0.90-1.34],0.343719158740554
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STAT2,Signal transducer and activator of transcription 2,19556,179,0.91 [0.75-1.11],0.3607104493019826
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STAT5B,Signal transducer and activator of transcription 5B,23056,203,1.01 [0.93-1.11],0.7623310733139593
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,19420,180,0.89 [0.71-1.13],0.3538672268947476
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STC1,Stanniocalcin-1,23351,205,1.12 [0.85-1.47],0.4084773402535635
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STC2,Stanniocalcin-2,23162,202,0.98 [0.59-1.64],0.9341534704093026
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STEAP4,Metalloreductase STEAP4,19490,181,0.93 [0.75-1.15],0.4889275094090289
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STIP1,Stress-induced-phosphoprotein 1,23157,202,1.07 [0.89-1.30],0.4742074225919896
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STK11,Serine/threonine-protein kinase STK11,22729,202,1.07 [0.90-1.28],0.4161235089449845
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STK24,Serine/threonine-protein kinase 24,22634,201,1.00 [0.81-1.22],0.9706936532789564
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STK4,Serine/threonine-protein kinase 4,23167,200,0.95 [0.82-1.09],0.4498877584280708
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STOML2,"Stomatin-like protein 2, mitochondrial",19420,180,0.88 [0.75-1.05],0.157369536992305
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STX16,Syntaxin-16,22648,194,1.04 [0.84-1.29],0.7218155626251286
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STX1B,Syntaxin-1B,19609,185,0.97 [0.68-1.39],0.8877048018721199
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STX3,Syntaxin-3,20115,186,0.94 [0.65-1.36],0.7536654275494739
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STX4,Syntaxin-4,23056,203,0.97 [0.78-1.20],0.747665220925942
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STX5,Syntaxin-5,19556,179,0.78 [0.52-1.16],0.2208006392846806
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STX6,Syntaxin-6,22648,194,0.88 [0.71-1.09],0.238468667656425
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STX7,Syntaxin-7,19556,179,0.88 [0.65-1.18],0.3792364553172955
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STX8,Syntaxin-8,23111,204,0.79 [0.60-1.03],0.0860363730086241
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STXBP1,Syntaxin-binding protein 1,20106,189,0.91 [0.76-1.09],0.305062562593769
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,STXBP3,Syntaxin-binding protein 3,22648,194,0.98 [0.73-1.32],0.8979154428516825
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SUGP1,SURP and G-patch domain-containing protein 1,20054,186,0.96 [0.67-1.37],0.8039012893028357
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SUGT1,Protein SGT1 homolog,22648,194,1.05 [0.89-1.23],0.569170415564662
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SULT1A1,Sulfotransferase 1A1,23351,205,0.99 [0.90-1.09],0.8989058796259306
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SULT2A1,Bile salt sulfotransferase,23111,204,0.87 [0.69-1.12],0.2813318954641969
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SUMF1,Formylglycine-generating enzyme,19556,179,1.06 [0.87-1.31],0.5546224447739702
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,23351,205,0.96 [0.76-1.21],0.7142017559865292
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SUOX,"Sulfite oxidase, mitochondrial",20106,189,0.96 [0.77-1.21],0.7397723996488794
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SUSD1,Sushi domain-containing protein 1,22729,202,1.01 [0.78-1.30],0.9631274822605892
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SUSD2,Sushi domain-containing protein 2,23193,202,1.06 [0.69-1.64],0.7938241364494985
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SUSD4,Sushi domain-containing protein 4,20057,185,1.12 [0.81-1.55],0.5038470242822171
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SUSD5,Sushi domain-containing protein 5,19607,185,0.86 [0.57-1.30],0.4812691118592368
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SV2A,Synaptic vesicle glycoprotein 2A,19609,185,0.92 [0.73-1.17],0.5065247089499922
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SWAP70,Switch-associated protein 70,20054,186,0.62 [0.40-0.97],0.0371420342432006
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SYAP1,Synapse-associated protein 1,19723,185,1.04 [0.81-1.33],0.7662234647229578
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,19490,181,1.19 [0.96-1.46],0.1078403036502363
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SYT1,Synaptotagmin-1,20115,186,1.09 [0.80-1.49],0.6004981532996486
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,SYTL4,Synaptotagmin-like protein 4,20148,187,1.03 [0.85-1.24],0.7777060945964058
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,19789,185,1.01 [0.88-1.15],0.9116496045872728
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TACC3,Transforming acidic coiled-coil-containing protein 3,23056,203,1.01 [0.91-1.12],0.8848768102791084
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TACSTD2,Tumor-associated calcium signal transducer 2,20462,175,1.07 [0.68-1.70],0.7635671367147898
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TADA3,Transcriptional adapter 3,20057,185,0.84 [0.58-1.20],0.3307387781801342
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TAFA5,Chemokine-like protein TAFA-5,23056,203,0.88 [0.63-1.24],0.4808560335660529
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TAGLN3,Transgelin-3,19420,180,0.83 [0.64-1.06],0.1352031845235413
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TALDO1,Transaldolase,20077,187,1.05 [0.77-1.44],0.7567343073937787
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TANK,TRAF family member-associated NF-kappa-B activator,22723,200,1.05 [0.88-1.26],0.5742734855350162
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TAP1,Antigen peptide transporter 1,19789,185,0.78 [0.58-1.05],0.0995359316489937
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TARBP2,RISC-loading complex subunit TARBP2,22634,201,1.05 [0.89-1.23],0.5864948418836351
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",19609,185,0.94 [0.78-1.14],0.5529255114936558
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",20057,185,0.81 [0.55-1.19],0.2795069012786392
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TAX1BP1,Tax1-binding protein 1,20115,186,0.96 [0.76-1.20],0.7135535353687216
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TBC1D17,TBC1 domain family member 17,22634,201,1.05 [0.80-1.38],0.7353307354712613
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TBC1D23,TBC1 domain family member 23,23056,203,0.97 [0.85-1.12],0.718471571013874
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TBC1D5,TBC1 domain family member 5,23111,204,0.94 [0.80-1.10],0.4450856746995614
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TBCA,Tubulin-specific chaperone A,19723,185,0.98 [0.82-1.15],0.7707243116854435
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TBCB,Tubulin-folding cofactor B,22961,199,1.04 [0.92-1.19],0.5142305580212726
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TBCC,Tubulin-specific chaperone C,22961,199,1.08 [0.93-1.27],0.3171916223841427
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TBL1X,F-box-like/WD repeat-containing protein TBL1X,22648,194,0.98 [0.84-1.14],0.7993071233652003
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TBR1,T-box brain protein 1,19609,185,1.15 [0.89-1.48],0.2840134327080958
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TCL1A,T-cell leukemia/lymphoma protein 1A,22938,198,0.99 [0.87-1.12],0.8315262658104557
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TCL1B,T-cell leukemia/lymphoma protein 1B,22729,202,1.05 [0.91-1.21],0.522868736268008
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TCN1,Transcobalamin-1,19746,185,0.81 [0.53-1.24],0.3390626732619259
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TCN2,Transcobalamin-2,23425,206,0.73 [0.49-1.10],0.1348988387970579
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TCOF1,Treacle protein,20148,187,0.89 [0.56-1.42],0.6368991196093494
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TCP11,T-complex protein 11 homolog,19789,185,0.87 [0.65-1.15],0.3285513609584169
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TCTN3,Tectonic-3,20148,187,0.89 [0.56-1.42],0.614565044599745
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TDGF1,Teratocarcinoma-derived growth factor 1,22634,201,1.02 [0.94-1.11],0.5934068705703144
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TDO2,"Tryptophan 2,3-dioxygenase",19609,185,0.81 [0.53-1.22],0.3116941472797566
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TDP1,Tyrosyl-DNA phosphodiesterase 1,20057,185,0.99 [0.81-1.20],0.887387938715355
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TDRKH,Tudor and KH domain-containing protein,22634,201,1.01 [0.87-1.17],0.9442155255195288
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TEF,Thyrotroph embryonic factor,19464,178,1.00 [0.71-1.39],0.9807214814086042
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TEK,Angiopoietin-1 receptor,23260,204,1.35 [0.77-2.37],0.3000563172594661
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TERF1,Telomeric repeat-binding factor 1,19556,179,0.45 [0.26-0.77],0.0038937757951266
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TET2,Methylcytosine dioxygenase TET2,19741,184,1.01 [0.88-1.16],0.8546461570442101
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TEX101,Testis-expressed protein 101,19609,185,0.90 [0.69-1.17],0.4357740918895671
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TEX33,Testis-expressed protein 33,19789,185,0.73 [0.47-1.14],0.1658184644816148
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TF,Serotransferrin,20182,187,1.16 [0.61-2.23],0.6502839550864072
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TFAP2A,Transcription factor AP-2-alpha,19490,181,0.99 [0.78-1.26],0.9586566941611714
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TFF1,Trefoil factor 1,23072,202,1.02 [0.88-1.19],0.7903176707623003
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TFF2,Trefoil factor 2,23224,203,1.01 [0.82-1.26],0.9041782966363154
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TFF3,Trefoil factor 3,23162,202,1.17 [0.88-1.55],0.2771018640401103
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TFPI,Tissue factor pathway inhibitor,23136,204,1.48 [1.04-2.13],0.0316257822516004
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TFPI2,Tissue factor pathway inhibitor 2,23199,204,0.89 [0.63-1.26],0.5102266053464912
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TFRC,Transferrin receptor protein 1,23278,203,1.06 [0.76-1.47],0.7366633415166216
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TG,Thyroglobulin,20057,185,1.01 [0.89-1.14],0.8648215774017806
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TGFA,Protransforming growth factor alpha,23111,204,0.97 [0.74-1.27],0.8248510941911498
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TGFB1,Transforming growth factor beta-1 proprotein,23359,205,0.84 [0.61-1.17],0.3127579715729075
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TGFB2,Transforming growth factor beta-2 proprotein,20057,185,0.96 [0.73-1.26],0.7815794038048179
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TGFBI,Transforming growth factor-beta-induced protein ig-h3,23059,204,0.98 [0.62-1.56],0.9450381475024532
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TGFBR1,TGF-beta receptor type-1,19556,179,0.99 [0.51-1.92],0.9704782347560544
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TGFBR2,TGF-beta receptor type-2,23260,204,1.03 [0.72-1.49],0.8581151354969714
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TGFBR3,Transforming growth factor beta receptor type 3,23453,207,0.79 [0.54-1.15],0.2117278497092819
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TGM2,Protein-glutamine gamma-glutamyltransferase 2,23136,200,1.03 [0.88-1.22],0.7009894279403424
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TGOLN2,Trans-Golgi network integral membrane protein 2,20164,189,1.10 [0.66-1.85],0.7098763308048378
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,THAP12,52 kDa repressor of the inhibitor of the protein kinase,19390,180,0.97 [0.82-1.15],0.7575169549081293
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,THBD,Thrombomodulin,23167,200,0.93 [0.60-1.43],0.7422980045542606
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,THBS2,Thrombospondin-2,23193,202,1.04 [0.74-1.45],0.8220829391584978
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,THBS4,Thrombospondin-4,23204,204,1.52 [1.16-1.99],0.0023376487125553
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,THOP1,Thimet oligopeptidase,23042,199,1.22 [0.82-1.81],0.3325827465037259
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,THPO,Thrombopoietin,22729,202,0.78 [0.56-1.08],0.130991594636554
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,THRAP3,Thyroid hormone receptor-associated protein 3,19464,178,0.87 [0.74-1.02],0.0907869284306883
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,THSD1,Thrombospondin type-1 domain-containing protein 1,19403,177,0.67 [0.42-1.05],0.0833842736837633
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,THTPA,Thiamine-triphosphatase,20025,185,0.99 [0.84-1.17],0.92378914182996
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,THY1,Thy-1 membrane glycoprotein,23351,205,1.26 [0.83-1.92],0.2828657561085274
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TIA1,Nucleolysin TIA-1 isoform p40,22468,195,1.03 [0.92-1.14],0.626686957805932
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TIE1,Tyrosine-protein kinase receptor Tie-1,23453,207,1.14 [0.83-1.55],0.4159618293953303
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",22599,201,0.93 [0.71-1.22],0.5829673694626929
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,19789,185,0.76 [0.50-1.14],0.1813858424183972
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,23291,204,1.23 [0.93-1.63],0.14813838695559
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,20148,187,0.88 [0.62-1.26],0.4971435731881808
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,20115,186,0.99 [0.84-1.17],0.9289557114774492
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TIMP1,Metalloproteinase inhibitor 1,22946,202,1.40 [0.92-2.12],0.1153828441717716
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TIMP2,Metalloproteinase inhibitor 2,20148,187,0.63 [0.33-1.21],0.1652253139799916
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TIMP3,Metalloproteinase inhibitor 3,23265,203,1.00 [0.91-1.09],0.9307112941705712
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TIMP4,Metalloproteinase inhibitor 4,23193,202,1.00 [0.74-1.36],0.99703534036618
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TINAGL1,Tubulointerstitial nephritis antigen-like,23090,200,1.32 [0.75-2.32],0.3441254280591217
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TJAP1,Tight junction-associated protein 1,23260,204,1.00 [0.86-1.16],0.9882493519065072
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TJP3,Tight junction protein ZO-3,19490,181,0.92 [0.65-1.32],0.6571004542694293
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TK1,"Thymidine kinase, cytosolic",19789,185,0.78 [0.54-1.11],0.1601091632716408
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TLR1,Toll-like receptor 1,19556,179,0.89 [0.51-1.54],0.6733725999419722
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TLR2,Toll-like receptor 2,19789,185,0.71 [0.39-1.30],0.2687445049308594
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TLR3,Toll-like receptor 3,23393,205,0.95 [0.78-1.16],0.6056422053160605
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TLR4,Toll-like receptor 4,19556,179,0.68 [0.40-1.13],0.1380287670810263
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,19609,185,1.08 [0.84-1.38],0.5504902532670963
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TMED1,Transmembrane emp24 domain-containing protein 1,19789,185,0.98 [0.75-1.27],0.8581102634046295
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TMED10,Transmembrane emp24 domain-containing protein 10,19464,178,0.96 [0.70-1.33],0.825805701414528
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TMED4,Transmembrane emp24 domain-containing protein 4,19464,178,0.95 [0.73-1.24],0.7178903172969056
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TMED8,Protein TMED8,20054,186,0.98 [0.85-1.12],0.7484374500833282
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TMEM106A,Transmembrane protein 106A,20057,185,0.91 [0.74-1.12],0.3567089652954123
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TMEM132A,Transmembrane protein 132A,19644,185,0.91 [0.73-1.15],0.4369403477336399
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TMEM25,Transmembrane protein 25,20106,189,1.09 [0.82-1.45],0.5522419326168977
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TMOD4,Tropomodulin-4,19420,180,1.12 [0.79-1.58],0.5401275024072356
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TMPRSS11B,Transmembrane protease serine 11B,19490,181,0.94 [0.77-1.15],0.5325373816343497
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TMPRSS11D,Transmembrane protease serine 11D,20086,186,0.79 [0.55-1.14],0.2038269888742185
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TMPRSS15,Enteropeptidase,23056,203,0.93 [0.81-1.07],0.3352019436918984
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TMPRSS5,Transmembrane protease serine 5,22862,198,1.37 [0.98-1.91],0.0638340195574027
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TMSB10,Thymosin beta-10,23193,202,1.04 [0.88-1.23],0.6493171547395726
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNC,Tenascin,23291,204,1.02 [0.79-1.32],0.8611712952180747
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNF,Tumor necrosis factor,22700,202,1.20 [0.90-1.59],0.2179420697797331
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,20054,186,0.98 [0.73-1.32],0.900365217215092
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,22723,200,0.93 [0.66-1.32],0.6963396853445301
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,19723,185,0.94 [0.74-1.18],0.570922089410863
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,22961,199,1.04 [0.72-1.52],0.8258806785113911
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,22961,199,1.15 [0.90-1.47],0.257863042095534
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,23248,205,0.76 [0.60-0.97],0.0277215168532238
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,23393,205,0.93 [0.68-1.27],0.6534227587652605
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,23156,203,1.21 [0.79-1.86],0.374988866976632
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,23260,204,1.27 [0.91-1.78],0.1622589587361186
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,23191,203,0.91 [0.64-1.31],0.6214503863549788
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,22723,200,1.06 [0.79-1.42],0.6990036157461406
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,23191,203,1.09 [0.73-1.63],0.6593562709716798
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,19723,185,0.80 [0.57-1.12],0.1869318384818044
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,23353,206,1.00 [0.69-1.45],0.9912196510016515
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,23193,202,1.21 [0.82-1.79],0.3396804671119577
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,23193,202,1.06 [0.77-1.47],0.723031088957277
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,23351,205,0.95 [0.61-1.49],0.8269012626163259
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,23359,205,1.08 [0.79-1.48],0.6251392467949235
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,22961,199,0.97 [0.78-1.22],0.8214425973434265
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,23351,205,1.05 [0.81-1.38],0.7042347626412215
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,22961,199,1.07 [0.81-1.42],0.6265714263389588
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFSF10,Tumor necrosis factor ligand superfamily member 10,23393,205,0.73 [0.45-1.19],0.2070113896958056
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFSF11,Tumor necrosis factor ligand superfamily member 11,23111,204,0.99 [0.81-1.22],0.9277750095533288
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFSF12,Tumor necrosis factor ligand superfamily member 12,23393,205,1.07 [0.69-1.66],0.7530435741447743
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFSF13,Tumor necrosis factor ligand superfamily member 13,23265,203,1.39 [0.89-2.19],0.1503619966741203
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,23423,207,1.10 [0.71-1.68],0.6753527113358816
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFSF14,Tumor necrosis factor ligand superfamily member 14,22961,199,0.99 [0.80-1.23],0.9329281647092926
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNFSF8,Tumor necrosis factor ligand superfamily member 8,20163,187,0.86 [0.58-1.27],0.4521929341612015
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNIP1,TNFAIP3-interacting protein 1,20115,186,1.03 [0.88-1.21],0.7231344708552491
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNN,Tenascin-N,20163,187,1.02 [0.74-1.40],0.9155458905081176
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNNI3,"Troponin I, cardiac muscle",22729,202,1.02 [0.88-1.19],0.7740275251294919
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNPO1,Transportin-1,19789,185,0.62 [0.41-0.94],0.0245091341184279
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNR,Tenascin-R,22961,199,0.93 [0.69-1.26],0.6579531997352028
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TNXB,Tenascin-X,23193,202,0.80 [0.50-1.30],0.3773777782966764
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,20148,187,0.98 [0.81-1.17],0.806783637563666
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TOP1,DNA topoisomerase 1,20054,186,1.09 [0.96-1.24],0.1724363667857814
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TOP1MT,"DNA topoisomerase I, mitochondrial",19420,180,0.90 [0.66-1.23],0.5177012552384777
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TOP2B,DNA topoisomerase 2-beta,19556,179,0.97 [0.81-1.17],0.7610424604374402
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TOR1AIP1,Torsin-1A-interacting protein 1,19644,185,0.95 [0.72-1.25],0.7176318009452332
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TP53,Cellular tumor antigen p53,22648,194,0.91 [0.67-1.22],0.5175988000017713
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TP53BP1,TP53-binding protein 1,19556,179,0.88 [0.74-1.05],0.1476286103593928
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TP53I3,Quinone oxidoreductase PIG3,19296,181,1.07 [0.81-1.40],0.6281623955728215
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TP53INP1,Tumor protein p53-inducible nuclear protein 1,22729,202,0.99 [0.67-1.48],0.9719629283819856
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TP73,Tumor protein p73,19609,185,0.93 [0.61-1.41],0.7302202570164089
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TPBGL,Trophoblast glycoprotein-like,19609,185,0.84 [0.58-1.20],0.3350484180347618
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TPD52L2,Tumor protein D54,19723,185,0.97 [0.85-1.11],0.6990234591369644
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TPK1,Thiamin pyrophosphokinase 1,20148,187,0.67 [0.40-1.12],0.127471680685449
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TPM3,Tropomyosin alpha-3 chain,19464,178,1.27 [0.94-1.70],0.1146388763979761
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TPMT,Thiopurine S-methyltransferase,22648,194,1.13 [0.95-1.33],0.1662189192562686
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TPP1,Tripeptidyl-peptidase 1,22998,202,1.05 [0.80-1.37],0.7470658153989882
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TPPP2,Tubulin polymerization-promoting protein family member 2,19789,185,1.00 [0.84-1.20],0.9801906052397378
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TPPP3,Tubulin polymerization-promoting protein family member 3,22634,201,1.11 [0.83-1.49],0.4781388322150097
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TPR,Nucleoprotein TPR,19464,178,1.06 [0.81-1.38],0.6939373927411473
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TPRKB,EKC/KEOPS complex subunit TPRKB,19420,180,0.80 [0.62-1.05],0.1039416113183048
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TPSAB1,Tryptase alpha/beta-1,23359,205,0.96 [0.76-1.21],0.7359678486458365
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TPSD1,Tryptase delta,20106,189,0.80 [0.53-1.21],0.2868934738946229
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TPSG1,Tryptase gamma,19556,179,0.57 [0.32-1.02],0.0581755923688318
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TPT1,Translationally-controlled tumor protein,22723,200,0.95 [0.78-1.17],0.6430403579398352
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TRAF2,TNF receptor-associated factor 2,23111,204,0.97 [0.81-1.16],0.7455985840685411
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TRAF3,"TNF receptor-associated factor 3, Isoform 2",19556,179,0.91 [0.61-1.36],0.6528250643708906
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,19464,178,0.97 [0.71-1.32],0.8342491412003816
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,19789,185,0.91 [0.77-1.08],0.2947228631774224
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TREH,Trehalase,20163,187,0.90 [0.75-1.09],0.277363320065681
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TREM2,Triggering receptor expressed on myeloid cells 2,23156,203,0.89 [0.70-1.14],0.3582981307914503
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TREML1,Trem-like transcript 1 protein,20164,189,0.91 [0.70-1.19],0.4852199325221984
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TREML2,Trem-like transcript 2 protein,23193,202,0.97 [0.67-1.39],0.8517451899012531
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TRIAP1,TP53-regulated inhibitor of apoptosis 1,23353,206,1.05 [0.86-1.29],0.6052316365246688
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TRIM21,E3 ubiquitin-protein ligase TRIM21,23111,204,1.01 [0.86-1.19],0.8932279168402016
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TRIM24,Transcription intermediary factor 1-alpha,19757,185,0.92 [0.73-1.15],0.4596298865976033
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,20054,186,0.96 [0.85-1.10],0.5909416602202122
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TRIM26,Tripartite motif-containing protein 26,19420,180,0.79 [0.59-1.05],0.1068162780669859
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TRIM40,E3 ubiquitin ligase TRIM40,19609,185,1.02 [0.83-1.24],0.8722937876918021
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TRIM5,Tripartite motif-containing protein 5,23111,204,1.01 [0.88-1.17],0.8445196299327286
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TRIM58,E3 ubiquitin-protein ligase TRIM58,20057,185,0.99 [0.84-1.16],0.8775406855924344
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TRPV3,Transient receptor potential cation channel subfamily V member 3,19464,178,0.81 [0.59-1.13],0.2225439814379747
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TSC1,Hamartin,19556,179,0.79 [0.62-1.02],0.0662795045358949
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TSC22D1,TSC22 domain family protein 1,20106,189,1.07 [0.87-1.31],0.5364931669802533
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TSHB,Thyrotropin subunit beta,23167,200,0.95 [0.81-1.11],0.5221106305359953
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TSLP,Thymic stromal lymphopoietin,22729,202,0.85 [0.67-1.08],0.182086840224773
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TSNAX,Translin-associated protein X,19464,178,1.14 [0.79-1.63],0.4828147295252656
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TSPAN1,Tetraspanin-1,22729,202,1.06 [0.90-1.25],0.5020192389505475
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TSPAN15,Tetraspanin-15,19464,178,1.10 [0.85-1.42],0.4828716426624979
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TSPAN7,Tetraspanin-7,19490,181,0.98 [0.84-1.15],0.8277802790482649
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TSPAN8,Tetraspanin-8,20054,186,1.04 [0.90-1.19],0.6034807469707902
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TSPYL1,Testis-specific Y-encoded-like protein 1,19556,179,0.78 [0.53-1.14],0.1942994709734483
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TST,Thiosulfate sulfurtransferase,22590,201,1.03 [0.87-1.22],0.7381533652897101
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TTF2,Transcription termination factor 2,19609,185,1.06 [0.80-1.42],0.6752323622614673
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TTN,Titin,19464,178,1.14 [0.94-1.38],0.1726691240420549
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TTR,Transthyretin,19965,186,1.21 [0.68-2.14],0.5157631482763771
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TUBB3,Tubulin beta-3 chain,19490,181,0.78 [0.46-1.32],0.3603980885828911
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TWF2,Twinfilin-2,20163,187,0.94 [0.79-1.11],0.4711236786104266
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TXK,Tyrosine-protein kinase TXK,19789,185,1.13 [0.97-1.33],0.127386557267738
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TXLNA,Alpha-taxilin,22961,199,1.04 [0.90-1.20],0.5876374590114979
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TXN,Thioredoxin,19828,186,0.96 [0.69-1.32],0.7860835436598588
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TXNDC15,Thioredoxin domain-containing protein 15,23260,204,0.81 [0.51-1.28],0.3704111471315966
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TXNDC5,Thioredoxin domain-containing protein 5,23351,205,0.97 [0.81-1.17],0.7551950635041396
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TXNDC9,Thioredoxin domain-containing protein 9,20115,186,0.93 [0.71-1.22],0.5909394537320053
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TXNL1,Thioredoxin-like protein 1,19451,180,0.92 [0.79-1.08],0.3042435745326854
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",23193,202,1.04 [0.79-1.36],0.7993822475528292
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TYMP,Thymidine phosphorylase,23013,199,0.94 [0.77-1.14],0.5099560852578067
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TYRO3,Tyrosine-protein kinase receptor TYRO3,23167,200,0.66 [0.43-1.02],0.0641326770434228
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",19556,179,0.99 [0.79-1.24],0.9199067497718432
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UBAC1,Ubiquitin-associated domain-containing protein 1,23056,203,1.00 [0.70-1.43],0.993735637796888
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UBE2B,Ubiquitin-conjugating enzyme E2 B,20057,185,0.91 [0.56-1.47],0.6890310732840456
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,20148,187,0.92 [0.73-1.16],0.4953223981790416
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,19556,179,0.80 [0.60-1.06],0.1155972253698317
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UBQLN3,Ubiquilin-3,19464,178,1.10 [0.86-1.41],0.4435586875860156
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UBXN1,UBX domain-containing protein 1,19723,185,0.97 [0.79-1.20],0.7689966068839507
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,20054,186,1.00 [0.91-1.11],0.9521035250489024
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UGDH,UDP-glucose 6-dehydrogenase,19464,178,0.89 [0.75-1.05],0.1729817846567345
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UHRF2,E3 ubiquitin-protein ligase UHRF2,19464,178,0.97 [0.64-1.48],0.9025210600589614
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ULBP2,UL16-binding protein 2,22961,199,1.20 [0.87-1.66],0.2620522201922166
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UMOD,Uromodulin,23387,207,1.16 [0.91-1.46],0.2279986639658671
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UNC5D,Netrin receptor UNC5D,19556,179,0.51 [0.29-0.92],0.024833472733786
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UNC79,Protein unc-79 homolog,19420,180,0.91 [0.69-1.19],0.4786473785698725
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UNG,Uracil-DNA glycosylase,20057,185,0.74 [0.48-1.14],0.1665515734140831
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UPB1,Beta-ureidopropionase,20148,187,1.08 [0.92-1.26],0.3402010162886536
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UPK3A,Uroplakin-3a,19490,181,1.00 [0.76-1.33],0.9810672096266722
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UPK3BL1,Uroplakin-3b-like protein 1,19744,185,0.83 [0.60-1.14],0.2447561908352364
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UROD,Uroporphyrinogen decarboxylase,19723,185,0.98 [0.80-1.20],0.8415074129770057
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UROS,Uroporphyrinogen-III synthase,19609,185,0.98 [0.79-1.21],0.8342864989836701
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,USO1,General vesicular transport factor p115,23056,203,1.03 [0.90-1.18],0.6648698860819147
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,USP25,Ubiquitin carboxyl-terminal hydrolase 25,20057,185,0.99 [0.81-1.21],0.925365934045439
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,USP28,Ubiquitin carboxyl-terminal hydrolase 28,20115,186,1.07 [0.74-1.54],0.727865345655434
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,USP47,Ubiquitin carboxyl-terminal hydrolase 47,19464,178,0.90 [0.75-1.08],0.2521817745664931
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,USP8,Ubiquitin carboxyl-terminal hydrolase 8,22729,202,1.00 [0.87-1.14],0.9483447625552476
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,UXS1,UDP-glucuronic acid decarboxylase 1,22648,194,1.24 [0.99-1.54],0.0589219738663092
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VAMP5,Vesicle-associated membrane protein 5,22729,202,0.93 [0.73-1.18],0.5337957657139227
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VAMP8,Vesicle-associated membrane protein 8,19556,179,0.96 [0.82-1.14],0.6461262950431261
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VASH1,Tubulinyl-Tyr carboxypeptidase 1,23111,204,0.98 [0.84-1.14],0.7804512761829725
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VASN,Vasorin,22823,201,1.31 [0.83-2.08],0.2505431207761579
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VASP,Vasodilator-stimulated phosphoprotein,20164,189,0.94 [0.77-1.14],0.520039537595125
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,23056,203,0.58 [0.30-1.10],0.0939267600100784
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VAV3,Guanine nucleotide exchange factor VAV3,19490,181,0.99 [0.86-1.15],0.9233890367737866
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VCAM1,Vascular cell adhesion protein 1,23243,204,1.52 [0.98-2.36],0.0589387111432427
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VCAN,Versican core protein,23351,205,0.73 [0.48-1.10],0.1293040173550953
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VCPKMT,Protein-lysine methyltransferase METTL21D,19420,180,0.83 [0.67-1.01],0.0656582633165785
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VEGFA,Vascular endothelial growth factor A,23319,205,1.04 [0.84-1.28],0.7265449602391596
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VEGFB,Vascular endothelial growth factor B,19556,179,0.86 [0.52-1.41],0.5446238776759769
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VEGFC,Vascular endothelial growth factor C,23260,204,0.99 [0.79-1.23],0.9309068152035624
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VEGFD,Vascular endothelial growth factor D,23357,205,1.04 [0.74-1.45],0.8413421529308025
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VGF,Neurosecretory protein VGF,20106,189,0.55 [0.34-0.87],0.010085657973685
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VIM,Vimentin,22729,202,0.98 [0.88-1.08],0.6555269635910009
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VIPR1,Vasoactive intestinal polypeptide receptor 1,19644,185,0.82 [0.44-1.52],0.5287623052296337
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VIT,Vitrin,20148,187,0.95 [0.66-1.38],0.7853654367080373
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VMO1,Vitelline membrane outer layer protein 1 homolog,23056,203,1.04 [0.87-1.25],0.6677508497230276
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VNN1,Pantetheinase,20164,189,0.85 [0.71-1.03],0.0961530806871924
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VNN2,Vascular non-inflammatory molecule 2,23056,203,0.93 [0.71-1.22],0.6073050000863291
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VPS28,Vacuolar protein sorting-associated protein 28 homolog,19789,185,1.02 [0.82-1.27],0.8341829554137751
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VPS37A,Vacuolar protein sorting-associated protein 37A,23056,203,1.06 [0.91-1.24],0.4429770556697288
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VPS4B,Vacuolar protein sorting-associated protein 4B,20057,185,0.97 [0.83-1.12],0.6544435215737466
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VPS53,Vacuolar protein sorting-associated protein 53 homolog,23056,203,1.01 [0.86-1.19],0.9063015222902564
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VSIG10,V-set and immunoglobulin domain-containing protein 10,20057,185,0.77 [0.49-1.21],0.254575385579187
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,19464,178,0.98 [0.63-1.52],0.915625525896956
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VSIG2,V-set and immunoglobulin domain-containing protein 2,20057,185,1.13 [0.92-1.40],0.2318896706675486
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VSIG4,V-set and immunoglobulin domain-containing protein 4,23162,202,1.08 [0.81-1.46],0.5915074851472477
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,23128,200,0.94 [0.77-1.16],0.5844382190599522
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VSNL1,Visinin-like protein 1,20115,186,1.18 [0.82-1.70],0.3711287574086001
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VSTM1,V-set and transmembrane domain-containing protein 1,22634,201,1.01 [0.79-1.29],0.9536724180620972
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VSTM2B,V-set and transmembrane domain-containing protein 2B,19789,185,0.70 [0.47-1.07],0.0969482529138975
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,22729,202,1.03 [0.83-1.27],0.8153269937940486
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,23351,205,0.97 [0.82-1.15],0.7351232228603883
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VTCN1,V-set domain-containing T-cell activation inhibitor 1,22648,194,0.90 [0.59-1.37],0.6266572721936128
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,19723,185,0.87 [0.68-1.13],0.3017550501198427
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VWA1,von Willebrand factor A domain-containing protein 1,23313,204,0.89 [0.66-1.20],0.4365744861707228
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VWA5A,von Willebrand factor A domain-containing protein 5A,19420,180,0.74 [0.58-0.96],0.021421707987453
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VWC2,Brorin,22890,199,0.88 [0.65-1.21],0.4421119515292431
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VWC2L,von Willebrand factor C domain-containing protein 2-like,20106,189,0.75 [0.52-1.10],0.1434305286809393
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,VWF,von Willebrand factor,23453,207,0.96 [0.81-1.13],0.6150385659050456
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,WARS,"Tryptophan--tRNA ligase, cytoplasmic",23193,202,0.97 [0.70-1.34],0.8338554096189317
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,WAS,Wiskott-Aldrich syndrome protein,22723,200,0.96 [0.79-1.16],0.6662313667795379
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,WASF1,Wiskott-Aldrich syndrome protein family member 1,22729,202,1.02 [0.89-1.17],0.7711404244076734
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,WASF3,Wiskott-Aldrich syndrome protein family member 3,22634,201,0.99 [0.86-1.15],0.9319540844258908
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,WASHC3,WASH complex subunit 3,20115,186,0.98 [0.81-1.18],0.8276346915123993
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,WASL,Neural Wiskott-Aldrich syndrome protein,19556,179,0.73 [0.56-0.97],0.0308485068682379
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,WDR46,WD repeat-containing protein 46,20057,185,0.77 [0.50-1.17],0.2215115653666352
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,WFDC1,WAP four-disulfide core domain protein 1,19642,183,0.99 [0.76-1.28],0.9337506828390458
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,WFDC12,WAP four-disulfide core domain protein 12,23321,206,1.03 [0.85-1.25],0.730154390853412
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,WFDC2,WAP four-disulfide core domain protein 2,22017,192,1.07 [0.78-1.46],0.6861435306125623
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",22882,198,1.30 [0.97-1.76],0.0813213975784924
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",23191,203,0.74 [0.51-1.08],0.116536084542755
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,WIF1,Wnt inhibitory factor 1,23353,206,0.81 [0.56-1.16],0.2445009222609328
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,WNT9A,Protein Wnt-9a,22723,200,1.07 [0.69-1.65],0.7573914161286052
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,22961,199,1.07 [0.85-1.35],0.5635291309120386
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,XCL1,Lymphotactin,23353,206,0.99 [0.79-1.24],0.929135642111184
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,XG,Glycoprotein Xg,23352,207,0.96 [0.67-1.38],0.8326320958830915
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,XIAP,E3 ubiquitin-protein ligase XIAP,19556,179,0.91 [0.70-1.18],0.4877646661948078
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,XPNPEP2,Xaa-Pro aminopeptidase 2,23260,204,1.00 [0.89-1.14],0.9395260183984622
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,XRCC4,DNA repair protein XRCC4,22634,201,1.00 [0.72-1.40],0.980143552382624
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,YAP1,Transcriptional coactivator YAP1,20115,186,0.99 [0.60-1.66],0.984202032452494
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",20054,186,0.98 [0.89-1.08],0.7530609387271653
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,YES1,Tyrosine-protein kinase Yes,23056,203,1.04 [0.93-1.16],0.4977033961740241
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,YJU2,Splicing factor YJU2,20057,185,0.69 [0.43-1.09],0.1139251863879714
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,YOD1,Ubiquitin thioesterase OTU1,19464,178,1.09 [0.87-1.37],0.4603576954682242
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,YTHDF3,YTH domain-containing family protein 3,22723,200,1.03 [0.89-1.20],0.689794955412316
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,YWHAQ,14-3-3 protein theta,19723,185,0.99 [0.81-1.20],0.8805407383690871
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,YY1,Transcriptional repressor protein YY1,19556,179,0.60 [0.35-1.02],0.0604139624319281
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ZBP1,Z-DNA-binding protein 1,19556,179,0.90 [0.61-1.31],0.5783164092161381
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ZBTB16,Zinc finger and BTB domain-containing protein 16,22648,194,0.98 [0.82-1.18],0.8564200415039585
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ZBTB17,Zinc finger and BTB domain-containing protein 17,22729,202,0.89 [0.65-1.22],0.4851085674046449
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ZCCHC8,Zinc finger CCHC domain-containing protein 8,19464,178,0.99 [0.78-1.26],0.9402274159704204
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ZFYVE19,Abscission/NoCut checkpoint regulator,20054,186,0.98 [0.84-1.15],0.7892728493622025
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ZHX2,Zinc fingers and homeoboxes protein 2,20115,186,0.99 [0.66-1.50],0.9687642576362148
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ZNF174,Zinc finger protein 174,19556,179,0.94 [0.63-1.40],0.7613517883832176
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ZNF75D,Zinc finger protein 75D,19789,185,1.14 [0.93-1.39],0.2092262961409239
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ZNF830,Zinc finger protein 830,20057,185,0.88 [0.71-1.07],0.2029742213652119
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ZNRD2,Protein ZNRD2,20054,186,1.12 [0.92-1.37],0.2458679193663822
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,20057,185,1.02 [0.79-1.31],0.9015733517819374
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ZP3,Zona pellucida sperm-binding protein 3,19644,185,1.00 [0.95-1.05],0.9048912082543832
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ZP4,Zona pellucida sperm-binding protein 4,19420,180,0.76 [0.46-1.27],0.2938459441362652
Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,ZPR1,Zinc finger protein ZPR1,19490,181,0.87 [0.73-1.04],0.1333441875292261
